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Cucumber mosaic virus (CMV) is a serious pathogen of many economically important 
crops. In Western Australia (WA), CMV is a serious disease of narrow-leafed lupin, 
Lupinus angustifolius, which is the main grain legume crop. There is no known natural 
resistance genes to CMV have been identified .in narrow-leafed lupin germplasm that 
can be transferred to new cultivars using classical breeding techniques. The aim of this 
project was to develop a series of molecular resistance constructs and to apply them to 
produce pathogen-derived resistance to CMV in narrow-leafed lupin. A total. of nine 
different CMV resistance gene constructs were developed. Eight constructs were based 
on the movement protein (MP), coat protein (CP) and replicase (Rep) genes of the WA 
subgroup II CMV-L Y isolate originally obtained from infected narrow-leafed lupin, and 
one was based on the CP gene of a WA subgroup I CMV isolate from banana. 
The gene constructs were cloned into the plant binary vectors pYR2 and pART27/7 
driven by promoters from subterranean clover stunt virus (pPLEX) and cauliflower 
mosaic virus (CaMV 35S) and transferred into Agrobacterium (strain: AGL0). The 
constructs were used to transform Nicotiana benthamiana and narrow-leafed lupin with 
Basta as the selectable agent. For N. benthamiana a total of 1,120 explants were 
cocultivated with A. tumefaciens containing the pART27/7 resistance gene constructs 
(80 explants per construct). Following selection in culture, 16 putative transformants 
for each construct were transferred to the glasshouse for seed production and analysis. 
PCR analysis of T 1 plants indicated that transformation had been successfully achieved 
for each of the resistance gene constructs. Transgenic plants were challenged with 
CMV and susceptibility or resistance was analysed by symptom development and 
ELISA. The results showed that some transgenic N. benthamiana plants that contained 
the Repml gene (defective CMV-LY ORF2a) were resistant to CMV-LY. In twenty­
two PCR positive T1 plants, 7 showed immunity, 12 were partially resistant, and 3 were 
susceptible to CMV-L Y infection. In contrast, the antisense defective CMV-L Y RNA 2 
construct (Repm2) did not give good resistance to CMV-LY. Three of 12 T1 plants with 
this construct were partially resistant (or had delayed symptoms) and the other nine 
were susceptible. Transgenic T1 plants containing a CMV-LY MP sense gene (MPl) 





( delayed symptoms) and two exhibited a recovery phenotype. The development of 
disease symptoms in the susceptible plants was faster than that in other transgenic and 
nontransgenic plants. Plants with the MPS transgene (untranslatable CMV-L Y MP 
gene) showed some resistance to CMV-LY. One of 11 plants was highly resistant and 
three were partially resistant to CMV-LY. Three different versions of CMV-LY CP 
gene (CPI, CP3 and CP4) were transformed into N. benthamiana and the T1 plants were 
challenged with CMV-L Y. The level of resistance varied in transgenic plants 
depending on the CP genes present. Although a limited number of transgenic plants 
have been tested so far, it appears that plants containing CP4-1 show more effective 
resistance to CMV than transgenic plants with either CPl-1 or CP3-l. This result 
appears to be the first example of the use of a mutated CP gene that is longer than the 
wild type gene product ( 12 additional amino acids) and confers resistance to CMV. 
For narrow-leafed lupin, 12,411 explants were subjected to meristem inoculation and 
cocultivated with A. tumefaciens containing a replicase construct (pYRRepml) and 
3,134 explants with a movement protein construct (pYRMPSl). One hundred and sixty 
one independent transformants survived in vitro selection and were grafted onto 
compatible nontransgenic rootstocks. Fifty nine plants survived the grafting process and 
were transferred to the glasshouse for seed production. PCR analysis of the 59 putative 
transgenic lines (To) identified 7 plants positive for the pYRRepml gene and 15 for the 
p YRMPS 1 gene. 
The complete genomic sequence of the CMV-L Y isolate was also determined. The 
RNAl molecule was determined to be 3,391 nucleotides (nt) in length and is predicted 
to contain a 5' untranslated region (UTR) of 95 nucleotides, a single open-reading frame 
(ORF) of 992 amino acids and a 3' UTR of 317 nt. The RNA2 molecule is 3,038 nt 
long and is predicted to contain a 5' UTR of 92 nt, two ORFs of 841 and 100 amino 
acids (ORF2a and ORF2b, respectively) and a 3' UTR of 423 nt. The RNA3 molecule 
is 2,003 nt long and is predicted to contain a 5' UTR of 96 nt, two ORFs of 279 and 218 
amino acids (ORF3a and ORF3b, respectively) and a 3' UTR of 322 nt. Nucleotide 
comparisons of RNAsl-3 indicate that the LY isolate shares between 70-78% and 98-
99% homology to subgroup I and subgroup II isolates, respectively. Similarly, ORFla 
iv 
shares 84-85% and 99% identity, ORF2a 81-84% and 94-96% identity, ORF2b 46-56% 
and 95-96% identity, ORF3a 82-84% and 99% identity, and ORF3b 81-83% and 99% 
identity. The sequence data clearly shows that there is a high degree of nucleotide and 
amino acid sequence homology between the CMV-L Y isolate and other CMV subgroup 
II strains. The sequence data confirms that the LY isolate belongs to CMV subgroup II. 
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Introduction and literature review 
Chapter 1 Introduction and Literature Review 
1.1 General Introduction 
Cucumber mosaic virus (CMV) is a serious pathogen of many economically important 
crops. It is distributed worldwide and is transmitted from infected to healthy plants by 
aphids. CMV is also seed-borne in some crop species (Jones, 1988; Palukaitis et al., 
1992). In Western Australia, CMV is a serious disease of grain legumes, such as 
lupins (Lupinus spp.). Virus infection can cause individual crop failures and 
widespread losses, and disrupts both breeding and trialing programs (Jones, 1988 and 
1991). 
To date, there is no known natural resistance to CMV in narrow-leafed lupin 
germplasm that can be transferred to new cultivars by classical breeding. However, 
integration of virus-encoded gene sequences into host plant genomes can provide 
resistance to pathogenic viruses in a broad range of plants. Several types of genes 
have been utilised, and protection has been conferred against a wide range of viruses 
(Beachy, 1997). The main aim of this project was to develop synthetic gene constructs 




The lupin genus, Lupinus, is comprised of more than 200 species which are distributed 
over a wide climatic range from the sub-arctic climate of Alaska, through 
mediterranean and semi-desert climates to the highlands of East Africa and the 
subtropical lowlands of eastern south America (Dracup and Kirby, 1996; Gladstones, 
1998). Although Virgil (70-19 BC) noted the benefit of rotating lupins with wheat, 
domestication from wild species into a crop plant only began in the early part of this 
century, with white (L. albus) and yellow lupin (L. luteus) in Germany (Hamblin, 
1998). In 1967, the narrow-leafed lupin (L. angustifolius) was fully domesticated by 
John Gladstones in Wes tern Australia. Since then, four additional species have been 
domesticated: L. mutabilis, L. cosentinii, L. atlanticus and L. pilosus. Of these seven 
domesticated species, L. angustifolius, L. albus, and L. luteus are the major cultivated 
lupin species. They are cultivated as summer annual seed or forage crops in regions 
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with cool climates, for instance, the USA, North Europe, and New Zealand. In regions 
with Mediterranean climates, such as South Africa, Chile, southern Australia, and the 
area surrounding the Mediterranean Sea, they are grown as a winter annual crop (Jones 
and McLean, 1989). 
1.2.2 Lupin as food 
Lupin grains are highly digestible and rich in protein (30-40%) and fibre (15-17% ), 
have a metabolisable energy content of 12.5 MJ/kg and make an excellent stockfeed 
for pigs, poultry, sheep and cattle (Hough and Jacobs, 1994; Van Barbeveld and 
Hughes, 1994; Edwards et al., 1998). Lupin seed has also been used as a soybean 
substitute in marine feed (Jenkins et al., 1994; Edwards et al., 1998) and for human 
consumption (Kyle, 1994; Petterson, 1998). The use of lupins for animal and human 
consumption is limited due to their bitter nature, which is largely caused by alkaloids. 
High levels of anti-nutritional factors (such as alkaloids, oligosaccharides, phytic acid 
and polyphenolics) can diminish the nutritive value of lupins for consumers and 
decrease their potential in the food industry. Lupins have also been shown to be an 
excellent substrate for both bacterial and fungal fermentation as used in making foods 
such as tempe (Indonesia), bread and pasta products (Australia) and milk (Petterson, 
1998). 
1.2.3 The lupin industry in Australia 
The Australian lupin industry began in Western Australia in 1967 with the release of 
the L. angustifolius cultivar "Uniwhite" by John Gladstones (Hamblin, 1998). In the 
last 30 years, the industry has grown in area from nothing to about 1.3 to 1.4 million 
ha, with production of 1.4 million tonnes (Table 1.1) (Perry et al., 1998). Western 
Australia farmers produce more than 80% of the national crop with cul ti vars of L. 
angustifolius continuing to be the major species grown (Abadi, 1994). 
The only other species grown on a commercial scale is the white lupin (L. albus). 
However, the use of this species is mostly confined to the eastern areas of Australia 
because of its requirements for fine textured, well-drained fertile soils (Gladstones, 
1994). As a result of the lupin anthracnose outbreak, caused by a fungus of the 
Colletotrichum spp., growth of L. alb us has been severely reduced since 1997. A new 
3 
- -�-�---�--�-- ���- -- -,-,---------� 
cultivar of yellow lupin (cv Wodjil), based on the reselection of the Polish cultivar 
"Teo", has been grown in Western Australia since 1998. This cultivar is grown in acid 
Wodjil soils in the Western Australian wheat-belt stretching from Mullewa to Hyden 
where L. angustifolius growth is poor. 













1969-70 5.0 5.0 
1970-71 12.0 12.0 
1971-72 27.0 27.0 
1972-73 44.0 44.0 
1973-74 64.0 64.0 
1974-75 119.0 119.0 
1975-76 122.0 122.0 
1976-77 2.4 2.9 13.5 95.9 115.0 
1977-78 10.2 6.4 13.4 57.4 87.8 
1978-79 8.3 9.1 11.0 39.0 67.6 
1979-80 30.7 15.0 13.7 46.2 105.7 
1980-81 23.2 21.7 17.8 55.1 117.9 
1981-82 17.2 25.0 21.9 96.8 161.0 
1982-83 19.1 21.0 19.1 197.4 256.7 
1983-84 22.2 16.2 21.3 318.9 378.9 
1984-85 35.3 20.1 20.7 517.3 593.7 
1985-86 46.5 24.2 23.6 492.9 587.4 
1986-87 37.1 28.0 28.9 653.1 748.1 
1987-88 57.2 37.0 43.0 876.5 1014.9 
1988-89 47.7 35.0 46.1 719.9 849.4 
1989-90 46.3 36.0 42.3 676.3 801.6 
1990-91 55.3 55.0 38.4 664.8 758.9 
1991-92 66.5 47.7 786.6 900.8 
1992-93 99.0 37.0 58.0 823.0 1017.0 
1993-94 80.0 53.0 57.0 900.0 1090.0 
1994-95 912.5 
1995-96 80.0 30.0 65.0 1105.0 1280.0 
* Area sown in (ha). 1. Production in Queensland and Tasmania has been less than
1000 ha in each year. 2. NSW = New South Wales, VIC = Victoria, SA = South
Australia, WA = Western Australia. (Adapted from Perry et al., 1998.) 
1.2.4 CMV disease in lupins 
At least seventeen viral and mycoplasma-like diseases are known to affect lupin (Piche 
et al., 1993). Two virus diseases pose a serious threat to lupins in Western Australia, 
and these are caused by CMV and bean yellow mosaic virus (BYMV) (Jones, 1988, 
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1991). CMV causes a serious disease of narrow-leafed lupins (L. angustifolius) which 
can result in crop failure, widespread loss of yield, and its presence also disrupts 
breeding and experimental programs (Bwye et al., 1995). In Western Australia, 
districts most at risk from CMV in lupins include the high rainfall zones of Geraldton, 
Three Springs, Moora, Northam, Esperance, Jerramungup and Albany. The virus 
decreases both grain yield and grain size. Yield loss varies but can exceed 50% in 
severely affected crops (Jones, 1994). Low rainfall areas are generally low risk, but 
the virus causes problems in medium rainfall zones in years when aphids arrive early 
and are active for the rest of the growing season (Bwye et al., 1995). 
1.2.4.1 Symptoms 
Plants grown from infected seeds are severely stunted and may have one or more of 
the following symptoms: leaf-bunching, downcurling, faint mottling. When plant 
density is high and the crop matures, the seed-infected plants are often shaded out by 
the surrounding healthy plants and die. In sparse stands, they persist through to the 
end of the growing season and provide a source of infection for aphids to pick up and 
spread the virus (Jones, 1994). Plants infected in the current-season have similar 
symptoms to those of seed-borne infected plants at the shoot tips or higher up the 
plant, whereas the lower leaves which developed before infection keep their normal 
appearance. When very young seedlings are infected, all the leaves may show 
symptoms resembling seed-borne infection. In general, however, the presence of 
normal lower leaves can be used to help to distinguish current-season from seed-borne 
infection (Jones, 1994; Bwye et al., 1995). Symptoms of seed-borne and early current­
season CMV infection in yellow lupin are similar to those in narrow-leafed lupins but 
more severe. However, symptoms are very difficult to see in late-current season 
infected yellow lupin plants (Bwye et al., 1995). 
1.2.4.2 Virus spread 
Aphid vectors
Aphids transmit CMV in a non-persistent manner during feeding. The common 
colonising aphids on lupins are the green peach (Myzus persicae ), blue-green 
(Acyrthosiphon kondoi) and cowpea (Aphis craccivora) aphids. The green peach and 
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cowpea aphids transmit CMV more efficiently than the blue-green aphid (Bwye et al., 
1995). 
Seed transmission 
CMV is seed-borne in narrow-leafed (Jones, 1988) and yellow lupins (cited by 
Palukaitis et al., 1992). Rates of seed transmission to seedlings vary with genotype 
from 5 to 20%, but may reach 75% or more in some genotypes (Jones and Latham, 
1996). Plants that grow from infected seed act as the major source of CMV 
acquisition and spread by aphid vectors (Sweetingham et al., 1998). 
Weed species 
CMV is seed-borne at low levels in naturalised burr medic, rufous stonecrop and 
subterranean clover. Seed of these species may occasionally act as a reservoir for the 
virus to persist though the dry summer period. Weed species such as rufous stonecrop, 
fumitory, certain wild clovers and volunteer subterranean clover readily become 
infected with CMV from infected lupins when growing in the same paddock. Then, 
they may then contribute to subsequent current-season spread within the lupin crop 
(Bwye et al., 1995). 
1.2.4.3 Strategies used for control of CMV in agriculture 
Certification of CMV clean seed 
One of the most important approaches to minimise the source of CMV infection is to 
use CMV-free seeds, and to rogue any plants that subsequently become infected. An 
example is the lupin seed diagnosis program for CMV by Agriculture Wes tern 
Australia and now run commercially by Biotest. Both enzyme-linked immunosorbent 
assay (ELISA) (Jones and McK.irdy, 1990) and reverse transcription-polymerase chain 
reaction (RT-PCR) assays (Wylie et al., 1993) have been developed and successfully 
applied to detect low amounts of seed-borne virus. More recently, a real time 
quantitative fluorescence PCR assay for CMV has also been developed (Dr. D. 
Berryman, personal communication). This assay is faster and more reliable than RT­
PCR and is being used to detect CMV in lupin seeds by Biotest at Murdoch 
University. 
Aphid control 
Insecticide sprays are an effective means of controlling aphid populations. However, 
insecticides often do not act fast enough to prevent inoculation of lupin by CMV, 
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which is transmitted during the initial probing phase of aphids on host plants. 
Nevertheless, insecticide treatments can reduce disease incidence by killing aphids 
before they have had enough time to move to another plant. 
Effective control of aphid numbers and consequentially low disease incidence can be 
achieved if winged aphid forms are kept at low levels. It has been found that CMV 
epidemics correlate positively with high aphid movement. In temperate regions like 
those of the Mediterranean basin, this usually occurs after mild winters or after high 
spring rainfall followed by a rapid temperature increase. These conditions greatly 
favour reproduction in aphid colonies that rapidly reach a crowded stage, and lead to 
emergence of numerous winged forms. Such colonies often develop on weeds that can 
also be virus reservoirs and therefore their destruction is a valid means for controlling 
and preventing virus outbreaks. In this case, weeds should be eliminated from the 
field at least one week before planting. This measure has been effective in reducing 
incidence of CMV in celery, cucumber and lettuce (Rist et al., 1988). To be really 
effective, this approach should be applied over large areas where CMV outbreaks 
correlate with infected weed rather than in the crop itself. 
Agricultural practices 
The potential of controlling CMV diseases by agronomic practices must be also 
considered in crop production. For instance, a dense canopy and continuous ground 
cover can be obtained by sowing lupins early at high seeding rate (more than 100 
kg/ha) to shade out the less competitive CMV seed-infected lupins that provide the 
source of virus infection (Bwye et al., 1995). 
Breeding for resistant cultivars 
The use of resistant varieties of plants, if available, is an effective strategy to minimise 
losses caused by virus diseases. So far, breeding for resistance to CMV has been 
successful for some crops including spinach, pepper and some cucurbits. Nono­
Womdim et al. (1993) studied multiplication and systemic invasion of CMV in 
susceptible and tolerant lines of pepper (Womdim et al., 1993). The lines "Perennial" 
and "Vania" were tolerant to CMV infection because Vania inhibited virus movement 
to uninoculated leaves and Perennial did not support viral multiplication. Through 
recurrent selection, tolerance has been introduced into commercial Fl hybrid pepper 
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that are also resistant to common strains of PVY and tobacco mosaic tobamovirus 
(TMV). New CMV-tolerant pepper lines were developed by Hobbs et al. (1995). 
1.3 CMV 
1.3.1 Introduction 
CMV was first reported in 1916 as the causal agent of a disease of cucumber and 
muskmelon in Michigan, USA (cited by Palukaitis et al., 1992). Since then, CMV has 
been reported in many countries around the world, especially in temperate regions, but 
has been reported to be increasingly important in tropical environments (Palukaitis et 
al., 1992). CMV probably has the largest host range of any virus. It infects over 800 
plant species in 365 genera from no less than 85 botanical families, including both 
monocotyledonous and dicotyledonous plants (Kaper and Waterworth, 1981; Rizzo et 
al., 1988). There are many strains of CMV that show differences in either symptoms 
or in host ranges (Kaper and Waterworth, 1981). 
CMV has been identified as the causal agent of several disease epidemics. Tomlinson 
(1987) identified CMV as the first virus of economic importance in celery, cowpea, 
cucurbit, lettuce, pepper, and tomato crops. CMV also causes severe diseases in 
banana and pasture legumes (Palukaitis et al., 1992). Tricoli et al. (1995) reported that 
CMV was the most damaging virus of the squash crop. In the Mediterranean basin the 
economic importance of CMV correlates with recurrent outbreaks in canning tomato 
crops (Gallitelli et al., 1995). Since tomato necrosis disease, which is caused by CMV, 
occurred in Alsace (France) in 1972, tomato diseases induced by CMV sudden! y 
became important in Italy and Spain in 1987 (Jorda et al., 1992) where the virus 
caused up to 100% crop losses in the main production areas. 
1.3.2 Taxonomy of CMV 
CMV is the type member of the genus cucumovirus in the family Bromoviridae 
(Ribicki, 1995) (Fig 1.1). The Cucumoviruses are similar in particle morphology, 
vector transmission, genome organisation, and can be differentiated by serological 
detection, host range, and by the molecular weight and nucleic acid sequences of their 
viral RNAs (Habili et al., 1974; Kaper and Waterworth, 1981; Diaz-Ruiz et al., 1983). 
Cucumoviruses are classified into three species based on biological, physio-chemical, 
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and serological relationships: CMV, peanut stunt cucumovirus (PSV), and tomato 
aspermy cucumovirus (TA V) (Harrison et al., 1971; Kaper and Waterworth, 1981; 
Diaz-Ruiz et al., 1983; Rybicki, 1995). Up to 1988, many different synonyms were 
used to differentiate between CMV isolates. However, Owen and Palukaitis (1988) 
proposed a classification of CMV as subgroup I and II (sg I, and sg II) based on 
symptoms, peptide mapping of the viral coat protein (CP), serological and nucleic acid 
hybridisation studies (Owen and Palukaitis, 1988). Recent sequ_ence data in the 
GenBank database indicate that a number of CMV strains within sg I originating from 
Asian countries differ by 7-10% in nucleotide sequence from other sg I strains, which 
differ by 2-3% from each other. The Asian strains also differ by only 2-3% from each 
other. Thus, the sg I strains from Asia are referred to as IB strains, and the other sg I 
strains originating from Australia, Japan, Europe, and North American are referred to 



















Figure 1.1 Taxonomy of the Bromoviridae family of plant viruses. Based on the 6th
report of the International Committee on the Taxonomy of Viruses (Rybicki, 1995). 
1.3 .. 3 The Virus Particle 
CMV virions are polyhedral, with a diameter of about 29 nm, morphologically 
indistinguishable from each other, composed of 180 subunits with a Mr ranging from 
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24,159 to 24,300), which exhibit icosahedral symmetry (T=3) (Wikoff et al., 1997). 
The particles are non-enveloped, spherical in profile and have no conspicuous 
capsomere arrangement. Virions contain 18% nucleic acid and 82% protein (Kaper 
and Re, 1974). 
1.3.4 Genomic RNAs 
The genome of CMV is tripartite, consisting of three single-stranded RNA species 
designated RNAs 1, 2 and 3, in decreasing order of M,. The M, of the RNA species 
varies slightly between strains (Peden and Symons, 1973; Lot et al., 1974). In addition 
to the three genomic RNAs, virions also contain two subgenomic RNAs (RNA 4 and 
RNA 4A). RNA 4 is derived from RNA 3, RNA 4A is derived from RNA 2 (Ding et 
al., 1994) (Fig. 1.2). RNAs 1 and 2 are encapsidated in separate particles, whereas the 
RNA strand comprising RNA 3 and RNA 4 are encapsidated together (Lot and Kaper, 
1976). Hence, CMV is a multi-component virus for which inoculation by the three 
types of particles is required to infect plants. In addition to genomic and subgenomic 
RNAs, low levels of smaller RNAs, designated RNA 5 and 6 (Peden and Symons, 
1973), and a small single-stranded satellite RNA, are also found in CMV particles 
(Roossinck et al., 1992). 
1.3.4.1 RNA 1 
Published sequences of CMV RNA 1 (Appendix 1.1), show that it varies from 3,357 to 
3,389 nucleotides (nt) in length. RNA 1 contains a 5' untranslated region (5'UTR) of 
94 to 97 nt followed by a large ORF of nucleotides 2875 to 2881, and a 3' untranslated 
region of 281 to 316 nt in different strains/isolates (Fig. 1.2). 
ORFla of CMV is monocistronic, coding for a single product of molecular weight 
~111 kDa, designated either the 111 kDa or ORFla protein. The carboxy-terminal 141 
amino acids of the la protein are predominantly basic, as is often observed in the 
carboxy-terminal domains of nucleic acid-binding proteins. This region is required for 
initiation of negative strand (-) RNA synthesis (Hahn et al., 1989), has a methyl 
transferase activity and contains six conserved domains associated with RNA helicase 
activity (Mi et al., 1989). At the N terminus of the ORFla protein, there is a putative 
methyl transferase domain (Mi et al., 1989). The ORFla protein, associated with the 
10 
ORF2a protein, acts as the virus-encoded component of the specific CMV-replicase 
complex isolated from CMV-infected tobacco plants (Hayes et al., 1990). Within the 
three dimensional structure of this complex, the functional regions for methyl 
transferase, helicase and polymerase activity are located in positions accessible to the 
viral RNA template with which they interact during replication (Hayes et al., 1990). 
The ORF 1 a protein may have the functions, and has been shown to influence the rate 
of systemic infection in zucchini squash and tomato (Gal-On et al., 1994� 1998). 
RNAI 
ORF la 










Figure 1.2 Genomic organisation and predicted proteins of CMV RNAs. 
- = 5' untranslated region (5'UTR)
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= Subgenomic RNA
= Proteins encoded by genomic RNAs (la, 2a and 3a)
= Proteins expressed by subgenomic RNAs (2b and 3b)
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1.3.4.2 RNA 2 and sg RNA 4A 
RNA 2 of CMV is 3,035 to 3,060 nt long in different strains (Appendix 1.1). It 
contains a 5' UTR of 78-96 nt, two ORFs (ORF2a and ORF2b) and a 3' UTR of 387-
423 nt (Fig. 1.2). 
The 5' -proximal ORF encodes a protein of 94-97 kDa, designated the ORF2a protein. 
The 3 '-proximal ORF encodes the ORF2b protein, which is expressed from sg RNA 
4A (Ding et al., 1994). The ORF2a protein contains conserved amino acid sequence 
motifs typical of positive strand RNA virus RNA-dependent RNA polymerases 
(RdRp). The ORF2a protein functions with the ORFla protein to form the virus­
encoded component of the specific CMV-replicase complex (Hayes et al., 1990). The 
2a protein also influences virus movement in some transgenic plants (Hellwald and 
Palukaitis, 1995). The 2b protein is essential for long distance virus movement (Ding 
et al., 1994, 1995) and acts as a suppressor of gene silencing (Brignti et al., 1998; Li et 
al., 1999). 
1.3.4.3 RNA 3 and sg RNA 4 
Twenty-four complete nucleotide sequences of CMV RNA 3 from sg I and II have 
been determined, as well as 38 partial nucleotide sequences (Appendix 1.1). RNA 3 
contains a 5' UTR of 95-122 nt, two ORFs (ORF3a and ORF3b), an intergenic region 
(IR) of 282-302 nt and a 3'UTR (297-321 nt) (Fig. 1.2). The 5'-proximal ORF encodes 
a protein of 30 kDa and the 3' -proximal ORF encodes a protein of 24 kDa. The 30 kDa 
protein is the translation product of RNA 3, whereas the 24 kDa is not expressed from 
RNA 3 but is translated from the subgenomic RNA (RNA 4), which is collinear with 
the 3' 1 kb of RNA 3 (Schwinghamer and Symons, 1975, 1977). 
ORF3a has been reported to be involved in cell-to-cell and long distance virus 
movement, and has been designated the movement protein (MP) (Cooper et al., 1995; 
Ding et al., 1995; Vaquero et al., 1996; Kaplan et al., 1995, 1997). Unlike MPs of 
other plant viruses, CMV MP is not localised in plasmodesmata but rather in the 
cytosol of infected plants. Although it requires the co-operation of CP (ORF3b) for 
viral cell-to-cell movement, it does not induce formation of tubular structures 
protruding from cell membranes, as reported for some other plant viruses with CP-
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mediated movement (Boccard and Baulcombe, 1993; Kaplan et al., 1995; Li & 
Pahikaitis, 1996; Canto et al., 1997). Recently, Blackman et al. (1998) demonstrated 
that the CMV MP is directly involved in the final entry of an infectious viral 
component into the minor vein phloem and implicated the MP in systemic spread of 
CMV throughout the plant. Taliansky et al. (1995) studied viral factors involved in 
long-distance movement of two different cucumoviruses, CMV and TA V. Their 
results indicated that in addition to its function in cell-to-cell movement and virus 
assembly, the CMV CP possesses host-specific determinants for long distance 
movement. 
1.3.4.4 5' Non-coding regions and tRNA-like 3'UTR regions 
Although the 5' UTRs of CMV RNAs 1, 2 and 3, share some sequence similarity, 
these homologies are not as great as within the 3' UTRs. The 5' UTRs of RNAs 1 and 
2 share the most extensive similarity. CMV RNAs have segments matching the box B 
recognition sequence of RNA polymerase III promoters (Marsh et al., 1987) and also 
to the conserved T'JIC loop of tRNAs, although there is a box B motif in the 5' end of 
CMV RNA 3 (Felden et al., 1996), its· similarity to the box B consensus is weaker. 
However, CMV RNA 3 contains an exact copy of the box B consensus in the IR. 
Conservation of this motif amongst the CMV RNAs suggests that it has an important 
function, and its similarity to the RNA polymerase T'lfC structure suggests a possible 
role in interaction with host factors. 
Cucumovirus RNAs lack a 3' poly(A) tail but contain highly conserved, highly 
structured 3' ends (Ahlquist et al., 1981). The 3' termini of all three genomic RNAs 
and subgenomic RNA 4 have a tRNA-like secondary structure (Rizzo and Palukaitis 
1988, 1989). The conservation of these secondary structures indicates that they have 
functional importance. The tRNA-like 3' ends of brome mosaic virus (BMV) RN As 
have been shown to be required for negative-strand synthesis and are recognized by 
multiple tRNA-specific host enzymes (Sullivan and Ahlquist, 1997). 
1.3.4.5 Satellite RNAs 
CMV particles often contain a satellite RNA. Satellite RNAs depend on a helper virus 
both for their replication and encapsidation (Mossop and Francki, 1977). The presence 
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of satellite RNAs can affect both the level of CMV replication and the resulting 
symptom severity. Most satellite RNAs replicate efficiently in solanaceous plants and 
poorly in cucurbits in the presence of almost all strains of CMV examined. Although 
host range studies with CMV and its satellite RNAs has been limited, an increase in 
severity of CMV symptoms has been found in only three host species; tobacco, pepper, 
and tomato. For most of the hosts investigated so far, the presence of satellite RNA in 
a CMV strain correlates with a major reduction in the synthesis of genomic RNAs, and 
as a consequence, with a striking attenuation of symptom gravity (Kaper et al., 1977; 
Smith et al., 1992). 
1.3.5 CMV life cycle 
The processes involved in the replication mechanism of CMV are very similar to that 
of other plant viruses. The life cycle of CMV includes: entry into the host plant cell, 
virion disassembly, viral replication, expressions of viral genes, encapsidation, 
movement within the plant and transmission between plants (Palukaitis et al., 1992) 
(Fig 1.3). 
1.3.5.1 Transmission 
When a viruliferous aphid feeds on a plant it introduces virus particles inside the plant 
cells (Fig. 1.3A). It is not known how many particles are introduced by each aphid, 
however, a single aphid can be used to separate virus strains from mixed infections 
(Palukaitis et al., 1992). Based on this phenomenon, it was suggested that each aphid 
injects relatively few particles. Once inside a cell, the virus particles must 
disassemble, releasing the viral RNAs (Fig. 1.3B). 
1.3.5.2 Viral RNA replication 
RNA 1 and 2 of CMV are translated on cytoplasmic ribosomes to synthesise proteins 
involved in virus replication (Fig. 1.3C), and act as components of the viral replicase 
complex, which is bound to membranes (Jaspars et al., 1985; Nitta et al., 1988b). 
Hayes and Buck (1990) suggested that one host protein is related to the viral replicase, 
which then becomes associated with viral RNAs to form the viral replication complex 
(Fig. 1.30). Symons (1979) proposed that the replicase recognises and binds to 
conserved nucleotide sequence or structures present at the 3' UTRs. 
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The viral replicase synthesises (-) RNA from the plus strand ( +) RNA templates of 
each of the CMV RN As (Fig. 1.3E). After synthesis of (-) strands the viral replicase 
then synthesises ( +) strands from the (-) strand templates (Fig. 1.3, El and E2). It is 
not known what controls this switch over or the selection of(-) RNAs 1 and 2 versus 
(-) RNA 3 as templates for(+) strand synthesis, and what regulates the synthesis of(+) 
RNA 3 versus (+) RNA 4 synthesis from (-) RNA 3. RNA replication and subgenomic 
mRNA synthesis in BMV have been studied extensively. Both in vitro and in vivo 
studies have defined the cis-acting sequences required for (-) RNA synthesis (Miller 
and Hall, 1983). A system for studying (-) RNAs synthesis in vivo has also been 
developed utilising yeast expressing ORFla, ORF2a, and RNA 3 templates from DNA 
(Quadt et al., 1995). This system confirmed the in vivo requirement for the 3' end in (­
) RNA synthesis. In addition, normal levels of(-) RNA 3 synthesis in vivo required 
intercistronic sequences, which stimulated (-) RNA synthesis by 100-fold (Quadt et 
al., 1995). For(+) RNA 3 of BMV, 5' terminal sequences as well as 3' terminal and 
intergenic sequences are required for RNA replication in vivo (French and Ahlquist, 
1987), suggesting that at least a subset of 5' terminal sequences is required for (+) 
RNA synthesis. 
1.3.5.3 Expression of viral genes 
Synchronised replication studies suggest that the rate of CP synthesis is slow during 
the initial stages of viral replication, but becomes predominant later in the infection 
cycle (Gonda and Symons, 1979; Nitta et al., 1988b) (Fig. l.3F). Regulation of viral 
protein synthesis probably occurs at the level of viral CP RNA (sgRNA 4) synthesis 
(E2; Fig. 1.3). Understanding of the control of sgRNA 4 synthesis is still scanty, but 
studies on the in vitro (Marsh et al., 1988) and in vivo (Smimyagina et al., 1994) 
synthesis of RNA 4 from BMV have identified a core subgenomic promoter extending 
about 20 bases upstream from the RNA 4 initiation site. This core promoter is able to 
direct low-level subgenomic mRNA synthesis. 
The time course of production of the 3a protein of CMV (Fig. l .3C) has not been 
determined in detail, although data on the synthesis of analogous proteins from TMV 
and alfalfa mosaic virus (AlMV) indicate that the MP is involved in potentiating cell­
to-cell movement and is not expressed from a "late" viral gene (Blum et al., 1989; 
Lehto et al., 1990). 
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Figure 1.3 Life cycle of CMV. (A) Viral infection is initiated by entry of viral 
particles into cells via an aphid vector (not to scale). (B) The viral RNA uncoats. (C) 
RNAs 1, 2, and 3 are translated "early" in infection. (D) The translation products of 
RNAs 1 and 2 form the viral components of complexes, which also contain host 
factor( s ). Plus-sense RN As are generated via a putative replicative form, which may 
include double-stranded RN As. (El) Genomic RN As are generated for packaging into 
viral particles. (E2) Subgenomic RNA 4 is generated. (F) Translation of RNA 4 
produces the CP. (G) Viral CP and genomic RNAs assemble to form virions. (H) 
Progeny virus is transported to either another plant via an aphid vector (HJ), or a new 
cell (H2) via the plasmodesmata, probably mediated by the 3a gene product (C). 
(from Palukaitis et al. 1992). 
1.3.5.4 Encapsidation 
Based on in vitro study of virus particles (Kaper and Geelen, 1971), it has been 
proposed that formation of virions is probably a spontaneous process involving direct 
interaction between the CMV RNAs and the CP polypeptides (Fig. 1.30). 
1.3.5.5 Movement 
CMV does not move from cell-to-cell encapsidated but as a ribonucleoprotein complex 
that is trafficked through plasmodesmata by the 3a J\.1P (Ding et al., 1995; Nguyen et 
al., 1996; Blackman et al., 1998). In contrast, it is thought that systemic movement of 
the infectious RNA from leaf-to-leaf occurs as virus particles (Fig. 1.3 H2). 
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1.3.6 CMV transmission 
CMV can be transmitted and spread both by aphids and by mechanical inoculation. 
Seed transmission of CMV has also been reported in a range of host plants. 
1.3.6.1 Seed transmission 
Seed transmission of CMV occurs in a range of susceptible plants. Palukaitis et al. 
(1992) listed 22 different plant species exhibiting seed transmission of CMV. Included 
in the list are two lupinus species, L. luteus (Zschau, 1960) and L. angustifolius (Jones 
and McLean, 1989). The mechanism of seed transmission of CMV is not well 
understood. In chickweed (Stellaria media) the virus is localised in the embryo, but is 
present in the endosperm of the wild cucumber (E. lobata) (cited by Palukaitis et al., 
1992). 
1.3.6.2 Aphid transmission 
CMV is spread by aphids in a non-persistent manner. More than 75 species of aphids 
can spread CMV. The most common aphid species found transmitting CMV are the 
green peach aphid (Myzus persicae) and the cotton aphid (Aphis gossypii). Most 
strains of CMV can be transmitted by these two species of aphids due to the low 
specificity of CMV transmission. The rate of transmission of CMV by aphids is 
affected by a number of factors, such as the strain of virus, the species of aphid, the 
species of the virus source plant, and the host species used to maintain the aphid 
colony. Aphids feeding on infected phloem cells acquire virus particles with the 
phloem sap, and when they move to a new host these transfer virus to other plants, 
reinitiating the cycle of infection (Fig. 1.3 Hl) (cited by Palukaitis et al., 1992). 
1.4 Pathogen-Derived Resistance-
1.4.1 Introduction 
In cultivated plants, the preferred approach to preventing losses due to viruses is 
genetic resistance to virus infection and disease. However, for many virus diseases 
natural resistance genes have not been identified or are not available in a particular 
species, and there is a serious need for new sources of virus resistance in many crops. 
Although traditional breeding for virus resistance has been very productive, and 




to conventional approaches. The desired resistance is not always available, and if 
available may be closely linked to undesired traits, or the resistance may be multigenic 
and difficult to transfer (Knott and Dvorak, 1976; Wenzel, 1985). Improvement of 
crop plants by genetic engineering has resulted in successful introduction of new forms 
of virus resistance into commercial crop varieties. 
1.4.2 Cross-protection 
In 1929, McKinney first reported that infection of a host plant with a mild strain of 
tobacco mosaic virus (TMV) protected the plant against subsequent super-infection by 
severe strains of the same virus (McKinney, 1929). This type of protective measure 
was termed "cross-protection", and has been found to apply to many other plant 
viruses with a few exceptions (Matthews, 1991). Cross-protection was widely used to 
establish relationships among virus strains. It is also has potential value for protecting 
some plants against viruses in the field. For example, this approach has been used 
commercially in the fields in China and Japan (Wu et al., 1993; Yoshida et al., 1985), 
and in small experimental fields in Italy and the U.S.A (Gallitelli et al., 1991; 
Montasser et al., 1991). 
Although classical cross-protection can be beneficial when no other effective means of 
disease control exists, it has many disadvantages. For example, not all agriculturally 
important viruses have a mild strain that can be used as the protecting virus, therefore, 
cross-protection cannot be used in such cases. Another important limitation is that, 
although a protecting strain prevents severe viral infection, it may still produce mild 
disease symptoms itself that can reduce crop yield, or it can be transmitted within or to 
other crops and perhaps cause serious disease. It is also not always possible to predict 
whether one virus will protect against subsequent infection by another virus. The 
challenging virus may act synergistically with the protecting strain to cause a more 
severe disease (Shintaku, 1991). 
1.4.3 The concept of pathogen-derived resistance 
Molecular biology has permitted rapid advances in the understanding of plant virus 
and their replicative strategies, but the mechanisms of cross-protection are not well 




that can be tested. For example, the viral CP may be responsible for conferring 
protection by interfering with attachment, entry, or uncoating of the incoming virus. 
Another hypothesis is that there is interference with replication or competition for 
limiting host factors. From these various hypotheses, the concept of inducing 
resistance to pathogens by transformation of genes derived from the genome of a viral 
pathogen, termed parasite-derived resistance, was first postulated for plant viruses by 
Hamilton in 1980. This idea developed into a generalised concept-"Pathogen-Derived 
Resistance" (PDR) by Sanford and Johnston (1985). They suggested the possibility of 
engineering resistance by genetically modifying a susceptible host with genes derived 
from the pathogen itself. This form of resistance was envisaged to operate by 
expression of the viral gene product in excess or in dysfunctional form or when 
expressed at the wrong developmental stage. 
1.4.4 CP mediated resistance (CPMR) 
1.4.4.1 Introduction 
Since the first report of engineered virus resistance in transgenic tobacco plants 
published by Powell-Abel et al. (1986), there have been more than 100 reports of 
plants genetically engineered for virus resistance. The most widely used strategy to 
engineer plant virus resistance is to use the viral CP gene (Appendix 1.2). Many CP 
genes, from homologous or from closely related viruses, introduced into susceptible 
hosts, are highly effective in preventing or reducing virus infection and disease 
(Gonsalves and Slightom, 1993), although, the frequency of obtaining plants with 
strong resistance varies widely. 
1.4.4.2 CPMR efficiency 
Many virus CP genes transformed into transgenic plants deliver only a small 
percentage of highly resistant lines, with the majority of lines showing moderate levels 
of resistance or susceptible responses (Kashiwazaki et al., 1998). In most cases, the 
transgenic plants were tested for resistance against the virus strain from which the CP 
gene was derived, that is, the homologous virus. For example, Quemada et al. (1991) 
showed that transgenic plants expressing the CP gene of CMV-C (sg I) are well 
protected against virus infection from the strains in sg I, but have poor resistance to 
WL strain (sg II). Similarly, the CMV-C CP gene gave good resistance to three strains 
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of sg I from Australia, but poor resistance to the CMV-L Y strain (sg II) from narrow­
leafed lupin in Western Australia (Singh et al., 1998). Tobacco plants transgenic for 
tobacco rattle virus (TRV) CP gene were resistant to the homologous TCM strain, but 
not to the PLB strain, with only 39% protein sequence homology (Van Dun et al., 
1987). Papaya ringspot virus (PRSV) CP in papaya provides resistance to some 
strains, but not to others (Lius et al., 1997). TSWV CP gave resistance to strains from 
the same sg (Pang et al., 1992). Transgenic soybean plants containing bean pod mottle 
virus (BPMV) CP only express resistance to the homologous virus (Di et al., 1996). 
On the other hand, there is strong experimental evidence that for many viruses, CP 
mediated resistance can be effective against different strains of the virus. Resistance to 
diverse virus strains or isolates has been reported for TMV (Nelson et al., 1988), 
tomato mosaic virus (ToMV) (Sanders et al., 1992), CMV (Namba et al., 1991; 
Quemada et al., 1991; Xue et al., 1994; Fuchs, et al., 1996; Gielen et al., 1996 and 
Murphy et al., 1998), AlMV (Loesch-Fries et al., 1987; Turner et al., 1987), potato 
virus X (PVX) (Hemenway et al., 1988), potato virus Y (PVY) (Perlak et al., 1994), 
PVYN (McDonald et al., 1997), lettuce �osaic virus (LMV) (Dinant et al., 1997), 
potato leafroll virus (PLRV) (Kaniewski et al., 1993; Barker 1996), PMTV (McGrath 
et al., 1997), TSWV (de Haan, 1992). 
In addition, there are two reports of CP mediated resistance across virus groups. One 
was published by Anderson et al. (1989), which was not well documented. These 
results could not be repeated (Kashiwazaki et al., 1998). The second reported by 
Murry et al. (1993) showed transgenic com plants containing the maize dwarf mosaic 
virus (MDMV) B isolate CP were resistant to not only MDMV-B and MDMV-A, but 
also maize cheorotic mottle virus (MCMV). 
1.4.4.3 Correlation of CP expression with resistance 
Transgenic virus CP-mediated resistance can be divided into two main groups. In the 
first, CP-mediated resistance correlates with the level of CP expression. For example, 
results for TMV ((Nelson et al., 1988; Powell-Abel. Et al., 1986), CMV (Cuozzo et 
al., 1988), AIMV (Turner et al., 1987; van Dun et al., 1987, Hill et al., 1991), and 
PVX (Hemenway et al., 1988; Hoekema et al., 1989) strongly indicate that there is a 
positive correlation between CP expression and resistance. Low expression of CMV 
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CP in tomato produced plants that were almost completely susceptible to infection, 
however when tomatoes were transformed with an improved construct resulting in 
higher CP expression, better resistance to infection was observed at a high frequency 
(Kaniewski et al., 1998). 
In the second group, CP-mediated resistance is not related to expression of CP in 
transgenic plants. In many published papers on CP resistance for members of 
potyviruses (Lawson et al., 1990; Namba et al., 1992; Regner et al., 1992; Xu et al., 
1995; Edwards et al., 1997; McDonald et al., 1997; Wang et al., 1997; Rabinowicz et 
al., 1998), luteovirus (Kawchuk et al., 1990) and tospovirus (Gielen et al., 1992; 
Mackenzie and Ellis, 1992; Pang et al., 1992), there has not been any direct correlation 
between transgene expression levels and virus resistance. The resistance conferred by 
the CP gene appears to be partially or completely operating at the transcriptional level 
rather than at the level of protein expression. 
Transgene CPs of different viruses have been driven with different promoters. The 
level of CP expression varied widely between plant lines and even more between 
different transformed plant species. Moreover, expression of transgenes can vary with 
the age of the plant, position of tissue sample collected from the plant, efficiency of 
extraction, and type of assays performed (Kashiwazaki et al., 1998). So, it is difficult 
to make general conclusions relating CP expression to resistance. 
1.4.4.4 Mechanism of CPMR 
Possible mechanisms which underlie CP mediated resistance have been reviewed 
extensively (Beachy, 1993; Reimann-Philipp and Beachy, 1993; Sturtevant et al., 
1993; Grumet, 1994; Hackland et al., 1994; Baulcombe, 1996). The initial explanation 
was that an excess of CP in transgenic plants prevented uncoating of incoming virus 
particles. This theory arose from experimental observations that inoculation with viral 
RNA could overcome resistance to TMV (Osbourn et al., 1989; Register et al., 1988, 
1989) and AlMV (Loesch-Fries et al., 1987; van Dun et al., 1987). 
However, for AlMV (Turner et al., 1987), PVX (Hemenway et al., 1988), potato virus 
S (PVS) (MacKenzie et al., 1991), arabis mosaic virus (ArMV) (Bertioli et al., 1992; 




grapevine chrome mosaic virus (GCMV) (Brault et al., 1993), transgenic CP resistance 
was also effective against viral RNA challenge. This suggests that rather than 
interference with virus uncoating, other steps in virus replication or spread were 
affected. Clark et al., (1995b) constructed TMV CP mutants that were defective in 
virion assembly, but were still able to confer resistance. In this case the CP would 
interact with the virus RNA to interfere with translation or with host component 
interactions. 
A different mechanism was observed in Russset Burbank potato transformed with 
double CP gene construct from which both PVX and PVY coat protein can be 
expressed (Lawson et al., 1990). With mechanical inoculation transgenic lines were 
not infected by either virus. However, after graft inoculation with a double infected 
wild type scion, PVX was able to spread throughout the plant and could be easily 
detected in the transgenic plant tissues while PVY was never detected in the transgenic 
portion of the grafted plant (Kaniewski et al., 1998). This suggests that there are two 
different mechanisms of interactions of CP with these infecting viruses. Even for the 
same plant-CP combinations clear differeµces can be found. Tobacco expressing 
AlMV-CP was resistant to virus and RNA inoculation (Turner et al., 1987). 
In summary, none of the proposed theories explain all of the observations of transgenic 
plant-virus resistance using the coat protein gene. 
1.4.5 Replicase-mediated resistance 
1.4.5.1 Introduction 
Replicase mediated resistance (RMR) as a PDR concept was first studied by 
Golemboski and co-workers (Golemboski et al., 1990). When the 54 kDa readthough 
region from the TMV replicase protein was expressed in transgenic plants, 
unexpectedly, they were completely resistant to infection by TMV. Furthermore, the 
level of resistance conferred by the 54 kDa transgenic plants appeared to be greater 
than that -observed by other researchers for TMV CP-mediated resistance. The 
resistance did not break down over time and could not be overcome with inoculum 
levels up to 1000-fold higher than for CP-mediated resistance (Golemboski et al., 
1990). The RMR approach has been used successfully with 13 virus genera 
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representing 11 plant virus taxa (Table 1.2). Gene constructs that have been 
introduced include replicase read-through sequences as well as full-length, truncated or 
mutated replicase genes. There are also two reports of replicase-mediated resistance in 
the plant DNA geminiviruses: African cassava mosaic virus (ACMV) (Hong and 
Stanley, 1996) and tomato yellow leaf curl virus (TYLCV) (Noris et al., 1996). 
1.4.5.2 RMR efficiency 
Resistance to the sg I strain of CMV, Fny, was obtained by transformation with a 
deletion modified RNA 2 transgene. Thesis modification removed the conserved 
GDD motif and introduced a frameshift over the remaining 3' sequence (Anderson et 
al., 1992). In addition, transgenic plants were resistant to 12 sg IA strains, but only 
partially resistant to 3 sg IB strains in one of the two plant lines tested. The plants 
were not resistant to any of the 4 sg II strains tested. Similar results were obtained in 
our laboratory (Singh et al., 1998). Transgenic tobacco plants were highly resistant to 
CMV sg I isolates from banana, but no resistance was found when challenged with the 
sg II CMV-LY isolate. However, transgenic tomato plants containing the same 
replicase gene were highly resistant not only to CMV sg I isolates, but were also 
partially resistant to CMV-LS (sg II) (Gal-on et al., 1998). Similarly, tobacco plants 
expressing a full-length PVX replicase gene were highly resistant to the homologous 
strain, but susceptible to distantly related South American isolates (Braun et al., 1992). 
Nicotiana benthamiana plants transformed with a truncated pea early browning virus 
(PEBV) replicase gene were resistant to various isolates, but not to other tobraviruses 
(Macfarlane et al., 1990; Davies 1992). Transgenic plants expressing the CPMV 
replicase were highly resistant to the homologous virus and closely related isolates, but 
not to other comoviruses, such as cowpea severe mosaic virus (CPSMV) (Sijen et al., 
1995). There are also examples in which plants expressing a viral replicase transgene 
exhibited no virus resistance (Van Dun et al., 1988; Taschner et al., 1991; Mori et al., 
1992). 
1.4.5.3 RMR mechanism 
The resistance conferred by replicase genes has been reported to occur- at both the 
protein level and the transcriptional level. The mechanism of replicase-mediated 
resistance acting at transcriptional level will be discussed in section 1.4.8 
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Table. 1.2 Viruses and viral genes tested for replicase-mediated resistance 
Virus genus Virus Gene Resistance Reference 
Alfamo- alfalfa mosaic (AIMV) la No van Dun et al. 1988 
2a No van Dun et al. 1988 
la/2a No Taschner et al. 1991 
Mod.2a Yes Brederode et al. 1995 
Partial 2a No Brederode et al. 1995 
Brome- brome mosaic (BMV) la No Mori et al. 1992 
2a No Mori et al. 1992 
la/2a No/Yes Mori et al. 1992; 
Kaido et al. 1995 
Como- cowpea mosaic (CPMV) 200-kDa Yes Sijen et al. 1995 
Cucumo- cucumber mosaic (CMV) la No Suzuki et al. 1996 
2a No/Yes Suzuki et al. 1996 
Mod. 2a Yes Anderson et al. 1992 
Yes Singh et al. 1998 
Yes Gal-On et al. 1998 
la/2a Yes Suzuki et al. 1996 
Gemini- tomato yellow leaf curl Partial Rep Yes Brunetti et al. 1997 
(TYLCV) 
Luteo- potato leaf roll (PLRV) la Yes Kaniewski et al. 1995 
2a Yes Kaniewski et al. 1995 
Potex- potato virus X (PVX) 166-kDa Yes Braun et al. 1992 
Mueller et al. 1995 
Partial 166- Yes/No Braun et al. 1992 
kDa Yes Mueller et al. 1995 
Mod. 166- Yes Mueller et al. 1995 
kDa Longstaff et al. 1993 
Mod. 166-
Poty- potato virus Y (PVY) kDa Yes Audy et al. 1994 
Yes Audy et al. 1994 
No Audy et al. 1994 
Plum pox virus (PPV) Nib Yes Guo et al.1998 
Partial Nib Yes/No Guo et al.1991
Mod. Nib 
Tobamo- pepper mild mottle Mod. Nia Yes Tenllado et al. 1995 
(PMMV) Mod. Nib 
tobacco mosaic (TMV) Yes Golembeski et al. 1990 
54-kDa Yes Marano et al. 1998 
No Golembeski et al. 1990 
54-kDa Donson et al. 1993 
54-kDa No Donson et al. 1993 
126-kDa Yes Donson et al. 1993 
Tobra- pea early browning 183-kDa Yes Macfarlane et al. 1992 
(PEBV) Mod. 126-
kDa 
Tombus- cymbidium ringspot Yes Rubino et al. 1993 
(CymRSV) 54-kDa
92-kDa
RMR is thought to act at the protein level by one of the following two mechanisms. 
Firstly, a replicase protein expressed in transgenic plants may be one that normally 
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functions as a regulatory protein during natural virus infection. Transgene expression 
may act to down-regulate virus replication or distort the balance of ( +) versus (-) 
strand replication, or disrupt a feedback inhibition loop (Carr and Zaitlin, 1993). Such 
a mechanism may be conceivable for the 54-kDa putative replicase protein of TMV 
(Carr et al., 1992), 141 and the 201-kDa replicase gene of PEMV (Hanley-Bowdoin 
and Hemenway, 1992; Macfarlane and Davies, 1992). The expression of a full-length 
functional replicase gene appears to confer a high level of resistance to an increasing 
number of viruses (Braun et al., 1992; Rubino et al., 1993; Audy et al., 1994; 
Kaniewski et al., 1994; Sijen et al., 1995). 
In the second model, the replicase expressed in a mutated or truncated form either 
constitutively, or at an inappropriate concentration in the cell, may interfere with 
replication by either competing for host factors/substrates or for association with other 
host- and virus-coded components of the replicase complex (Carr and Zaitlin, 1993). 
This may be a working model for replicase mediated resistance to CMV (Carr and 
Zaitlin, 1991), PVX (Braun et al., 1992; Mueller et al., 1995), PPV (Audy et al., 1994; 
Guo et al., 1998) and AlMV (Brederode �t al., 1995). Regardless of the diversity of 
replicase transgenes used to induce resistance, it is possible that a reduction in the rate 
of viral replication is the common mechanism involved. 
RMR is postulated to inhibit long-distance transport by preventing virus entry into the 
vascular system or by shutting down the plasmodesmata resulting in a lack of cell-to­
cell movement (Carr et al., 1994; Hellwald and Palukaitis, 1995; Nguyen et al., 1996; 
Gal-On et al., 1998). Nguyen et al. (1996) used a microinjection method to directly 
examine cell-to-cell trafficking of CMV viral RNA in the transgenic tobacco plants, 
which expressed a truncated replicase gene sequence of CMV-Fny. Based on this 
study, the authors proposed that an inhibition of cell-to-cell RNA trafficking might be 
correlated with replicase-mediated resistance. However, more recently, Palukaitis and 
Canto (1999) inoculated transgenic tobacco plants with a virus expressing the green 
fluorescent protein (GFP) fused to the CMV MP. The results showed that the 
transgenic defective replicase neither prevented localisation of the MP to 
plasmodesmata, nor inhibited trafficking of the MP. So, replicase-mediated resistance 
to CMV does not directly inhibit the MP from functioning in nonvascular tissues. 
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1.4.6 MP-Mediated resistance 
Transformation with the MP gene is another option for obtaining virus resistance. 
Initial studies did not report protection in plants expressing a natural MP gene (Deom 
et al., 1992). Instead, a complement for.movement functions was observed (Deom et
al., 1990; Cooper et al., 1995). Extensive experiments confirmed this result and also 
showed that wild type MP could even increase virus susceptibility and exacerbate 
symptoms in the host plant (Ziegler-Graff et al., 1991; Cooper et al., 1995). The 
results to date suggest that mutant MP should be used rather than wild-type MP for 
engineering virus resistance. In contrast to replicase-mediated resistance, protection is 
not strongly strain-specific. Indeed, a broad spectrum of resistance has been reported 
using defective MP genes (Malyshenko et al., 1993; Beck et al., 1994; Cooper et al.,
1995). The protection conferred by the mutant MP of TMV, for example, mediates 
resistance to viruses of the potex-, cucumo-, and tobraviral groups in addition to the 
tobamoviruses (Cooper et al., 1995). Similarly, transgenic expression of the BMV MP 
in a non-host plant conferred resistance to TMV (Malyshenko et al., 1993). These 
examples of broad-spectrum resistance indicate that MPs of several different viruses 
may interact with the same plasmodesmatal components (Schaad and Carrington, 
1996). 
The cellular and molecular mechanisms of resistance conferred by the dysfunctional 
MP (dMP) of TMV are currently under study (Beachy et al., 1998; Heinlein et al.,
1998). It has been proposed that the dMP prevent accumulation of the MP of the 
challenge virus in such a way that the MP of the challenge virus is unable to carry out 
its function. Interference of function could be at the level of multiprotein interactions, 
or at the level of protein targeting to the cell wall or plasmodesmata, or the association 
of the MP with nucleic acids, modification of plasmodesmata structure and/or 
function, or by some other mechanism (Beachy et al., 1998). 
1.4.7 Protease-mediated resistance 
Potyviruses express their genes as a polyprotein that is cleaved by virus encoded 
proteases (Riechmann et al., 1992). Studies on factors controlling the proteolytic 
processing lead to the unexpected finding that plants expressing the viral protease 
domain of either tobacco vein mottling virus (TVMV) or PVY exhibited a high degree 
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of resistance to the respective viruses (Maiti et al., 1993; Varcli et al., 1993). The 
resistance was very strain-specific and is presumably due to interference with the 
normal processing of the primary polyprotein product, resulting in disruption of the 
viral infection-cycle. 
1.4.8 RNA-mediated resistance 
Although the original idea of PDR related to expression of viral proteins, it became 
clear that in many cases RNA transcripts of viral transgenes, and not their protein 
products, are responsible for protection. The major evidence was that untranslatable 
transgenes exhibited a high degree of protection in the absence of expressed protein. 
In addition, protection can be obtained in plants with antisense RNA constructs, or 
expressing satellite or defective interfering (DI) RNAs. If protein is not necessary to 
confer resistance, untranslatable constructs can be used, avoiding the accumulation of 
any foreign protein and eliminating any risks of trans-encapsidation. A disadvantage 
of RNA-mediated resistance, however, is the high sequence specificity. The resistance 
appears only to be effective against viruses with a high sequence homology (up to 88% 
or more) to the transgene (Mueller et al., 1995). 
1.4.8.1 Sense RNA-mediated resistance 
In 1992, Lindbo and Dougherty demonstrated that untranslatable sense RNA could 
provide protection against tobacco etch potyvirus (TEV). Similar observations were 
reported for PVY (Farinelli, 1992; van der Vlugt et al., 1992) and tomato spotted wilt 
(TSWV) (de Haan et al., 1992). In the TEV experiments, three phenotypic responses 
were observed in plants transformed with an untranslatable form of the CP transgene: 
(1) plants susceptible to infection, (2) plants highly resistant to infection and (3) plants
with the ability to recover from systemic infection 2-3 weeks after initial inoculation 
(Dougherty et al., 1994). 
The TEV resistance was functional at the single-cell level and was highly sequence 
specific, working only against closely related viruses. When the recovered transgenic 
plants were challenged with TEV, the steady-state transgene RNA levels dropped five 
to eight fold, compared with uninoculated tissue at the same developmental state 
(Dougherty et al., 1994). Nuclear run-on assays showed that transcription rates were 
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virtually the same in both infected and uninfected plants, suggesting post­
transcriptional mRNA degradation. A mechanism was triggered that affected both the 
mRNA of the transgene and the replicating viral RNA. The difference between the 
two phenotypes, recovery and resistance, appeared to correlate with the number of 
integrated copies (Goodwin et al., 1996). One to two copies resulted in recovery 
whereas three or more copies resulted in resistance. Plants with the immunity 
phenotype could also display a recovery phenotype when infected early in 
development, suggesting that immunity and recovery are based on the same principles 
(Tanzer et al., 1997). 
A double haploid family of transgenic plants, containing an untranslatable PVY CP 
gene, showed differences in their response to PVY inoculation (Smith et al., 1994). 
These genetically identical plants had differences in steady-state mRNA levels related 
to the methylation state of the transgene, and this could be partially responsible for the 
different levels of resistance. 
Developmental regulation of RNA-mediated resistance has also been observed. 
Homozygous transgenic plants, containing the nucleoprotein gene of TSWV, were 
silenced earlier in development than hemizygous transgenic plants. When plants were 
transformed with randomly chosen sequences (sense or antisense) of the TSWV 
ambisense genome, sequences from only two genes, the N gene or NSM gene were able 
to induce gene silencing (Prins et al., 1996). 
Resistance to CPMV, after transformation with the MP gene, was shown to be RNA 
mediated (Sijen et al., 1996). Transcripts of recombinant PVX clones, containing 
small MP gene sequences, were suppressed in CPMV MP transgenic plants. For 
recombinant PVX transcripts containing small MP gene sequences, there was, in 
addition to complete immunity, another phenotype observed in some plants. 
Compared with nontransgenic plants, these plants exhibited a delay of 3 to 4 days 
before becoming systemically infected. ,vhen plants were transformed with a direct 
repeat of the MP gene, the number of resistance lines increased from 20% to 60%, 
indicating a causal role for transgene structure in silencing. 
Induction of RNA-mediated resistance may depend on transgene length. Plant lines 
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with gene constructs containing about 1/2 to 1/32 of the nucleoprotein gene of TSWV 
alone or when appended to the non-viral GFP sequence have been produced. 
Transgenic plants expressing large N trans gene fragments (387-453 bp) were resistant. 
Small N transgene fragments (235-110 bp) were not resistant when expressed alone, 
but conferred resistance through a post-transcriptional gene silencing (PTGS) 
mechanism when fused to the non-target GFP DNA. These results indicated that the 
inability of small N transgenes alone to induce homology-dependent virus resistance 
was not due to insufficient lengths of homology to the silenced transgene, but because 
they are incapable of inducing gene silencing (Pang et al., 1997). 
1.4.8.2 Homology-dependent gene silencing 
The stability of the expression of heterologous transgenic sequences is an important 
aspect in development of virus resistant transgenic plants for commercial applications. 
Homology-dependent gene silencing is a phenomenon whereby the presence of 
(multiple) transgenes can lead to the inactivation of one or all of the transgenes 
(Dougherty and Parks, 1995; Matzke and Matzke, 1995; Baulcombe and English, 
1996; Meyer and Saedler, 1996; Stam et al., 1997). This gene inactivation can be a 
major problem in applied plant biotechnology if the requirement is for overexpression 
of a gene product. In a survey in 1994 of 30 biotechnology companies, almost all of 
them had encountered problems associated with gene silencing (Finnergan and 
McElroy, 1994). Gene silencing can occur either at the transcriptional or post­
transcriptional level. RNA-mediated resistance to virus is associated with PTGS. 
1.4.8.3 Mechanism of PTGS and RNA-mediated resistance 
PTGS and RNA-mediated resistance have many common features. Both require 
sequence homology between a transgene and an endogenous gene or a transgene and 
an incoming virus. Both have post-transcriptionally inactivated (trans) genes that, in 
turn, have trans-inactivating capacities on homologous sequences, so the two 
phenomena may have a common mechanism. The strongest evidence for a link 
between PTGS and RNA-mediated resistance comes from the work of Mueller et al. 
(1995) and English et al. (1996). Two types of transgenic lines were available, both 
containing the RdRp of PVX. The first showed highly strain-specific resistance 
against PVX and a low level of RdRp mRNA, and had properties associated with post-
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transcriptional silencing of transgene expression. The second type was susceptible to 
infection with PVX and displayed a higher level of RdRp mRNA. When the progeny 
of a cross between these two transgenic lines were analysed, the resistant line had 
tra:Qs-inactivating capabilities toward the homologous transgenes of the susceptible 
line (Mueller et al., 1995). 
There have been three models put forward that attempt to explain PTGS. The first 
involves a threshold level of RNA (Jorgensen, 1992; Meins and Kunz, 1994; Smith et
al., 1994). In this model, the plant is able to sense the transcription level of the 
transgene and, if the level is too high, the plant targets the mRNA for degradation. ' 
This hypothesis came from the work on transgenic tobacco plants containing an 
untranslatable TEV CP gene (Lindbo et al., 1993). As mentioned in section 1.4.8.1, 
two resistant phenotypes were observed, resistant and recovery, which were related to 
the number of integrated copies of the transgene (Goodwin et al., 1996). Resistance 
was observed when three or more copies were present whereas one or two copies 
resulted in a recovery phenotype. The authors suggested that the induction of the 
resistance phenotype depended on the transcription level of the transgene. Three or 
more copies would lift the mRNA above a critical threshold to induce resistance. One 
or two copies, initially, would not be sufficient to induce the resistance, however, the 
RNA of the replicating virus combined with the transgene transcription level would be 
sufficient to reach the threshold and induce the degradation mechanism. It was 
suggested that once the threshold level was reached, a RdRp, present in the cytoplasm 
of plants (Fraenkel-Conrat, 1996), would produce short, antisense RNA molecules 
with sequence homology to the target DNA. Annealing of the antisense RNA 
molecules would lead to the formation of a duplex RNA structure that could be a target 
for degradation by double-strand, specific RN ases. Further support for the threshold 
level model has been reported (Baulcombe, 1996; Goodwin et al., 1996; Prins and 
Goldbach, 1996; Stam et al., 1997). 
However, there are a number of reports that can not be explained by the threshold 
model. Van Blokland et al. (1994) found steady state levels of transgene expression in 
suppressed and non-suppressed chs genes were similar. A similar result was reported 
for virus resistance (Mueller et al., 1995; English et al., 1996), which led these authors 
to suggest another model that involved a qualitative feature of the mRNA known as 
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aberrancy (Baulcombe and English, 1996). 
In this model, aberrant mRNA would be distinct from the normal mRNA. This 
distinction in tum would be recognised by the plant, and this would then lead to 
degradation of the aberrant and "normal" mRNA. An ectopic pairing model has been 
suggested to account for the production of aberrant RNA. This involves a silencer 
locus and a receptor locus. Transcription of the silencer locus is not essential. If 
DNA-DNA pairing between the two loci takes place, transcription at the receptor locus 
would be changed, leading to the production of an aberrant mRN A. It is this aberrant 
RNA that would induce a sequence-specific degradation mechanism affecting all RNA 
with sequence homology. Support for the role of aberrant RNA in gene silencing 
comes from work of English et al. (1996). Both models assume the presence of an 
RNA degradation mechanism. This is supported by the reports from Metzlaff et al. 
(1997) and Tanzer et al. (1997). In both systems it has been shown that silencing 
correlates with the presence of low molecular weight RNA fragments derived from 
degradation of, respectively, chs mRNA and TEV CP mRNA. 
More recently, Waterhouse et al. (1998} proposed a third model for explaining PTGS 
and virus resistance. The cornerstone of this model is that PTGS is induced by dRNA 
and that it is mediated by a RdRp present in the cytoplasm that requires a double 
strand RNA (dsRNA) template. This specificity for a dsRNA template is the key to 
producing sequence-specific degradation. The dsRNA is formed by hybridisation of 
complementary transgene mRNAs or complementary regions of the same transcript. 
The dsRNA-dependent RNA polymerase produces complementary RNA (cRNA) to 
which RNase molecules are attached. These cRNA-RNase molecules hybridise to the 
endogene mRNA or viral RNA and cleave the single-stranded RNA adjacent to the 
hybrid. The cleaved single-stranded RNAs are further degraded by other host RNases 
because one will lack a capped 5' end and the other will lack a poly (A) tail. If the 
transgene is derived from a viral sequence, this will provide sequence-specific 
cleavage of viral genomic and subgenomic RNAs, thus preventing viral infection. If 
the transgene is derived from an endogene, this will lead to cleavage and degradation 
of the endogene mRNA. The model predicts that the dsRNA formed by cRNA and the 
target RNA will remain and act as a template for the dsRNA-dependent RNA 
polymerase to generate more cRNA (Waterhouse et al., ·1998) 
I I i. 
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1.4.8.4 Antisense RNA-mediated resistance 
The antisense approach is based on the idea that complementary nucleic acids form 
double-stranded helices. Single-stranded nucleic acids present in a living cell are 
therefore susceptible to hybridise to a nucleic acid of complementary ( anti sense) 
polarity. Specific binding of "antisense" nucleic acids results in interference with the 
biological function of the sense nucleic acid or induces degradation of the double­
stranded complex. 
Protection by antisense RNA was demonstrated in early experiments on PDR. For 
several constructs, the CP gene was inserted either in sense or antisense orientation. 
However, experiments with CMV, TMV, PVX and PVY showed that the anti sense 
constructs conferred a weaker protection than the sense CP constructs (Cuozzo et al., 
1988; Hemenway et al, 1988; Powell et al., 1989; Farinelli et al., 1990). In a few 
instances, significant resistance has been observed from antisense transgenes. The 
antisense RNA is thought to interfere with the viral replication or translation by 
hybridising with the sense genomic RNA ( or DNA) or by competition for viral or host 
components needed for replication. For CMV, anti sense genes corresponding to the 
genomic regions of the putative replicase, MP and 3' site of replication initiation have 
been used for plant transformation (Rezaian et al., 1988). Only one line expressing 
relatively low amounts of the antisense RNA corresponding to the replicase region 
showed some protection against CMV. Antisense RNA of the TMV 54 kDa gene did 
not confer protection (Golemboski et al., 1990). 
The general low efficiency of antisense RNA as an antiviral agent against RNA viruses 
contrasts with the effectiveness of mRNA-directed antisense RNA in gene 
suppression. One major reason that may account for this difference is that antisense 
RNA and the viral target RNA are synthesized in different cellular compartments. The 
stable transformed antisense gene is transcribed in the nucleus whereas the viral target 
RNA is synthesized by the viral replicase complex in the cytoplasm. In this case, only 
a small amount of the nuclear antisense RNA is actually transported intact to the site of 
virus replication. Because duplex formation is a bi-molecular reaction, it requires the 
antisense RNA to be present in at least stoichiometric amounts to viral sense RNA at 
the site of virus replication to be effective. Since the local cytoplasmic concentration 
of the viral RNA target may be high but the concentration of intact antisense RNA is 
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relatively low, it is understandable that protection has often been observed only at a 
low concentration of viral inoculum. 
DNA viruses, unlike RNA viruses, have a nuclear phase during which the viral DNA 
is transcribed into RNA. This resembles the situation of mRNA transcription and the 
antisense technology should be expected to work much better. Indeed, expression of 
antisense RNA directed against the ALI gene of tomato golden mosaic virus (TGMV), 
a geminivirus, efficiently inhibited viral replication (Day et al., 1991). The plants 
expressing the TGMV antisense gene also showed considerable protection against beet 
curly top virus (BTCV), whereas no protection was observed against another 
geminivirus, ACMV (Bejarano and Lichtenstein, 1994). Both viruses have similar 
organisation and 64% sequence identity over the entire region of TGMV, which was 
expressed as an antisense gene in transgenic tobacco. However, BCTV, unlike 
ACMV, contains local domains with similarity levels of up to 82%. This 
demonstrated that no absolute sequence complementarity is required for resistance to 
related viruses, but the similarity must exceed a certain threshold level to allow duplex 
formation. Similarly, van der Krol et al. (1988) observed that the chsA antisense RNA 
also suppressed the chsJ genes, which_ share 86% sequence similarity. Moreover, 
inhibition also worked in a heterologous system, when the petunia chsA antisense gene 
was expressed in tobacco (van der Krol et al., 1988). The corresponding tobacco gene 
shares about 80% sequence similarity. 
1.4.8.5 Ribozyme-mediated resistance 
RNA enzymes (ribozymes) are derived from naturally occurring self-cleaving RNAs 
(Cech et al., 1987; Edington and Nelson, 1992). Several classes of catalytic RNAs are 
known. Since they can be used to bind specifically and cleave a particular RNA target 
they can be considered as an extension and improvement of antisense technology. 
Like antisense RNAs, ribozymes bind to their targets, but unlike antisense RNAs they 
also induce specific cleavage of the complementary RNA. In line with this, ribozymes 
have also been described as antisense RNAs with a "warhead" (Wilson et al., 1993). 
Ribozymes have been used against viral RNAs, both in vitro or in vivo. Intermolecular 
processing of PLRV CP and polymerase genes (Lamb and Hay, 1990), and of the 5' 
region of TMV RNA (De Peyter et al., 1996), has been achieved in vitro, but with low 
efficiency at temperatures comparable to those in plants (De Peyter et al., 1996). In 
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transgenic plants a multiple ribozyme construct against TMV was no more effective 
than the antisense RNA in which the ribozymes were embedded for targeting. These 
results suggest that addition of the ribozyme domains to the antisense RNA sequences 
did not affect the ability of the antisense RNA to confer resistance to TMV in any way 
(Wilson, 1993). The effect of the ribozymes was additionally analysed by creating a 
TMV mutant that would not be cleaved by the ribozymes, but no differential resistance 
was observed, indicating that the ribozyme did not contribute to resistance in planta 
(De Feyter et al., 1996). Atkins et al. (1995) compared resistance to CEVd in 
transgenic plants expressing either antisense RNA or antisense RNA with three 
hammerhead ribozyme domains embedded; separate constructs directed against both 
CEV d ( +) and (-) strands were tested. Although the ribozyme constructs cleaved the 
viroid RNAs in vitro, the ribozyme constructs actually were less effective compared to 
the antisense RNA alone when tested in planta. It appears that under physiological 
conditions the ribozyme sequences were ineffective, and the observed effects were due 
entirely to the antisense RNA (Atkins et al, 1995). 
1.4.8.6 Satellite RNA-mediated resistance 
Satellite RNAs (satRNA) are RNAs which need a helper virus to replicate in host 
plants, and which differ from defective interfering (DI) RNA by having no sequence 
homology with the helper virus (Collmer and Howell, 1992; Roossinck et al., 1992). 
Some satellite RNAs decrease symptoms caused by the helper virus, whereas others 
make them more severe (Collmer and Howell, 1992). Transgenic plants expressing 
symptom-ameliorating satellites of CMV or tobacco ringspot virus (TRSV) can 
provide protection from the severe effects of their respective helper virus and inhibit 
virus replication (Grumet, 1994). CMV satRNA also protected against the symptoms 
of TAV but without causing any reduction in virus replication (Harrison et al., 1987). 
Satellite TRSV also interferes with the replication and disease caused by another 
nepovirus, cherry leafroll virus (CLRV), even though CLRV is not a helper virus for 
satellite TRSV (Ponz et al., 1987). 
The mechanisms underlying the use of satRNAs (free or transgenic) to generate 
resistance seem even more empirical and enigmatic than do the other approaches. The 
risk of mutation to a more severe satRNA, their limited occurrence in nature, and 
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possible changes in helper virus relations have detracted from widespread use of the 
transgenic satRNA protection strategy. 
1.4.8.7 DI RNA-mediated resistance 
It has been shown that DI RNAs can act in vitro as competitive inhibitors for the 
replication of turnip yellow mosaic virus (TYMV) (Valle et al., 1989). The region 
used contained the 3'-terminal end of the TYMV genome, which comprises the 
recognition site of the replicase. Although Dis have not been found often in nature in 
association with plant viruses, it may be possible to produce artificial DI RNAs that 
could be useful in conferring resistance. March et al. (1991) developed artificial DI 
RNAs of BMV that were capable of reducing the replication of helper virus in 
inoculated protoplasts. Furthermore, the expression of ACMV DI RNA in transgenic 
plants gave some protection by inhibiting viral replication (Frischmuth and Stanley, 
1991). 
1.5 Engineering protection without pathogen sequences 
1.5.1 Plant defence genes 
Viruses, fungi, nematodes and bacteria can induce hypersensitive responses in host 
plants. This response is triggered by recognition of a pathogen and results in 
programmed cell death around the site of infection. The recognition is followed by the 
induction of a large number of pathogenesis-related genes (Bowles, 1990). These 
genes act locally or systemically and �re involved in the development of a higher state 
of resistance of the host plant termed systemic acquired resistance (SAR) (Ward et al., 
1991). This response has been extensively studied in tobacco after inoculation with 
TMV. SAR confers a high degree of protection not only to subsequent challenge with 
TMV, but also to other viral, bacterial or fungal pathogens. Broad range protection 
against virus infection was reported for transgenic plants expressing ribosome­
inactivating proteins (Lodge et al, 1993). These proteins are found in a number of 
plant species and have the ability to modify ribosomal RNA and therefore interfere 
with translation process. Such proteins have been expressed in tobacco and potato. 
The transgenic plants were protected against infection by PVX, PVY or CMV (Lodge 
et al, 1993). 
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1.5.2 Natural resistance genes 
Several natural resistance genes have been identified by plant breeders, and numerous 
varieties resistant to one or more viruses have been obtained by conventional breeding. 
However as mentioned in section 1.3.1, it is often difficult to transfer resistance 
characters from one plant species or variety to another without losing quality of the 
recipient cul ti var. Genetic engineering technology has the potential to facilitate such 
gene transfer. However, most natural resistance genes identified have been difficult to 
isolate. Considerable progress was made toward the isolation of various genes using 
restriction fragment length polymorphism (RFLP) mapping approaches (Ohmori et al., 
1995; Simcox et al., 1995). The first natural resistance gene, the TMV resistance gene 
N, was recently isolated and cloned (Whitman et al., 1994). Since then, a series of 
other resistance genes have been isolated and characterised. These genes may initiate a 
cascade of reactions that result in a hypersensitive response. When the N gene was 
transformed into susceptible tobacco, the resulting plants were resistant to TMV. This 
gene has homologies to other disease resistant genes isolated from plants. If virus 
resistant genes represent a family of genes it may be possible to identify such genes 
from other plants that will provide resistance to a wide range of viruses and other 
pathogens. 
Identification of proteins in plants that are specific for disease resistance may provide 
alternative means of developing host resistance. Proteins correlated with resistance to 
barley yellow dwarf virus (BYDV) have been identified in barley genotypes carrying 
the Yd2 gene for resistance to this virus (Holloway et al., 1992). Antibodies specific 
for this protein should provide a means of identifying this gene in a genetic library 
from resistant barley. 
The isolation of a CMV resistance gene (Ncm-1) which results in the induction of the 
hypersensitive response in an accession of L. luteus is being undertaken in our lab 
(Jones and Latham, 1996; Li., et al., 1999). 
1.5.3 Antibodies and oligoadenylate synthetase 
Expression of antibodies in plants is an attractive strategy to obtain resistance to 
viruses and other pathogens. Expression of antibodies in plants was first reported in 
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1989 (Hiatt et al., 1989). In this case the light chain and heavy chain were expressed 
in separate plants and these plants were crossed to produce plants that expressed both 
light and heavy chains. Many groups have since worked on expressing antibody genes 
in plants with limited success. In 1994, Van Engelen et al. were able to produce 
functional antibodies in the same T-DNA but each driven by a different promoter. 
Both genes were expressed in a coordinated manner and in the same cell types. This 
resulted in assembly of functional antibodies in the plant. 
The scFv (single chain Fv) specific for the CP of artichoke mottle crinkle virus 
(AMCV) has been expressed in tobacco plants (Taviadorakl et al., 1993), the presence 
of the scFv resulted in lower virus titres in systemically infected leaves and a delay in 
symptom expression. Experiments with protoplasts confirmed that the resistance was 
the result of specific binding of the antibody chain to the virus particles. 
There are some advantages to the use of scFv for engineering resistance to plant 
viruses. Firstly, they avoid the use of viral sequence expression in the transgenic plant. 
This negates concerns about the risks associated with expressing viral genes in plants. 
In addition, the cloning strategy is the same for the production of any scFv. The scFv 
approach could be applied to any stage of the life cycle of a virus, and it is likely that a 
scFv which interferes with early stages of the virus life cycle would be most effective. 
Another interesting approach using a mammalian defence system in plants relies on 
the expression of oligoadenylate synthetase in plants. This enzyme is activated by the 
presence of double-stranded RNA and polymerizes ATP into an oligomeric form that 
activates a latent ribonuclease, which degrades viral and cellular RNAs. Several lines 
of evidence suggest that part of this pathway operates in plants, a finding which has 
been confirmed experimentally by the expression of this enzyme in transgenic potato 
plants. These plants were indeed resistant to infection by PVX under field conditions 
(Truve et al., 1993). 
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1.6 Aims of this study 
The overall aim of this project was to engineer effective resistance to CMV in the 
narrow-leafed lupins (L. angustifolius). · The experimental approach was based on 
similar studies in the literature that demonstrated effectiveness of virus resistance in 
transgenic plants carrying virus-derived gene sequences. The major aims of the 
project were: 
1. To determine the complete genomic sequence of the Western Australian sg II
CMV-L Y isolate and compare it, at the nucleotide and amino acid level, with
published CMV sg I and sg II isolates. 
2. To develop a series of binary constructs containing the movement protein (MP),
coat protein (CP) or replicase gene (Rep) sequences of sgll CMV-L Y for
Agrobacterium-mediated transformation of plants, and to develop a CP resistance
gene construct, based on a CMV sg I isolate from banana.
3. To generate transgenic N. benthamianci'"plants carrying different MP, CP, and Rep
resistance genes for analysis of transgene activity in planta.
4. To undertake molecular analysis of transgenic N. benthaniana plants to determine
the effectiveness of the introduced genes for conferring resistance to sg II CMV
isolates.
5. To generate transgenic L. angustifolius cv Kalya plants carrying MP, CP, or Rep
genes shown to confer effective resistance against sg II CMV isolates (from 4).
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Chapter 2 General Materials and Methods 
In this chapter the general materials and methods that were routinely used in the study 
are given. Materials and methods specific to a particular topic that are not given here 
will be described in the appropriate chapters that deal with those issues. 
2.1 Materials and Methods 
2.1.1 Virus source 
Two CMV isolates, LY (sg II) and Banana (sg I) were used in this study. The CMV­
LY isolate was originally isolated from infected L. angustifolius cv Wandoo, in 
Western Australia (Jones, 1988). The CMV-Banana isolate was found infecting 
banana plants in the Carnarvon and Kununurra regions of Western Australia (Singh et 
al., 1995). Samples of CMV-LY and CMV-Banana were obtained from Dr Roger 
Jones (Agriculture Western Australia, South Perth). 
2.1.2 Maintenance of virus isolates 
Both CMV-L Y and CMV-Banana isolates were maintained in N. glutinosa host plants. 
The plants were mechanically inoculated with sap inoculum (made by grinding 5.0 g 
of infected leaves in 5 ml of 0.1 M potassium phosphate buffer (pH 7) containing 0.1 % 
celite as an abrasive) when the plants were at the three-leaf stage. The inoculation 
mixture was gently rubbed onto the upper leaf surface with the forefinger. The 
inoculum was washed off with distilled water after 5 min. The inoculated plants were 
then covered with damp newspaper for two days to prevent excessive dehydration 
from damaged cuticles. The plants were grown in 15 cm diameter pots and maintained 
in either a temperature controlled glasshouse or in a growth chamber with a day length 
of 16 hr and day/night temperatures of 25/18°C. 
2.1.3 Extraction of CMV RNA from plants 
CMV RNA used for RT-PCR was extracted from infected N. glutinosa leaf tissue 
using a phenol/choroform method modified from Wylie et al., (1993). Two to three 
infected N. glutinosa leaves were macerated to a fine powder in liquid nitrogen. The 
powder was transferred to a 1.5 ml disposable centrifuge tube. 500 µl of extraction 
buffer (200 mM Tris-HCl pH 7.5, 250 mM NaCl, 25 mM EDTA, 0.5% SDS) and 500 
µl of phenol:chloroform:isoamylalcohol (50:50:1) was added, the tube vortexed for 1 
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min, and centrifuged at 20,800 g for 1 min. The aqueous layer was transferred to a 
new tube and one volume of chloroform:isoamyalcohol (50:1) added, vortexed for one 
min, and centrifuged at 20,800 g for one minute. The aqueous layer was transferred to 
a new tube, an equal volume of ice-cold isopropanol was added, the contents mixed 
thoroughly by inversion and nucleic acids were precipitated at -80°C for 30 min. After 
thawing, the tube was centrifuged for 15 min to pellet total nucleic acids, the 
supernatant was removed and the pellet resuspended in 100 µ1 TE (pH 7.4 ). Nucleic 
acids were precipitated again with the addition of 4 µ1 0.5 M NaCl and 2.5 volume 
95% ice-cold ethanol, and cooled at -20
°
C for 30 min. The tube was then centrifuged 
at 20,800 g for 15 min, the supernatant removed, the pellet washed with 250 µ1 70% 
chilled ethanol followed by centrifugation at 20,800 g for 5 min. Finally, the pellet 
was air-dried, resuspended in 50 µl RNase-free water and stored at -20°C. 
2.1.4 Design of PCR primers 
The oligonucleotide primers used for RT-PCR and PCR amplification were designed 
from CMV-L Y sequence data already available or by comparing similar template 
sequences from multiple sequence alignment of published sequences, and selecting 
primer sequences from conserved regions. Primer sequences were analysed for 
primer-dimer and structural defects using the primer analysis programs Primer 
Designer, version 1.01 (Scientific Educational Software) and Amplify, version 1.2 
(Genetic Dept., University of Wisconsin, USA). Primers were synthesised by Life 
Technologies, Melbourne, Australia, or Fisher Biotech, Perth, Western Australia. The 
amount of each primer used for amplification ranged from 20 to 35 pmol for general 
PCR reactions, and 3.2 pmol for cDNA sequencing reactions. 
2.1.5 RT-PCR and PCR 
A large number of RT-PCR and PCR reactions were done during this study. 
Specific reaction conditions and primer sequences for each experiment will be 
described in the appropriate chapters. In general, the reagents were supplied by 
Perkin-Elmer (MuLV Reverse Transcriptase, RNase Inhibitor, AmpliTaq® DNA 
Polymerase, 10 X PCR Buffer II (500 mM KCl, 100 mM Tris-HCI pH 8.3, and a 
separate vial of 25 mM MgCh), and Promega deoxynucleoside triphosphates 




A standard RT-PCR consisted of 4 mM MgCh, 1 X PCR Buffer Il, 5 U RNase 
Inhibitor, 12.5 U MuLV Reverse Transcriptase, 1 mM dNTPs, 20 to 35 pmol 
downstream primer, 0.5 µl RNA extract, and RNase-free H20 to a final volume of 10 
µI. The reaction was incubated at 42°C for 15 min and then 99°C for 5 min to 
denature the reverse transcriptase enzyme. For PCR, the volume was increased to 50 
µl maintaining conditions of 4 mM MgCh and 1 X PCR Buffer II, and adding 1.25-5 
U Taq DNA Polymerase and 20 to 35 pmol upstream primer. A typical PCR cycling 
run would consist of an initial denaturation period of 3 min at 94 ° C followed by 30 
cycles of 94 °C 1 min, 60 ° C 1 min, 72 ° C 1 min, followed by a final extension cycle of 
72°C for 10 min. A Perkin Elmer Cetus DNA Thermal Cycler (model 480) or the 
Perkin Elmer PCR System 2400 Thermal Cycler was used for RT-PCR and PCR 
experiments in 0.5 ml and 0.2 ml reaction tubes, respectively. 
2.1.6 Molecular weight standard markers 
1. 100 bp DNA marker (Life Technologies)
2. 1 kb DNA marker (Life Technologies)
3. Bacillus subtilis phage SPPl DNA digested with Eco RI (Progen Industries, Ltd)
4. Lambda DNA-Hind III Digest (New England Biolabs)
5. pUC72 marker (Gene Works)
2.1. 7 Agarose gel electrophoresis 
Agarose gel electrophoresis was employed to check the progression of a restriction 
enzyme digestion, to quickly determine the yield and purity of a DNA isolation or 
PCR reaction, and to size fractionate DNA molecules. Agarose gel electrophoresis 
was carried out as described by Sambrook et al. (1989). The equipment used was 
either a Bio-Rad Mini Sub™ DNA cell or Bio-Rad Wide Mini Sub™ DNA cell 
apparatus. Agarose gel electrophoresis was done in 1 x T AE buffer (0.2 M Tris­
acetate, � mM EDTA, pH 8.0) as described by Sambrook et al. (1989). A 1.0% 
agarose gel was typically used, however, in cases where accurate size fractionation 
was required (eg. DNA molecules smaller than 1 kb), a 1.5 or 2% agarose gel was 
used. 3 µg/ml ethidium bromide (Sigma-Aldrich) was included in the gel to enable 
fluorescent visualisation of the DNA fragments under UV light. The DNA samples 
were mixed with gel tracking dye and loaded into the sample wells. Electrophoresis 
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was carried out at a constant voltage (70 - 85 V) for 30 - 60 min, depending on the 
desired separation. Gels were photographed on either a UVP Video Imager or a 
Polaroid MP4+ Instant Camera System. 
2.1.8 DNA purification 
2.1.8.1 DNA precipitation 
Nucleic acids in solution were often required to be concentrated by alcohol 
precipitation. The usual method was to precipitate nucleic acids by adding 2.5 
volum.es absolute ethanol and 1/10 volume 3 M sodium acetate (pH 5.3), cooled on ice 
for 30 - 60 min (or at -20°C overnight for smaller molecules) and then centrifuged at 
20,800 g for 30 min at 4°C. The supernatant was carefully discarded, the pellet 
washed at least once with 70% (v/v) ethanol and then centrifuged at 20,800 g for 5 
mm. The supernatant was carefully discarded and the pellet dried by vacuum
desiccation in a Speedvac (Savant Instruments). The pellet was then resuspended in 
the desired volume of distilled water for DNA, or diethyl pyrocarbonate (DEPC) 
treated water for RNA. 
2.1.8.2 Purification of DNA from agarose gels 
DNA fragments were purified from low-melting point (LMP) agarose gels using the 
BresaClean DNA Purification Kit (Gene Works). A 0.8-1.0% LMP agarose (Promega) 
gel containing 3 µg/ml ethidium bromide solution was prepared in lX T AE buffer. 
After electrophoresis, the band of interest was excised from the gel with a clean razor 
blade, 3 gel volumes of Bresa-Salt was added and the mixture incubated at 56°C for 5 
min to dissolve the agarose. 5-7 µl Bresa-Bind silica matrix was added, the solution 
mixed thoroughly and the tube incubated at room temperature for 5 min to bind DNA. 
The Bresa-Bind/DNA matrix was pelleted by centrifugation at 20,800 g for 17 sec, the 
supernatant discarded and the pellet washed by resuspending the matrix in an equal 
volume of Bresa-W ash solution. The tube was then centrifuged for 17 sec, the 
supernatant discarded and all traces of wash removed by evaporation in a Speedvac. 
The DNA was eluted from the Bresa-Bind matrix by resuspending the pellet in 2 
volumes distilled water and incubating the solution in a water bath for 5 min at 56°C. 
The tube was centrifuged at 20,800 g for 1 min and the supernatant, containing the 
purified DNA, was transferred to a new tube. 
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2.1.8.3 Plasmid purification 
Alkaline lysis method 
A single bacterial colony was inoculated in a 20 ml McCartney bottle containing about 
10 ml LB medium with the appropriate antibiotics. The bottle was shaken overnight at 
225 rpm at the optimum temperature for cell growth. The culture was transferred to a 
10 ml disposable centrifuge tube and the bacterial pelleted by centrifugation at 1,700 g 
for 5 min at 4 ° C. The liquid broth was removed and the cell pellet resuspended in 250 
µl of chilled Solution I (50 mM Tris-HCl, pH 8.0; lOmM EDTA; 100 µg/ml RNase 
A). The solution was transferred to a 1.5 ml centrifuge tube and 250 µl of freshly 
prepared Solution II (0.2 N NaOH and 1 % SDS) was added, the tube inverted gently" 5-
6 times to lyse the cells and the reaction was allowed to incubate at room temperature 
for 5 min. Then 250 µl chilled Solution ill (3 M potassium acetate, pH 5.5) was 
added, the tube gently inverted 5-6 times and placed on ice for 10 min before being 
centrifuged at 14,000rpm for 10 min to pellet cellular debris. The supernatant was 
transferred to a new Eppendorf tube, 0. 7 volumes of 100% isopropanol were added to 
precipitate the DNA and the solution centrifuged at 20,800 g for 20 min. The pellet 
was washed with 250 µl 70% chilled ethanol, centrifuged at 20,800 g for 5 min at 
room temperature and dried in a Speedv·ac:· The pellet was then resuspended in 50 µl 
water and stored at -20°C until required. 
QIAprep spin plasmid kit 
An overnight E. coli or A. tumefaciens culture was transferred to a 1.5 ml centrifuge 
tube and centrifuged at 20,800 g for 1 min to pellet bacterial cells. The supernatant 
was drained and the pellet resuspended in 250 µl Pl buffer (50 mM Tris-HCI, pH 8.0; 
10 mM EDTA; 100 µg/ml Rnase A). 150 µl P2 buffer (0.2 N NaOH and 1 % SDS) 
was added, the tube gently inverted 5-6 times and the reaction incubated at room 
temperature for 5 min. 350 µl of buffer N3 (3 M potassium acetate, pH 5.5) was 
added, the mixture inverted gently 5-6 times and centrifuged at 20,800 g for 10 min. 
The supernatant was transferred to a QIAprep DNA spin column to bind DNA, 
centrifuged at 20,800 g for 1 min, and the flow-through discarded. Bound DNA was 
washed twice, first with 0.5 ml buffer PB and then with 0.75 ml buffer PE (the tube 
centrifuged for 1 min and the flow-through discarded at each step). The DNA was 
eluted by placing the column into a fresh Eppendorf tube, covering the silica 
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membrane with 50 µl sterile distilled water, incubating it at room temperature for 1 
min and then centrifuging at 20,800 g for 1 min. 
2.1.8.4 Plant genomic DNA purification 
This method was adapted from that described by Dellaporta et al. (1983). Leaves were 
harvested fresh from the plant to obtain 1-2 g of tissue. The leaves were quickly 
frozen in liquid nitrogen and then crushed to a powder. The powder was transferred to 
a 50 ml centrifuge tube and 15 ml of extraction buffer added (500 mM NaCl, 100 mM 
Tris-HCl pH 8.0, 50 mM EDTA and 0.6% 2-mercaptoethanol). Then 1 ml of 20% 
SDS was added to the tube which was incubated at 65°C with occasional shaking for 
10 min. After incubation, 5 ml of 5 M potassium acetate was added with shaking and 
the tube placed on ice for 20 min. Following centrifugation at 20,800 g for 20 min the 
contents were poured though two layers of cheesecloth into a clean 50 ml tube 
containing 10 ml isopropanol. The tube was then incubated at -20°C for 1 hr before 
centrifugation at 20,800 g for 20 min. The supernatant was removed and the tube 
drained for a few minutes before resuspending the pellet in 700 µl of TE ( 10 mM Tris­
HCl pH 8.0, 10 mM EDT A). This was transferred to an Eppendorf tube containing 7 
µl of ribonuclease enzyme (10 mg/ml) and incubated at 37°C for 1 hr. 75 µl of 3 M 
sodium acetate (pH 5.3) was added and the sample centrifuged at 20,800 g for 15 min. 
The supernatant was transferred to a new Eppendorf tube and the DNA precipitated 
with 500 µl of isopropanol at room temperature. After 5 min, the DNA was pelleted 
by centrifugation at 20,800 g for 15 min and the supernatant discarded. The pellet was 
washed with cold 70% ethanol, the pellet dried in a Speedvac and then resuspended in 
200 µl TE. 
2.1.9 DNA quantification 
Three methods were used to measure the concentration of DNA in solution: (1) 
Spectrophotometer, (2) Fluorometer and (3) gel quantification using a standardised 
DNA molecular weight marker. 
Spectrophotometer 
To estimate the quantity of DNA in solution the absorbance was measured using a 
Pharmacia LKB Ultrospec III. The absorbance at 260 nm was measured in a quartz 




The concentration of DNA samples (ng/µl) was determined by fluorometric analysis in 
a Hoefer TKO 100 DNA fluorometer. An aliquot of DNA solution was added to 2 ml 
of a fluorometer working solution in a quartz cuvette. The working solution contains a 
fluorochrome dye [Hoechst 33258 in IX TNE (Tris-C 10 mM, NaCl 100 mM, EDTA 
1 mM, pH 7.4, Hoechst 33258 solution, 0.1 mg/mg)] which binds to double stranded 
DNA in solution and emits a fluoroscence at 460 nm relative to the DNA 
concentration. The fluorescence was quantified by comparison to a calf thymus DNA 
standard (25 ng/µl) (Promega). 
Gel quantification 
A serial dilution of the DNA sample (e.g. 0.5, 1, 2 and 4 µl) was electrophoresed 
alongside a serial dilution of a known molecular weight standard (e. g. 0.25, 0.5 and 
lµg DNA). The amount of DNA present in each sample was estimated by visually 
comparing the intensity of the experimental band with that of a similar sized fragment 
in the standard marker. DNA in each sample was then calculated using the following 
formula: 
Size of DNA standard X amount of standard used 
Total molecular weight of marker 
2.1.10 Cloning 
2.1.10.1 Restriction digest 
A large number of restriction enzyme digestions were performed for preparation and 
analysis of cloned plasmid DNA. Restriction enzyme digests were carried out by 
incubating the DNA with an appropriate amount of restriction enzyme in the buffers 
recommended by the supplier, and at the optimal temperature for that specific enzyme. 
A typical restriction digest was done in a 1.5 ml Eppendorf tube containing 10 U 
restriction enzyme, lX reaction buffer, Xng DNA and 100 µg/ml bovine serum 
albumin (BSA), made up to a final volume of 20 µl with sterile distilled water. The 
reactions were incubated for 1-3 hours at the optimal temperature for enzyme activity 
to insure complete digestion. The restriction products were then analysed by gel 
electrophoresis. 
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2.1.10.2 Dephosphorylation of plasmid vectors 
Linearised plasmid DNA was dephosphorylated using Calf Intestinal Alkaline 
Phosphatase (CIAP) (Promega). The reaction was carried out in a 1.5 ml Eppendorf 
tube containing lX CIAP reaction buffer (0.5 M Tris-HCl pH 9.3, 10 mM MgCh, 1 
mM ZnCh, 10 mM spermidine), 1 µl CIAP (1 U/µl) and 1 µg plasmid DNA, made up 
to a final volume of 50 µl with sterile distilled water. The reaction was incubated at 
37°C for 30 min, then 1 µl of CIAP was added and the reaction incubated for a further 
30 min at 56°C. The reaction was stopped by adding 2 µl 0.5 M EDT A and incubating 
the mixture at 75°C for 15 min. The DNA was then gel purified using the BresaClean 
DNA purification Kit and quantified using one of the methods given above. 
2.1.10.3 DNA ligation 
For the majority of ligations, a typical reaction consisted of 400 cohesive-end ligation 
units of T4 DNA ligase (New England Biolabs), lX reaction buffer (50 mM Tris-HCl 
pH 7.5, 10 mM MgCh, 10 mM dithiothreitol (DTT), 1 mM ATP, 25µg/ml BSA), Xng 
vector and Yng insert (depending on the desired ratio), and made up to a final-volume 
of 10 µl with sterile distilled water. The ligation reactions were incubated at 14°C 
overnight and then heated to 70°C for 10 min to denature the ligase before 
transformation. Ligations involving pGEM-T or pGEM-T Easy were done according 
to the manufacturer instructions using the reagents supplied with the vector. 
2.1.10.4 pGEM-T and pGEM-T Easy cloning vectors 
The TA cloning vectors pGEM-T and pGEM-T Easy (Progema) were routinely used 
for cloning PCR products. These plasmids have been especially designed for cloning 
PCR products by blunt-ending the pGEM-5zf(+) vector with Eco RV and adding a 3' 
terminal thymidine base (dTTP) to the ends. Ligation of PCR products takes 
advantage of the non-template dependent addition of a single adenosine base ( dATP) 
to the 3' ends of the PCR product by thermostable DNA polymerase that lack 3-5' 
exonuclease activity (e.g. AmpliTaq® DNA Polymerase). The multiple cloning sites 
(MCS) of the pGEM-T vectors have been placed into the a-peptide coding region of 
the B-galactosidase enzyme. Insertion of a PCR product disrupts enzyme activity and 
recombinant clones can be identified by blue/white screening. The only difference 
between the two vectors is the presence of two Eco RI and two Not I restriction sites in 
47 
the MCS of the more recently developed pGEM-T Easy plasmid. These sites allow the 
insert to be digested from the plasmid with a single enzyme for use in screening for 
cloned inserts or for downstream cloning purposes. The pGEM-T Easy plasmid 
played a very important role in this study because the Eco RI site was used to clone 
CMV trans genes into the binary vectors p YR2 and pART27 /7-4. 
2.1.11 Bacterial strains used in this project 
The E. coli strains used in this project were JM109 F' [traD36 lacl
q 
Li(lacZ) Ml5] 
proA +i3+/e14- (McrA) Li(lac-proAB) thi gyrA96 (Nair) endAl hsdRl 7 (rk-mk+) relAl 
SupE44 recAl; DHSa; F' /endAl hsdR17 (rk-mk+) supE44 thi-1 recAl gyrA (Nair) 
relAl Li(laclZYA-argF) U169 deoR (<)>80dlacii(lacZ0M15); and XLl-Blue
F'[proAB+laclq lacZLiM15Tn10 (tef)] supE44hsdR17 recAl endAl gyrA46 thi 
relAllac+. 
2.1.12 Preparation of chemically competent E. coli cells 
The method used for preparing chemically-competent E. coli cells was essentially that 
described in the 'Promega Protocols an_d �pplications Guide' (1996). E. coli cells 
were streaked on a LB medium plate and incubated at 37°C for 24 h. A single colony 
was inoculated into 5 ml LB liquid medium (10g bactotryptone, 5 g NaCl, 5 g yeast 
extract, pH 7 .0) and incubated at 37°C with shaking (250 rpm). The following 
morning, the entire overnight culture was used to inoculate 250 ml of LB medium 
containing 20 mM MgSO4• The cells were grown in a 1 L flask until the OD6oo 
reached 0.4-0.6 (about 3 hr). The culture was chilled on ice for 30 min and the cells 
pelleted by centrifugation at 4,500 g for 5 min (Beckman JA14 rotor) at 4°C. The cells 
were gently resuspended in 0.4 volume of ice-cold TFBl (30 mM potassium acetate, 
10 mM CaCh, 50 mM MnCh, 100 mM RbCl and 15% glycerol), incubated on ice for 
5 min, and then centrifuged at 4,500 x g for 5 min at 4 °C. The cells were resuspended 
gently in 1/25 of the original culture volume of ice-cold TFB2 (10 mM MOPS or 
PIPES, pH 6.5, 75 mM CaCh, 10 mM RbCl and 15% glycerol). The mixture was 
incubated on ice for 15-60 min and then 200 µl aliquots were transferred to 1.5 ml 




2.1.13 Heat-shock transformation of E. coli cells 
Chemical competent E. coli cells were transformed according to the method of 
Sambrook et al. (1989). Frozen competent cell aliquots were slowly thawed on ice 
and 100 µI aliquots transferred to chilled 1.5 ml Eppendorf tubes containing 5 µI of the 
ligation mixture. The reagents were mixed gently by flicking the base of the tube and 
then returned to ice for 30 min. The cells were then subjected to a heat shock at 42°C 
in a water bath for 45 sec and immediately cooled on ice for 2 min. The cells were 
allowed to recover by adding 0.9 ml of LB liquid medium to each tube, followed by an 
one-hour incubation on a shaking platform at 37°C. The cells were plated out on a LB 
agar plate containing the appropriate antibiotics and incubated overnight at 37°C. 
2.1.14 Preparation of electro-competent A. tumefaciens cells 
A. tumefaciens strains AGL0 and LBA4404 were kindly supplied by Dr S. Wylie
(SABC). A. tumefaciens cells were streaked on LB agar plates containing 50 mg/I 
rifampicin and incubated for 48 hr at 28°C. A single colony was used to inoculate 10 
ml LB containing 50 mg/I rifampicin in a 30 ml McCartney bottle and shaken at 225 
rpm overnight at 28°C. 5 ml of the cells were added to 500 ml of modified LB 
medium containing 5 g bacto-tryptone, 2.5 g yeast extract and 0.5 g NaCl, pH 7 .0. 
The culture was shaken at 225 rpm at 28°C until the OD600 reached 0.45-0.55. The 
cell� were then chilled on ice for 1 h and collected by centrifugation in a cold JA14 
rotor (Beckman) at 2000 x g for 10 min at 4 °C. The pellet was gently resuspended in 
500 ml of ice cold sterile distilled water. The cells were collected as above and the 
pellet resuspended in 100 ml, then 50 ml, and finally 20 ml of 10% glycerol. 200 µI 
aliquots were snap-frozen in liquid nitrogen and stored at -80°C. 
2.1.15 Electroporation of electro-competent A. tumefaciens cells 
A tube containing 50 µI of the A. tumef aciens cells was taken from -80°C storage and 
thawed on ice. 1 µI of low ionic strength plasmid DNA was added and gently mixed. 
The mixture was left on ice for l-2 min before transferring the mixture to an ice cold 
0.2 cm electroporation cuvette (Bio-Rad). The cuvette was tapped gently a few times 
to ensure that the cells were at the bottom of the chamber. Electroporation was carried 
out with a Bio-Rad Gene Pulser™ set at 2.5 kV and 2.5 µFD and a Bio-Rad Pulse 
Controller set to 200 Q. The cells were given a single pulse. Immediately following 
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electroporation, 1 ml of LB medium was added to the cuvette and the cells transferred 
to a 1.5 ml centrifuge tube and allowed to recover at room temperature before being 
incubated on a shaker (100 rpm) at 28°C for 2 hr. Following recovery, 200 µl of the 
cells were spread onto a selective LB plate containing 100 mg/I spectinomycin and 
incubated at 28°C until colonies became visible, usually 36-48 hr later. 
2.1.16 Screening and analysis of putative transformants 
Single colonies were grown overnight in 5-10 ml LB containing the appropriate 
antibiotics. Presence of an insert was confirmed by PCR using primers specific for the 
insert or by restriction digestion. For restriction digest analysis, the plasmid DNA was 
linearised with restriction enzymes unique to either the insert or the MCS of the 
plasmid and the digests analyzed by agarose gel electrophoresis using a linearised non­
recombinant vector as the marker. Insert orientation was determined by PCR or by 
restriction digestion with enzymes that cut in either the vector or the insert, or both. 
2.1.17 Confirmation of Agrobacterium culture 
2.1.17 .1 3-ketolactose test 
The 3-ketolactose test is used to confirm that the bacterial culture being examined is in 
fact A. tumefaciens and not an E. coli contaminant (Bemaerts and De Lat, 1963). For 
this procedure a negative E. coli JM109 control was streaked out as a circle (0.5 cm in 
diameter) onto an agar plate of solid lactose medium (10 g/1 lactose, 1 g/1 yeast extract, 
20 g/1 agar) and incubated overnight at 37°C. Two A tumefaciens strains, AGL0 and 
LBA4404, were then streaked as circles onto the same plate. The plate was then 
incubated at 28°C for two days until dense colonies had formed. The plate was then 
flooded with a layer of Benedict's reagent (173 g sodium citrate and 100 g anhydrous 
sodium carbonate dissolved in 600 ml distilled water with heating. 17 .3 g Cupric 
sulfate was dissolved in 150 ml distilled water and slowly added to the sodium 
citrate/sodium carbonate solution with constant stirring. The solution was made up to 
1 litre with water) and left for one hour at room temperature. Colonies of A.
tumefaciens produced 3-ketolactose on the lactose medium, which reacts with the 
Benedict reagent to form a distinctive yellow ring (Cu20) around the colony. 
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2.1.17.2 Confirmation of Agrobacterium cultures by PCR 
It is also possible to confirm the presence of Agrobacterium using PCR. This method 
is based on PCR amplification of a fragment of the Ti plasmid. For this study, a pair 
of PCR primers (Primer 1 5'AAGATCATITGTAGCGAC and primer 2 
5'AGCTCAAACCTGCTT) that amplify a 560 bp fragment of the A. tumefaciens vir D 
gene, but does not amplify genomic E. coli DNA, was used to check the bacterial 
colonies. The reaction conditions for PCR was done using the typical protocol as 
described in section 2.5. 
2.1.18 Antibiotics used in this study 
Antibiotic stock solutions were made by mixing a weighed amount of antibiotic power 
with water or ethanol as described by Sambrook et al. (1989). The solution was then 
passed through a 0.22 µm filter and stored in ready-made aliquotes at -20
°
C. 
Antibiotics added to autoclaved media were added after the broth had cooled to 50
°
C. 
The selective agents and working concentrations are listed below: 
Ampicillin 50-100 µg/ml 
50-100 µg/ml Chloramphenicol 
Kanamycin 100 µg/ml (for transgenic plant selection) 







2.1.19 DNA sequencing reactions 
DNA sequencing was carried out using with AmpliTaq DNA Polymerase with half the 
recommended reagent concentrations as described in the ABI Prism TM Dye Terminator 
Cycle Sequencing Ready Reaction Kit technical manual (PE Biosystem). For the PCR 
reaction the following reagents were used: 4 µl Terminator Ready Reaction Mix, 200 
ng/µl plasmid DNA, 1.6 pmol specific primer, made up to 10 µI with sterile distilled 
water. The sequencing reactions were carried out in a Perkin Elmer GeneAmp PCR 
System 2400 thermal cycler under the following conditions: 96°C for 10 sec, 55°C for 
5 sec, 60°C for 4 min, for a total of 25 cycles. The completed reactions were 
transferred to a 0.5 ml centrifuge tube containing 1 µl 3M sodium acetate (pH 5.4) and 
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25 µ195% ethanol, incubated on ice for 10 min and then centrifuged at 20,800 g for 20 
min. The supernatant was removed, the pellet washed with 250 µI of 70% ethanol and 
dried in a Speedvac. The sequencing gels were prepared, electrophoresed and the data 
collated by either Ms. Judy Smith or Ms. Frances Briggs (SABC technical staff). 
2.1.20 Computer programs 
The large collections of computer programs available through the Australian National 
Genomic Information Service (ANGIS) were used extensively to analyse DNA and 
protein sequences. This service offers a comprehensive range of nucleic acid and 
protein sequence analysis programs as well as providing a direct link to the computer 
analysis programs of the Genetics Computer Group, Inc, Wisconsin, USA (GCG). 
The SeqEd™ version 1.0.3 software (Applied Biosystems Industries) was used to 
analyse raw sequence data generated with the 373A sequencer. Plasmid maps were 
generated with MacPlasmap, version 2.05r5 (CGC Scientific Inc.). DNA Strider, 
version 1.0 (Dept. Biology, Commissariat a l'Energie Atomique, France) was used for 
restriction site analysis. Amplify, version 1.2 (W. R. Engels, University of Wisconsin, 
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Chapter 3. Development of CMV resistance gene constructs 
Overview of the Chapter 
In this chapter, the design and development of a range of molecular constructs based 
on the CMV MP, CP and replicase (Rep) genes are described. The "Materials and 
Methods" and "Results" section have been combined to make it easier to follow the 
developmental processes used for each type of construct. The strategies used for 
constructing the resistance genes in pUC based vectors varied for the different gene 
types and they have therefore been given separately. The methods used to transfer the 
gene constructs into plant binary vectors were similar and have been combined. The 
chapter has been divided into five parts: 
Part 1. Modification of the plant binary vectors pPZBlOl and pART27 
Part 2. The development of three CMV-L Y JvlP transgenes 
Part 3. The development of two CMV-L Y Rep trans genes 
Part 4. The development of four CMV CP transgenes 
Part 5. Transgene cloning into the plant binary vectors 
In total, nine different constructs were made. Eight were based on the MP, CP and 
Rep genes of the Western Australian sg II CMV-LY isolate from narrow-leafed lupin 
(L. angustifolius), and one based on the CP gene of a Western Australian sg I CMV­
Banana isolate. The transgene constructs were cloned into plant binary vectors for 
transformation of lupin (pYR2) and tobacco (pART7/7-4). 
3.1 Part 1: Construction of pYR2 and pART27/7-4 binary vectors 
3.1.1 Introduction 
The main aim of this project was to generate a range of CMV resistance constructs to 
induce and analyse virus resistance in transgenic lupins. However, transformation 
efficiency of the narrow-leafed lupin is low ( ~0.1 % ) and the in vitro regeneration 
process is slow. To help speed up the process and aid in identifying the most effective 
transgenes, the same constructs were also made for transformation and analysis in 




Three plant binary vectors were available for Agrobacterium transformation, pT AB 10 
and pPZBlOlexp (Wylie, 1996) and pART27 (Gleave, 1992). In addition to these 
vectors a plant expression cassette (Sc4-Sc5) derived from the promoter/terminator 
sequences of the subterranean clover stunt virus (SCSV) components 4 and 5 was 
available (P. Boevink 1997, personal communication). This cassette has been shown 
to provide constitutive and high expression of transgenes in legumes (P. Waterhouse, 
1998, personal communication). 
pPZBlOl and pPZBlOlexp are derivatives of the pPZPlOO plant binary vector series 
(Hajdukiewicz et al., 1994). The plasmid backbone contains the ColEI replicon for 
elevated copy number in E. coli and a chloramphenicol resistance gene for bacterial 
selection. The T-DNA region of the pPZPlOlexp plasmid contains two plant 
expression cassettes. The first cassette contains the CaMV 35S promoter driving the 
plant selectable marker gene bar which confers resistance to the herbicide Basta, and 
the Agrobacterium octopine synthase gene transcription termination sequence (ocs 3'). 
The second cassette consists of the CaMV 35S promoter and the 3' UTR and the 5' 
UTR of CMV. A N co I restriction site is located at the junction of the 5' and 3' UTRs, 
and is used for cloning the gene of interest. pPZB 101 is an earlier version of 
pPZBlOlexp and only contains the bar selectable marker cassette (Wylie, 1996). 
The pART27 backbone contains the ColEI replicon for elevated copy number in E.
coli, the RK2 minimal replicon for replication in E. coli and Agrobacterium, and a Tn7 
spectinomycin/streptomycin resistance gene for bacterial selection. The T-DNA 
region of pART27 contains a lacZ' gene for a-complementation and a chimaeric 
kanamycin resistance gene for plant selection. The gene of interest is usually cloned 
into an intermediary cloning plasmid, pART7, which contains a plant expression 
cassette consisting of the CaMV 35S promoter, a MCS and the ocs 3' termination 
sequence. The whole cassette is then transferred as a Not I fragment into the lacZ 
gene of pART27. When cloned in this manner, positive recombinants can be selected 
using blue/white screening of transformed colonies. 
In order to meet the requirements for narrow-leafed lupin and tobacco transformation 
two different binary vectors were used. The narrow-leafed lupin has natural resistance 
or tolerance to kanamycin but is quite susceptible to the herbicide Basta. The CMV-
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LY gene sequences (MP, CP and Rep) all contain at least one Nco I restriction site, 
which precluded the use of the full pPZBlOlexp binary vector. It was therefore 
necessary to clone the Sc4-Sc5 expression cassette into pPZB 101 and use this vector 
for expressing the gene(s) of interest in lupins (Fig. 3.1). Unfortunately, transgenes 
driven by the Sc4 promoter are poorly expressed in tobacco (P. Waterhouse, personal 
communication) precluding the use of this binary vector for tobacco transformation. 
However, tobacco is quite sensitive to kanamycin and the pART27 binary vector has 
been successfully used for transforming this plant. Therefore, this vector was chosen 
for expression of CMV transgenes in tobacco. The results of plant transformation and 








Eco RI Hind III 
Sc5 3' UTR 
irid III 
Figure 3.1 The pPZBlOl plant binary vector and Sc4-Sc5 plant expression cassette
used for construction ofpYR2. (a) The Sc4-Sc5 plant expression cassette showing the 
Hind III restriction sites used for excision of the cassette from pBS272 and the Eco RI 
site used for cloning the gene of interest. (b) A plasmid map showing pPZBl 01 and 




3.1.2 Materials, Methods and Results 
3.1.2.1 The pPZBlOl binary vector and Sc4-Sc5 expression cassette 
The plasmid pBS272 containing the Sc4-Sc5 plant expression cassette (Fig 3.1 (a)) 
was kindly supplied by Dr P. Waterhouse (Division of Plant Industry, CSIRO, 
Canberra) and the plant binary vector pPZBlOl (Fig 3.1 (b)) was provided by Dr S. 
Wylie (SABC, Murdoch University). 
3.1.2.2 Construction of the p YR2 binary vector 
Deletion of an Eco RI site in pPZBlOl 
The restriction enzyme Eco RI is used for cloning the gene of interest into the Sc4-Sc5 
plant expression cassette, however, there was also an Eco RI site present in the left 
border (LB) sequence of pPZBlOl (Fig. 3.1 (b)). This site was deleted by digesting 
the pPZBlOl plasmid with Eco RI, blunt-ending the linear DNA with Kienow DNA 
polymerase and re-ligating it to the circular form with T4 DNA ligase. This resulted 
in the removal of the Eco RI site, as determined by Eco RI digestion (Fig. 3.2). The 
modified plasmid was given the name pYRl. 
12 kb -+ 
1 2 3 4 5 6 7 8 
Figure 3.2 Electrophoretic analysis of a deleted Eco RI site in pPZBlOl. 
Lanes (1) 1 kb marker; (2) pPZBJOJ plasmid digested by Eco RI; (3-7) mutated 
pPZBJOJ plasmids digested by Eco RI (uncut); (8) mutated pPZBJOJ plasmids 
digested by Hind III. 
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Preparation of Sc4-Sc5 cassette and p YRl plasmid for cloning 
Hind m restriction digestion was used to excise the Sc4-Sc5 plant expression cassette 
from pBS272 and to linearise pYRl and pGEM3zf(+) plasmid DNA. The latter 
plasmid was used for obtaining the nucleotide sequence of the Sc4-Sc5 cassette (see 
section 3.3.2.4). The restriction digests were electrophoresed in a 1 % LMP gel, the 
desired fragments excised and purified using the BresaClean DNA Purification Kit, 
and the amount of DNA recovered quantified by gel electrophoresis. 1 µg linear 
p YRl plasmid was dephosphorylated with CIAP, gel purified using the BresaClean 
DNA Purification Kit and the DNA quantified for ligation. 
Cloning the Sc4-Sc5 plant expression cassette into p YRl 
The Hind Ill digested Sc4-Sc5 fragments was ligated into pYRl plasmid in a 3:1 ratio 
(insert:vector), transformed into competent E. coli JM109 cells and incubated 
overnight at 37°C on LB plates containing 100 µg/ml chloramphenicol. Eight single 
colonies were screened for positive recombinants by the Hind III restriction pattern 
observed following electrophoresis. The orientation of the cassette in p YR 1 was 
determined by Pst I/Eco RI double digestion (Fig. 3.3). The p YRl plasmid containing 
the cassette in a convergent orientation with the bar cassette was chosen for future use 
and named pYR2 (Fig. 3.4). 
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680bp + 
180bp 
1 2 3 4 5 
Figure 3.3 Restriction digest analysis of Sc4-Sc5 cassette in p YRJ. 
Lanes (1) 1 kb marker; (2) pYRJ digested by Hind Ill; (3) positive recombinant of 
pYR1/Sc4-Sc5 plasmid digested by Hind Ill; (4) PYR2 plasmid double digested by Eco 











Figure 3.4 Plasmid map of the p YR2 plant binary vector. The plasmid contains two 
plant expression cassettes, the bar selectable marker cassette and the Sc4-Sc5 
transgene expression cassette. The gene of interest is cloned in as an Eco RI 
fragment. 
59 
I I I I 
DNA sequencing of the Sc4-Sc5 cassette 
The Sc4-Sc5 expression cassette was sequenced to compare the cloned fragments with 
the original entries at the GenBank sequence database. To achieve this aim, purified 
Sc4-Sc5 DNA was cloned into Hind III digested pGEM3zf( +) plasmid (both from 
section 3.1.2.1.1.). The cassette was ligated into pGEM3zf(+) in a 3:1 ratio 
(insert:vector), transformed into competent E. coli JM109 cells and incubated 
overnight at 37°C on LB plates containing 100 µg/ml ampicillin. Plasmid DNA was 
extracted from single colonies grown overnight in LB containing 100 µg/ml ampicillin 
using the QIAprep spin plasmid kit. The colonies were screened for positive 
recombinants by Hind III digestion of purified plasmid DNA (Fig. 3.5). The Sc4-Sc5 
cassette was sequenced on an automated ABI 373 sequencer using the ABI Prism™
Dye Terminator Cycle Sequencing Ready Reaction Kit described in Chapter 2. The 
cassette was sequenced in both directions using the T7 universal primer and a 
modified SP6 primer (Table 3.1). These primers anneal to plasmid DNA on either 
side of the MCS and are ideal for sequencing cloned inserts. 
3kb -+
680bp -+
1 2 3 4 5 
Figure 3.5 Restriction digest analysis of recombinant pGEM-3ef ( +) plasmids 
containing the Sc4-Sc5 plant cassette. Lanes ( 1) 1 kb marker; (2) linearised pGEM-
3if ( +) plasmid DNA ( 3-5) recombinant pGEM-4if ( + )/Sc4-Sc5 plasmids digested 




Table 3.1 T7 and SP6 primers used for sequencing inserts cloned into pGEM-T. 
T7 5'CTATGACCATGATTACGCCAAGC 
SP6 5'CGGCCAGTGAATTGTAATACGAC 
The Sc4 promoter and Sc5 terminator sequences were aligned with the corresponding 
sequences in the GenBank database (Boevink et al., 1997) using the CLUSTALW 
multiple alignment program. The alignment is given in Figure 3.6. There are seven 
differences between the Sc4 promoter that was used in this study and that of the 





























































Figure 3. 6 Sc4-Sc5 cassette DNA nucleotide sequence alignment with the original 
GenBank entry (ul6732 and ul6734). The GenBank entry on the top and the Sc4-Sc5 
cassette is given on the bottom line. The Eco RI site is shown in bold and the Hind III 
restriction sites used for cloning into pYRJ is underlined 
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3.1.2.3 Construction of the pART27 /7-4 binary vector 
The pART7 and pART27 plasmids 
The primary cloning vector pART7 [Fig 3.7(a)] and the plant binary vector pART27 
[Fig 3.7(b)] were kindly supplied by Dr P. Waterhouse, Division of Plant Industry, 
CSIRO, Canberra. As stated earlier, the gene of interest is generally cloned into 
pART7 and then the whole cassette is transferred as a Not I fragment into the lacZ' 
gene of pART27. However, because there was a Not I restriction site present in CMV­
L Y CP gene, the pART7 cassette was first cloned into pART27 to generate 
pART27 /7, and then the CMV resistance genes were cloned into the unique Eco RI 
restriction site in the MCS (Fig. 3.7). 
Preparation of pART7 cassette and pART27 plasmid for cloning 
Single E. coli XLl-Blue colonies carrying either the pART7 or pART27 plasmids 
were grown overnight in LB broth containing 25 µg/ml kanamycin. Plasmid DNA 
was purified using QIAprep spin columns. Not I restriction digestion was used to 
excise the plant expression cassette from pART7 and to linearise pART27 plasmid 
DNA. The restriction digests were electrophoresed in a 1 % LMP gel, the desired 
fragments excised from the gel, purified u�ing the BresaClean DNA Purification Kit 
and the amount of DNA recovered quantified by gel electrophoresis. 1 µg of linear 
pART27 plasmid was dephosphorylated with CIAP, gel purified using the BresaClean 
DNA Purification Kit, and the amount of DNA fluorometrically quantified. 
(b) 
Figure 3. 7 pART7 and pART27 plasmid maps. ( a) The plant expression cassette in 
pART7 consists of a CaMV 35S promoter, a MCS and the ocs 3' termination sequence. 
(b) The T-DNA region of pART27 contains the lacZ' gene for a-complementation and












._ 1.35 kb 
Figure 3.8 Restriction digest analysis of a pART7 expression cassette cloned into 
pART27. (a) Lanes: (1)-(3) and (5)-(7) pART27/7 digested by Not I, show all of the 
six colonies are positive; (4) SPP molecular marker. (b) Lanes: (1) 1 kb molecular 
marker; (2) pART27 digested by Not I; (3) pART7 digested by Not I; (4) pART27/7 
digested by Barn HI, shows the 35S and pnos promoters transcribe in parallel 
orientation; (5) pART27/7 digested by Barn HI, shows the 35S and nos promoters in a 





Cloning the plant expression cassette into pART27 
The Not I digested pART7 cassette was ligated into pART27 m a 3:1 ratio 
(insert:vector), transformed into electrocompetent E. coli XLI-Blue cells and 
incubated overnight at 37
°
C on LB plates containing 50µg/ml spectinomycin. Six
colonies were screened for positive recombinants by the Not I restriction pattern 
observed following electrophoresis. The orientation of the cassette in pAR T27 was 
determined by Bam HI restriction digest (Fig. 3.8 (a)). A plasmid with both cassettes 
in parallel direction was selected for further use and was named pART27/7-4 (Fig. 3.8 
(b) and Fig. 3.9).
oriV ax2 pART2717--4 
12.9 kb 




Figure 3.9. The pART27/7-4 plasmid map. The T-DNA region contains two plant 
expression cassettes. The first contains the kanamycin resistance gene for plant 
selection and the second contains the CaMV 35S promoter, a MCS and the ocs 3' 
terminal sequence. The Eco RI restriction site in the MCS was used for cloning CMV 
resistance genes. 
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3.2 Part 2: The development of three CMV-LY MP transgenes 
3.2.1 Introduction 
The CMV gene constructs presented in Parts 2 to 4 of this Chapter have been designed 
to compare the mechanism(s) of resistance (protein-mediated vs. RNA mediated) and 
to determine whether a particular gene ( eg. MP, Rep, CP) is likely to be most 
effective. The results derived from this work may not provide definitive answers to 
these questions, but will add to the body of information already available in the 
literature. The use of virus MP genes to confer resistance to plant viruses is a 
relatively new PDR approach and there have been no reports of the CMV MP gene 
being used for this purpose. The development and analysis of CMV MP transgenes in 
plants would therefore provide additional information for the scientific community and 
the results would be useful for comparisons with other PDR virus genes. A flowchart 
outlining the procedures used for construction of the CMV-L Y MP resistance genes is 
· given in Figure 3. 10.
RNA3 S'lITR ORF3a 
i RT-PCR 
UNMP, :MP and :MPS PCR products 
Clone into the pGEM-T plasmid 
t 
Sequence CMV :MP clones 
pYR-:MP sense 
Clone into plant binary vectors, 
pYR2 and pART27/7-4 
p YR-:MP antisense 
pYR-:MPS sense 
__. p YR-:MPS antisense 









Figure 3.10 A flowchart outlining the procedures used in the development of 
CMV-LY MP constructs. MP refers to a full-length ORF3a gene sequence, MPS
refers to an untranslatable full-length ORF3a gene sequence, and UNMP refers to a
full-length ORF3a gene sequence preceded by the native CMV-LY 5' UTR.
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3.2.2 Materials, Methods and Results 
3.2.2.1 Cloning strategy 
Three CMV-LY MP resistance genes based on full length MP coding sequences were 
developed in this project (Fig. 3.11). 1. The sequence coding for the entire ORF, plus 
the upstream 5' UTR from RNA 3a (UNMP), 2. the sequence coding for the entire 
ORF (MP), and 3. the sequence coding for the entire ORF but rendered untranslatable 
by the insertion of a stop codon just downstream of the translation initiation start 
codon (MPS). The constructs allow a direct comparison of protein and RNA-mediated 
resistance strategies (MP vs. MPS, respectively). The UNMP construct contains the 
native CMV RNA 3a 5' UTR sequence immediately upstream of the ORF3a. When 
cloned into the plant expression cassette of the binary vectors it results in tandem 5' 
UTR sequences. This construct was used to examine whether an additional and native 
UTR sequence could be used to enhance transcription/translation of the transgene in 
the host. 
ATG 









MPS I ORF3a 
TtA 
� 
Figure 3.11 Schematic illustration of the CMV-LY MP resistance genes. RNA 3 
shows the native CMV RNA 3 molecule, gene organization and regulatory sequences. 
UNMP contains the 5' UTR and fully translatable ORF3a coding region. MP contains 
a fully translatable ORF3a coding region. MPS contains the full ORF3a coding 
sequence rendered untranslatable by insertion of a downstream stop codon (TGA). 
The arrows indicate the region of the ORF 3a amplified for cloning and the acronyms 
above or below the arrows give the names of the primers used for RT- PCR. ATG is 
the start codon, TGA is the stop codon and IR refers to the IR between ORF 3a and 
ORF 3b. 
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3.2.2.2 Oligonucleotide primer design 
Four oligonucleotide primers were used to amplify the desired region of the CMV-L Y 
:MP required for the constructs. (Fig.3.11, Table 3.2). The primer sequences were 
based on the CMV-LY :MP sequence (Accession No. Yl 1876) previously submitted to 
the GenBank database (unpublished). An Eco RI restriction site was incorporated at 
the 5' end of the primers to facilitate cloning into plant expression cassettes. 
Table 3.2. Primer sequences used for amplifying CMV-LY MP genes 
5'UNMP 5'GCAGAATTCGTAATCTTACCACTITC 
5'MP 5'TATGAATTCAACCATGGCTITCCAAGGTCC 
5'MPS 5'GAA TTCATGGCTTTCCAA TGAACCAGT AGGACG 
3'MP 5'GCTGAA TTCCT AAAGACCGTT AACCACC 
* Eco RI restriction sites used for cloning are underlined. The start codon (ATG) and
the stop codon (TGA) in the 5' MPS primer are in bold.
3.2.2.3. RT-PCR 
CMV RNA was extracted from infected N. glutinosa host plants as described in 
Chapter 2. Following optimisation of the RT-PCR reaction, the reagents and volumes 
given in Table 3.3 were used for production_of first-strand cDNA from genomic CMV 
RNA. The reaction was incubated in a thermal cycler at 42°C for 30 min, and then 
99°C for 5 min to denature the reverse transcriptase enzyme. 
The PCR step was done by adding the reagents given in Table 3.4 as a master mix 
directly to the tube containing the completed RT reaction. The reaction was then 
heated to 94°C for 3 min for initial denaturation followed by 30 cycles of 94°C for 30 
s, 60°C for 30 s; 72°C for 2 min, with a final extension cycle of 72°C for 10 min. The 
products of PCR were analysed on a 1 % (w/v) agarose gel (Fig. 3.12). 
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Stock Cone. Volume (µI) Final Cone. 
25 mM 6.4 4 mM 
lOX 4.0 lX 
5 U/µl 0.25 1.25 U/10µ1 
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Figure 3.12 RT-PCR amplification of three CMV-LY MP gene fragments. 
Lanes: (1) 1 kb maker; (2) positive control (CMVLY-CP3); (3) negative control 
(H20); (4) MP; (5) UNMP; (6) MPS; (7) 100 bp marker. 
3.2.2.4 Cloning of CMV-LY UNMP, MP and MPS resistance genes 
into pGEM-T 
The UNMP, MP and 1-fPS PCR products were electrophoresed in a 0.8% (w/v) LMP, 
the bands excised from the gel, purified using the BresaClean DNA Purification Kit, 
and the amount of DNA recovered fluorometrically quantified. The purified 
fragments were ligated into pGEM-T in a ratio of 3:1 (insert:vector), transformed into 
chemical competent E. coli JM109 cells and incubated overnight at 37°C on LB plates
containing 100 µg/ml ampicillin, coated with 20 µl of 50 mg/ml X-Gal and 100 µl of 
100 mM IPTG to facilitate blue/white screening. Screening for positive colonies was 
done by Eco RI restriction digestion of purified plasmid DNA extracted from single 
white colonies grown overnight in LB broth containing 100 µg/ml ampicillin (Fig. 
3.13). 
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Figure 3.13 Eco RI restriction digest analysis of recombinant pGEM-T plasmids. 
Lanes (1) 1 kb marker; (2) UNMP PCR fragment; (3) recombinant pGEM-TIUNMP 
plasmid cut with Eco RI; (4) MP PCR fragment; (5) recombinant pGEM-T/MP 
plasmid cut with Eco RI; (6) MPS PCR fragment; (7) recombinant pGEM-T/MPS 
plasmid cut with Eco RI; (8) linearised pGEM-T. 
3.2.2.5 Sequence analysis of UNMP, MP and MPS resistance genes 
The CMV-LY UNMP, MP, and MPS resistance genes were sequenced to ensure that 
they had not undergone mutation during the PCR process and that the desired 
modifications placed in the primers had been correctly incorporated. Recombinant 
pGEM-T plasmids were gel purified using QIAprep Spin Columns, the DNA 
fluorometrically quantified and the inserts sequenced in both directions using T7 and 
SP6 primers. The nucleotide and predicted amino acid sequences for each gene 
fragment are shown in Fig. 3.14 and Fig. 3.15, respectively. 
The UNMP resistance gene contains 96 nt of the 5' untranslatable region (5'UTR) and 
840 nt (279 amino acids) of the ORF3a of CMV-LY. The MPS gene, was the same 
length as the MP gene and contains 840 nt (279 amino acids) of ORF3a. It was 
confirmed that the UNMP and MP genes were in-frame. The two desired mutations 
located at 109 and 111 (G to T, T to A, respectively) of MPS gene introduced a stop 
codon (TGA), so that translation of MPS could not take place (Fig.3.14; Fig.3.15). 
Two unexpected nucleotide differences were found in the MPS gene. The first was 
located at 530 and changed an adenine base to a guanine (A ➔G), resulting in an 
amino acid change from aspartic acid (Asp) to glycine (Gly). The second mutation 
was at 859 and changed an adenine base to a cytosine (A➔C). 
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1 50 
LYMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
LYUNMP GTAATCTTAC CACTTTCTTT CACGTCGTGT CGCGTCAGTC CACGCTGTGT 
LYMPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . .
Consensus ---------- ------------ ---------- ______ ,._ ___ -----------
51 100 
LYMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...... ATGG 
LYUNMP GTGTGCGTGT GTTAGTTAGT GTGTCGTGTT TAGATTACCG AAGGTTATGG 
LYMPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . ...... ATGG 
Consensus ---------- ---------- ---------- ---------- ------**** 
101 150 
LYMP CTTTCCAAGG TACCAGTAGG ACGTTAACTC AACAGTCCTC GGCGGCGTCG 
LYUNMP CTTTCCAAGG TACCAGTAGG ACGTTAACTC AACAGTCCTC GGCGGCGTCG 
LYMPS CTTTCCAATG CCAGTAGG ACGTTAACTC AACAGTCCTC GGCGGCGTCG 
Consensus ********-* -********* ********** ********** ********** 
151 200 
LYMP TCTGACGACT TACAGAAGAT ATTATTCAGC CCCGATGCCA TCAAGAAGAT 
LYUNMP TCTGACGACT TACAGAAGAT ATTATTCAGC CCCGATGCCA TCAAGAAGAT 
LYMPS TCTGACGACT TACAGAAGAT ATTATTCAGC CCCGATGCCA TCAAGAAGAT 
Consensus ********** ********** ********** ********** ********** 
201 250 
LYMP GGCTACTGAG TGTGACCTAG GTCGACATCA TTGGATGCGC GCGGATAACG 
LYUNMP GGCTACTGAG TGTGACCTAG GTCGACATCA TTGGATGCGC GCGGATAACG 
LYMPS GGCTACTGAG TGTGACCTAG GTCGACATCA TTGGATGCGC GCGGATAACG 
Consensus ********** ********** ********** ********** ********** 
251 300 
LYMP CCATCTCTGT CAGACCTCTC GTTCCCCAAG TAACCAGTAA CAATTTATTG 
LYUNMP CCATCTCTGT CAGACCTCTC GTTCCCCAAG TAACCAGTAA CAATTTATTG 
LYMPS CCATCTCTGT CAGACCTCTC GTTCCCCAAG TAACCAGTAA CAATTTATTG 
Consensus ********** ********** ********** ********** ********** 
301 350 
LYMP TCTTTCTTTA AATCTGGGTA TGATGCCGGT GAATTGCGCT CTAAAGGCTA 
LYUNMP TCTTTCTTTA AATCTGGGTA TGATGCCGGT GAATTGCGCT CTAAAGGCTA 
LYMPS TCTTTCTTTA AATCTGGGTA TGATGCCGGT GAATTGCGCT CTAAAGGCTA 
Consensus ********** ********** ********** ********** ********** 
351 400 
LYMP TATGAGCGTT CCTCAAGTGC TGTGTGCCGT TACCAGGACG GTTTCTACGG 
LYUNMP TATGAGCGTT CCTCAAGTGC TGTGTGCCGT TACCAGGACG GTTTCTACGG 
LYMPS TATGAGCGTT CCTCAAGTGC TGTGTGCCGT TACCAGGACG GTTTCTACGG 
Consensus ********** ********** ********** ********** ********** 
401 450 
LYMP ATGCTGAGGG TTCTTTGAAA ATTTATTTGG CTGACCTAGG TGATAAAGAA 
LYUNMP ATGCTGAGGG TTCTTTGAAA ATTTATTTGG CTGACCTAGG TGATAAAGAA 
LYMPS ATGCTGAGGG TTCTTTGAAA ATTTATTTGG CTGACCTAGG TGATAAAGAA 
Consensus ********** ********** ********** ********** ********** 
451 500 
LYMP TTATCCCCAA TTGATGGGCA ATGTGTTACT TTACATAATC ATGAGCTCCC 
LYUNMP TTATCCCCAA TTGATGGGCA ATGTGTTACT TTACATAATC ATGAGCTCCC 
LYMPS TTATCCCCAA TTGATGGGCA ATGTGTTACT TTACATAATC ATGAGCTCCC 
Consensus ********** ********** ********** ********** ********** 
501 550 
LYMP TGCTTTGATA TCTTTCCAAC CTACCTACGA TTGCCCCATG GAATTAGTTG 
LYUNMP TGCTTTGATA TCTTTCCAAC CTACCTACGA TTGCCCCATG GAATTAGTTG 
LYMPS TGCTTTGATA TCTTTCCAAC CTACCTACGG TTGCCCCATG GAATTAGTTG 
Consensus ********** ********** *********- ********** ********** 
551 600 
LYMP GCAATCGGCA TCGATGTTTC GCGGTAGTCG TTGAGAGACA TGGTTATATT 
70 
LYUNMP GCAATCGGCA TCGATGTTTC GCGGTAGTCG TTGAGAGACA TGGTTATATT 
LYMPS GCAATCGGCA TCGATGTTTC GCGGTAGTCG TTGAGAGACA TGGTTATATT 
Consensus ********** ********** ********** ********** ********** 
601 650 
LYMP GGTTACGGTG GTACCACTGC TAGCGTGTGT AGTAACTGGC AAGCTCAGTT 
LYUNMP GGTTACGGTG GTACCACTGC TAGCGTGTGT AGTAACTGGC AAGCTCAGTT 
LYMPS GGTTACGGTG GTACCACTGC TAGCGTGTGT AGTAACTGGC AAGCTCAGTT 





TTCTTCAAAG AATAATAATT ACACACACGC CGCTGCTGGT AAGACTCTTG 
TTCTTCAAAG AATAATAATT ACACACACGC CGCTGCTGGT AAGACTCTTG 
TTCTTCAAAG AATAATAATT ACACACACGC CGCTGCTGGT AAGACTCTTG 
Consensus ********** ********** ********** ********** ********** 
701 750 
LYMP TGTTGCCTTA CAACAGATTA GCTGAGCATT CGAAACCGTC AGCCGTCGCT 
LYUNMP TGTTGCCTTA CAACAGATTA GCTGAGCATT CGAAACCGTC AGCCGTCGCT 
LYMPS TGTTGCCTTA CAACAGATTA GCTGAGCATT CGAAACCGTC AGCCGTCGCT 
Consensus ********** ********** ********** ********** ********** 
751 800 
LYMP CGCCTGTTGA AGTCGCAGTT AAACAACGTT AGCTCATCGC GCTATCTTTT 
LYUNMP CGCCTGTTGA AGTCGCAGTT AAACAACGTT AGCTCATCGC GCTATCTTTT 
LYMPS CGCCTGTTGA AGTCGCAGTT AAACAACGTT AGCTCATCGC GCTATCTTTT 
Consensus ********** ********** ********** ********** ********** 
801 850 
LYMP GCCGAACGTT GCTCTTAATC AAAATGCGTC TGGGCACGAG TCCGAGATTT 
LYUNMP GCCGAACGTT GCTCTTAATC AAAATGCGTC TGGGCACGAG TCCGAGATTT 
LYMPS GCCGAACGTT GCTCTTAATC AAAATGCGTC TGGGCACGAG TCCGAGATTT 
Consensus ********** ********** ********** ********** ********** 
851 900 
LYMP TAAACG G CCCTCCCATC GCTATAGGGA GTCCGTCCGC GTCCCGTAAC 
LYUNMP TAAACGAAAG CCCTCCCATC GCTATAGGGA GTCCGTCCGC GTCCCGTAAC 
LYMPS TAAACGAACG CCCTCCCATC GCTATAGGGA GTCCGTCCGC GTCCCGTAAC 
Consensus ********-* ********** ********** ********** ********** 
901 936 
LYMP AATAGCTTCA GATCGCAGGT GGTTAACGGT CTTTAG 
LYUNMP AATAGCTTCA GATCGCAGGT GGTTAACGGT CTTTAG 
LYMPS AATAGCTTCA GATCGCAGGT GGTTAACGGT CTTTAG 
Consensus ********** ********** ********** ****** 
Figure 3.14 cDNA sequence alignment of CMV-LY UNMP, MP and MPS genes. 
Start codons are shown in bold type. The G->T and T->A mutations at position 113 
and 115 in MPS were intentionally incorporated to insert a stop codon thereby 
preventing translation of the gene. Two mutations at position 530 and 859 of MPS are 
shown red type. The multiple sequence alignment was done using the GCG ''PileUp" 





3.3 Part 3: The development of two CMV-L Y replicase transgenes 
3.3.1 Introduction 
In this part, the development of full-length translatable and mutated CMV-L Y Rep 
resistance genes are presented. The mutated gene was based on the design Anderson 
et al. (1992) used to make the sg I CMV-Fny Rep mutant referred to in the Chapter 1. 
The Fny mutant was made from a full-length RNA 2 clone (pFNY206) that had a 94 
bp region surrounding the conserved ODD amino acid motif (the putative catalytic 
centre of RNA-dependent RNA polymerases) removed by restriction digest. The 
linear plasmid was re-ligated to generate a mutant Rep gene that was only translatable 
as far as the re-ligation/mutation juncture, at which point the coding sequence was 
shifted to a different reading-frame. Previous work done in our lab had clearly shown 
that transgenic tobacco plants carrying the Fny mutant were highly resistant to sg I 
CMV strains but were still susceptible to infection by Western Australian sg II CMV 
strains (Singh et al., 1998). The equivalent CMV sg II mutant was made here because 
lupins grown in Western Australia are infected by sg II strains and not by sg I strains 
(Jones, 1988; Singh et al., 1998). The full-length Rep transgene was included for 
comparative analysis of the resistance mechanism (protein vs. RNA-mediated). A 
flow chart showing the procedure used in the development of the resistance genes is-­








ORF2a cDNA (Rept) 
Clone into pGEM-T Easy 
Excise using Eco RI 
I\ 
Clone into pGEM-T _,. SequenceRepfgene 
I Inverse PCR 
+ mutagenesis
pGEM-T /Repm 
Excise using Eco RI 
Clone Repf and Repm genes into p YR2 and pART27 /7-4 
p YR-Repf sense 
p YR-Repf antisense 
pAR T-Repf sense 
pAR T-Repf antisense 
pYR-Repm sense 
p YR-Repm antisense 
pART-Repm sense 
pART-Repm antisense 
Figure 3.15 Flow chart outlining the procedures used in development of CMV-LY 
Rep gene. Repf refers to a full-length ORF2a gene sequence. Repm refers to an 
ORF2a gene sequence with the GDD motif deleted by inverse PCR mutagenesis. 
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3.3.2 Materials, Methods and Results 
3.3.2.1 Cloning strategy 
The strategy used for construction of the CMV-LY Rep mutant somewhat differed 
from that used by Anderson et al. (1992) because the same, or otherwise suitable 
restriction enzyme sites, were not available in the desired region for removal of the 
GDD motif. To remove the GDD motif of CMV-LY, the Rep gene was first cloned 
into pGEM-T to generate Repf, and then inverse PCR mutagenesis was used to create 
a defined deletion in the insert to remove the GDD motif. A stop codon (TGA) was 
also inserted to make the construct (RepM) similar to that of Anderson et al. (1992) 




RNA ORF2a ■ 
.. .. + .. + 
Repl Rep3 Repm2 Repml Rep2 
Repf ORF2a ■ -
Repm �------M_ut_at_ed_O_R_f2_a _____ _
Figure 3.16 Schematic illustration of CMV-LY RNA 2a resistance genes. Repf 
represents the full-length ORF2a Rep gene. Repm represents the Rep gene with the 
GDD removed. The arrows indicate the position of primer annealing for RT-PCR of 
RNA 2 (Rep], 2, & 3) and for inverse PCR mutagenesis (Repml & Repm2). 
3.3.2.1 Design of primers for RT-PCR amplification of CMV-LY 
RNA2 
The CMV-L Y RNA 2 sequence had not been determined when this work was 
commenced. There were, however, twelve different CMV RNA 2 sequences present 
in the GenBank database, although only one was from a sg II isolate (CMV-Q, 
Rezaian et al., 1984), the other eleven all being sg I strains. The RNA 2 sequences 
were aligned using the CLUSTALW program and the primers (Table 3.5, Fig. 3.16) 
designed by comparing the CMV-Q sequence for nucleotide conservation with the sg I 
sequences. A 3 5 bp upstream primer (Rep 1) was designed from the beginning of the 
CMV-Q RNA 2 sequence making sure that at least 10 bases at the 3' end of the primer
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were conserved in all sequences. A 31 bp downstream primer (Rep2) spanning 
nucleotides 2834-2867 of CMV-Q RNA 2 was designed from conserved sequence of 
all strains. This pair of primers was used to amplify CMV-L Y RNA 2, which was 
then sequenced at each end to obtain correct sequence data for use in designing 
primers specific to the start end of the CMV-L Y ORF2a. 
Table 3.5 PCR primers used for amplification of the CMV-LY Rep gene. 
Repl 5'- GTTTATTCTCAAGAGCGTATGGTTCAACCCCTGCC 
Rep2 5'- ACTGACCATTTTAGCCGTAAGCTGGATGGAC 
3.3.2.2 RT-PCR 
CMV-L Y RNA was extracted from infected N. glutinosa leaves as described in
Chapter 2. First-strand cDNA synthesis (Table 3.6) was carried out using 
Superscript™ II, RNase H- Reverse Transcriptase (Life Technologies). An aliquot of 
CMV-LY RNA extract was incubated at 70°C for 10 min to denature the RNA and
then quickly chilled on ice. A 2 µl aliquot was immediately added to a fresh tube 
containing the first-strand reaction mixture (minus the polymerase) and incubated for 
10 min at 25°C and then for 2 min at 42°C to hybridise the random hexamers to 
template RNA. Superscript II, RNase H- Reverse Transcriptase was added, the tube 
mixed gently and-the reaction incubated at 42°C for 50 min. The RT enzyme was heat 
inactivated at 70°C for 15 min. The RNA template was removed by incubating the 
mixture at 37°C for 15 min in the presence of 1 µl RNase H. 
Table 3.6 First-strand cDNA synthesis reagent mixture 
Reagent Stock Cone. Volume (µI) Final Cone. 
Reaction buffer 5X 4.0 lX 
DTT lOmM 1.0 lmM 
dNTPs lOmM 1.0 lmM 
Random hexamers 20 pmol/µl 5.0 20 pmol/15 µl 
Superscript 5 U/µl 1.0 5 U/15µ1 
CMV RNA extract 2.0 
H20 To 15 µl 
The PCR amplification step was done using a Taq!Pyrococcus GB-D DNA 
polymerase ELONGase® Enzyme Mix (Life Technologies) to minimise nucleotide 





robust amplification ability of Taq DNA polymerase and the proofreading (3 to 5' 
exonuclease) activity of Pyrococcus DNA polymerase. 2 µI of cDNA from the first­
strand reaction was added to a mixture containing the PCR reagents given in Table 
3.7. The reaction mix was then heated to 94°C for 3 min for initial denaturation 
followed by 30 cycles of 94°C for 1 min, 60°C for lmin, 72°C for 4 min, followed by a 
final extension cycle of 72°C for 7 min. Following agarose gel electrophoresis, a PCR 
product of the correct size (approx. 2870 nt) was obtained (Fig. 3.17). 
Table 3.7 Elongase PCR reagent mixture. 
l0mM dNTP 1µ1 
Mix I 
(20 µl) Repl primer (30pmol) 1µ1 
Rep2 primer (32pmol) 1µ1 
CDNA 2µ1 
H2O 15µ1 
Mix II Buffer A 6µ1 
(30µ1) Buffer B 4 
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Figure 3.17. RT-PCR amplification of CMV-LY RNA 2.
Lanes: (1) SPP marker; (2) positive control (CP l); (3) negative control (H20) (4-7) 
CMV-LY RNA 2 PCR product; (8) 100 bp marker ( only 2.25 kb band visible).
3.3.2.3 Cloning of cDNA of CMV-LY RNA 2 into pGEM-T Easy 
Ligation of PCR products to pGEM-T vectors takes advantage of the non-template 
dependent addition of a single adenosine base to the 3' ends of amplified cDNA by 
DNA polymerases that lack 3-5' exonuclease activity. However, when DNA is 
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amplified with enzymes that possess 3-5' exonuclease activity, such as Pyrococcus, the 
majority of 3' ends are blunt. It was therefore necessary to first purify the PCR 
product (to remove residual Pyrococcus DNA polymerase) and then incorporate 3' 
adenosine overhangs using Taq DNA polymerase before ligation to pGEM-T/ pGEM­
T Easy. 
Following gel purification, the CMV-LY RNA 2 PCR product was mixed with 1 µI of 
2 mM dATP, 4 µI 25 mM MgCh, 5 µI 10 X PCR buffer, 1.25 U Tag (0.25 µI) DNA 
polymerase, and sterile distilled water to a final volume of 50 µI. The reaction mixture 
was incubated at 72
°C for 1 hr, gel purified using the BresaClean DNA Purification 
Kit, and the amount of cDNA recovered fluorometrically quantified. The PCR 
product was then ligated into the pGEM-T Easy vector in a 3:1 ratio (insert:vector). 5 
µI of the ligation mix was transformed into chemical competent E coli JM109 cells 
and incubated overnight at 37°C on LB plates (containing 100 µg/ml ampicillin) 
coated with 20 µI of 50 mg/ml X-Gal and 100 µI of 100 mM IPTG. Screening for 
positive colonies was done by Eco RI restriction digestion of purified plasmid DNA 
extracted from eight single colonies grown overnight in LB broth containing 100 
µg/ml ampicillin. The results indicated that five of cloned colonies contained the 
correct insert. Due to the similar sizes of pGEM-T vector (3 kb) and the insert (2.88 
kb), the two bands are not separated very clearly (Fig. 3.18). One colony, LY-Rl, was 
used for sequencing and other downstream cloning purposes. 
3kb + 
1 2 3 4 5 6 7 8 
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Figure 3.18 Restriction digest analysis of recombinant pGEM-T plasmids 
containing the CMV-LY Rep gene sequence. Lanes ( 1) 1 kb marker; (2) PCR 
product of CMV-LY RNA 2; (3-7) recombinant pGEM-T/CMV-LY plasmids digested 
with Eco RI (the similar sizes of pGEM-T and the Rep gene make it hard to separate 




3.3.2.4 CMV-LY RNA 2 sequence analysis 
The 5' UTR/start codon junction of LY R2-1 was sequenced so that a CMV-L Y 
specific primer could be designed for amplification of the full-length Rep gene. The 
first 180 bp are given in Figure 3.19. The first start codon (ATG) occurs at position 
19-21. It is presumed that this codon is not used for translation initiation because there
are two downstream in-frame stop codons (TGA) at positions 43-45 and 63-65. The 
second start codon occurs at position 93-95 and translation from this point results in a 
polypeptide of 840 amino acids (see Chapter 4). Two additional ATG codons occur 
just downstream at positions 136-138 and 145-147. Translation initiation from these 
codons would result in polypeptide of 86 and 83 amino acids, respectively. 
GTTTATTCTCAAGAGCGTATGGTTCAACCCCTGCCTCCTCTGTGAAATTACCCTAGTTTT 
1 ---------+---------+---------+---------+---------+---------+ 60 
CAAATAAGAGTTCTCGCATACCAAGTTGGGGACGGAGGAGACACTTTAATGGGATCAAAA 
a V Y S Q E R M V Q P L P P L * N Y P S F 
b F I L K S V W F N P C L L C E I T L V L 
c L F S R A Y G S T P A S S V K L P * F Y
ATTGATCTACTTCTGATCTCTTTTCTGTTACTATGACAAGTCCTCCACCCACTTTCTCAT 
61 ---------+---------+---------+---------+---------+---------+ 120 
TAACTAGATGAAGATCAGAGAAAAGACAATGATACTGTTCAGGAGGTGGGTGAAAGAGTA 
a I D L L L V S F L L L * Q V L H P L S H 
b L I Y F * S L F C Y Y D K S S T H F L I 
c * S T S S L F S V T M T S P P P T F S F 
TCGCCAATCTGTTGAATGGCTCCTATGGTGTTGACACTCCCGAGGAAGTGGAACGCGTTA 
121 ---------+---------+---------+---------+---------+---------+ 180 
AGCGGTTAGACAACTTACCGAGGATACCACAACTGTGAGGGCTCCTTCACCTTGCGCAAT 
a S P I C * M A P M V L T L P R K W N A L 
b R Q S V E W L L W C * H S R G S G T R *
c A N L L N G S Y G V D T P E E V E R V R 
Figure 3.19 Upstream 180 hp cDNA sequence of the CMV LY-Rl clone. 
The functional ATG is given in bold type. The sequence used for design of the Rep3 
prim_er is under! ined. 
3.3.2.5 RT-PCR Amplification of a full-length CMV-LY Rep gene 
A new pair of primers specific for the CMV-L Y isolate was designed for amplification 
and cloning of the Rep gene. The upstream primer contains the start codon preceded 
by 3 bases found in the LY-Rl sequence to maintain the native context surrounding 
the initiation codon, and a Bam HI restriction site for cloning purposes (Fig. 3.19; 
Table 3.8). The downstream primer (Rep4) was the same as Rep2 except that a Bam 
HI restriction site was incorporated at the 5' end for cloning. Figure 3.20 shows the 




RT-PCR conditions were the same as that used in 3.3.2.2. 
Table 3.8 Primers for amplification of a CMV-LY Rep gene. 
Rep3 5'GGATCCACT A TGACAAGTCCTCCACC 
Rep4 5'GGATCCAT ACTGACCA T1TI AGCCGT AAG 




1 2 3 4 5 
Figure 3.20 RT-PCR amplification of CMV-LY full-length Rep gene. 
Lanes; (1)1 kb marker; (2) positive control (CMV-CP3); (3) negative control (H2O), 
( 4-5) LY full-length Rep PCR products. 
3.3.2.6 Cloning of the CMV-LY Rep gene into pGEM-T 
The CMV-LY Rep gene was cloned into pGEM-T and the cDNA sequence 
determined before transfer of the insert to pGEM-T Easy. The cDNA sequence (see 
Chapter 4) was obtained to ensure that the gene was fully translatable and that 
nucleotide misincorporation had not occurred during PCR amplification. It was 
necessary to transfer the insert to pGEM-T Easy so that Eco RI restriction sites in the 
MCS could be used for cloning into the plant binary vectors without the need for 
additional PCR amplification. The gene was cloned into pGEM-T first because an 
Eco RI restriction site was incorporated into the primers for deletion of the GDD motif 
by inverse PCR mutagenesis (see 3.3.2.7). This could not be done in pGEM-T Easy 
because of the Eco RI restriction sites that flank the MCS. 
The CMV-L Y Rep PCR product was gel purified using the BresaClean DNA 
Purification Kit, gel quantified and ligated into pGEM-T in a 3: 1 ratio (insert:vector). 
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5 µI ligation of the mix was used to transform chemical competent E. coli XLl-Blue 
cells and incubated overnight at 37
°C on LB plates (containing 100 µg/ml ampicillin) 
coated with 20 µl of 50 mg/ml X-Gal and 100 µl of 100 mM IPTG. Four single white 
colonies were screened for the presence of an insert by Barn HI restriction digestion of 
purified plasmid DNA. All of the four colonies contained the correct insert (Fig. 
3.21). 
3kb + 
1 2 3 4 5 6 
+ 2.77kb 
Figure 3. 21 Restriction digest analysis of a cloned CMV-LY Rep gene. 
Lanes (1) 1 kb marker; (2) linearised pGEM-T plasmid DNA (3-6) recombinant 
pGEM-T/CMV-LY full-length Rep plasmids digested with Eco RI (the similar sizes of 
pGEM-T and the Rep gene make it hard to separate the two bands properly). 
3.3.2.7 Inverse PCR mutagenesis and cloning 
The GDD motif was removed from the CMV-L Y Rep gene using an inverse PCR 
mutagenesis method that results in the deletion of a defined sequence in cloned 
plasmid DNA (Dwyer, 1998). The mutagenesis reaction used a pair of primers that 
anneal to template DNA and amplify away from each other to give a linear PCR 
product minus a 121 bp region between the primers (Fig 3.22). The PCR product was 
then digested with Dpn I, an enzyme that only restricts methylated DNA (i.e. the 
original plasmid template), and the ends ligated to generate a functional plasmid 
following E. coli transformation. 
80 





+ Dpn I digestion 
Ligate ends of PCR product and transform into E. coli 
cDNA sequence analysis 
Figure 3.22 Schematic diagram outlining the inverse PCR mutagenesis method. 
In the PCR reaction, the primers anneal to plasmid DNA and prime outward to give a 
linear PCR product minus the region to be deleted. The PCR product is then digested 
with Dpn I to remove the initial plasmid template, the ends self-ligated and the 
circular product transformed into E. coli to regenerate a functional plasmid. The 
insert is sequenced to ensure that nucleotide misincorporation during synthesis has 
not occurred. 
Two primers (RepMutl and RepMut2) were designed for the inverse PCR 
mutagenesis reaction (Table 3.9). PCR amplification was done using the 
ELONGase® Enzyme Mix and materials given in Table 3.10. The reaction mix was 
heated to 94
°
C for 3 min for initial template denaturation, followed by 30 cycles of 
94
°
C for 1 min, 60°C for 1 min, 72
°
C for 6 min, followed by a final extension cycle of 
72
°
C for 7 min. The product of PCR was analysed by gel electrophoresis and a 
fragment of the correct size observed (Fig. 3.23 Lane 2-8). 
I I 
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Table 3.9 PCR primers used for mutagenesis of the CMV-LY Rep gene 
RepMutl 5'GTCGAA TTCACCAAGCAAACTCAGCCATCG 
RepMut2 5'GTCGAATTCGGTGATGGAACCTGCAGT ACC 
• The Eco RI restriction sites are underlined.
Table 3.10 The conditions used in Inverse PCR-mutagenesis reaction 
l0mM dNTP 1µ1 
RepMutl primer 1µ1 
Mix! 
(20 µl) 
RepMut2 primer 1µ1 
Plasmid DNA 2ng 
H20 15µ1 
Buffer A 2.8µ1 
Mix II Buffer B 7.2µ1 
(30µ1) Elongase 1µ1 
H20 19µ1 
5.7 kb 
1 2 3 4 5 6 7 8 9 
Figure 3.23 Inverse PCR mutagenesis and cloning of the CMV-LY Rep gene. 
Lanes ( 1) 1 kb marker; (2-8) pGEM/Repf inverse PCR product; (9) J00bp marker. 
The PCR product was digested with Dpn I for 2 hr at 37°C, gel purified and treated 
with T4 polynucleotide kinase (PNK) to phosphorylate the 5' ends of the DNA 
molecules. The PNK reaction was comprised of 100 ng PCR product, 5 µl 1 OX PNK 
buffer, 1 µl of 1 mM ATP, 10 U polynucleotide Kinase (New England Bioabs) and 
sterile distilled water to 50 µI. The mixture was heated to 70°C for 5 min before the 
addition of PNK. The reaction was carried out at 37°C for 30 min and then heated for 
20 min at 65°C to heat inactivate the enzyme, and the DNA purified by 
phenol/chloroform extraction as described in Chapter 2. The linear DNA was re­
circularised with T4 DNA ligase and transformed into chemically competent E. coli 
82 
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JM109 cells. Single colonies were screened for the presence of positive recombinants 
by Barn HI and Eco RI double digest of purified plasmid DNA using the restriction 
buffer supplied for E. coli (Fig. 3.24, lane 2-7). These sites only occur in the primer 
sequences used in the initial amplification of the Rep from genomic RNA (Barn HI) 




2 1 4 � 6 7 8 
Figure 3.24 Restriction digest analysis of mutated CMV-LY Rep gene in pGEM-T. 
Lane 1 SPP marker; (2-7) pGEM-T/mutated Rep plasmid double digested by Barn HI 
and Eco RI, show the Rep gene was mutated during the inverse PCR and an Eco RI 
site was introduced into the gene, (8) pGEM-T/CMV-LY Replicase plasmid double 




1 2 3 4 5 6 
Figure 3. 25 Restriction digest analysis of mutated CMV-LY Rep gene in pGEM-T. 
( 1) SPP marker; (2-5) pGEM-T/mutated Rep plasmid (removed the Eco RI site) double
digested by Barn HI and Eco RI, show all of the four colonies are positive; (6) pGEM­
T/mutated Replicase plasmid (with an Eco RI site) double digested by Barn HI and Eco
RI, as a control.
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A positive recombinant plasmid was digested with Eco RI, the ends flushed using 
Kienow DNA polymerase, re-ligated to the circular form and transformed into 
competent E. coli XLl-Blue cells. Plasmid DNA from four colonies was screened for 
the desired mutation by Barn HI and Eco RI digestion (Fig 3.25, lanes 2-5). The Eco 
RI site in all four had been removed and a positive result gave linear DNA. The 
resultant plasmid was named pGEM-T/Repm. 
3.3.2.8 Sequence analysis of the mutated region in pGEM-T/Repm 
The pGEM-T/Repm plasmid was sequenced to ensure that the desired changes had 
been successfully incorporated and that no PCR-induced mutations had occurred. A 
180 bp sequence spanning the deleted/modified region of Repm is given in Figure 
3.26. The entire RNA 2 sequence is given in Chapter 4. The inverse PCR 
mutagenesis reaction resulted in the removal of 121 bp from the Rep gene, which 
included the GDD motif. The addition of Eco RI restriction sites in the primers, and 
the subsequent blunt-ending of the these sites, inserted an extra 10 nt and resulted in 
the incorporation of a stop codon (TGA) that should result in translation termination at 
this point. 
TGGGGTTGGAATGCCCATCAGCTTTCAACGCCGTACTGGTGACGCTTTCACCTATTTTGG 
1683 ---------+---------+---------+---------+---------+---------+ 1742 
AGGGGAACCTTACGGGTAGTCGAAAGTTGCGGCATGACCACTGCGAAAGTGGATAAAACC 
G V G M P I S F Q R R T G D A F T Y F G 
CAATACTATTGTCACGATGGCTGAGTTTGCTTGGTGAATTAATTCGGTGATGGAACCTGC 
1743 ---------+---------+---------+----- ---+---------+---------+ 1802 
GTTATGATAACAATGCTACCGACTCAAACGAACCACTTAATTAAGCCACTACCTTGGACG 
N T I V T M A E F A W * I N S V M E P A 
AGTACCTTATATTTGTTCGAAGTTTCTACTCTCTGATGAGTTTGGTAATACGTTTTCAGT 
1803 ---------+---------+---------+---------+---------+---------+ 1862 
TCATGGAATATAAACAAGCTTCAAAGATGAGAGACTACTCAAACCATTATGCAAAAGTCA 
V P Y I C S K F L L S D E F G N T F S V 
Figure 3.26 Nucleotide and predicted amino acid sequences surrounding the GDD 
deletion site in the Repm gene. The RepMut 1 and RepMut2 primer sequences are 
underlined. The introduced stop codon is shown in bold type. An additional JO bp, 
representing the blunt-ended and re-ligated Eco RI sites (GAATTAATTC), has been 




3.3.2.9 Preparation of the Repm gene for cloning into plant binary 
vectors. 
The Repm gene was excised from pGEM-T using Barn Ill restriction sites, added to 
the initial primer pair for RT-PCR of genomic RNA 2, and transferred to pGEM-T 
Easy for excision as an Eco RI fragment for cloning into the plant binary vectors. The 
Bam Ill linearised Repm gene was treated with Taq DNA polymerase to add an 
adenosine base at the 3' ends for cloning into the pGEM-T Easy vector. The reaction 
was carried out under the following conditions: 100 ng DNA, 1 µl 10 mM dNTPs, 4 µl 
25 mM MgCh, 5 µl lOX PCR buffer, 1.25U Taq DNA polymerase, and sterile 
distilled water to 50 µ1. The reagents were mixed gently and incubated at 72°C for 40 
min. The DNA was gel purified, gel quantified and ligated into pGEM-T Easy in a 3:1 
ratio (insert:vector). 5 µl of the ligation mix was transformed into chemically 
competent E. coli JM109 cells and incubated overnight at 37°C on LB plates 
(containing 100 µg/ml ampicillin) coated with 20 µl of 50 mg/ml X-Gal and 100 µl of 
100 mM IPTG. Six single white colonies were screened for positive recombinants by 
Eco RI restriction digestion of purified plasmid DNA. All six colonies contained the 
correct Repm insert (Fig 3.27). 
3 kb 
2.66 kb 
1 2 3 4 5 6 7 8 
Figure 3.27 Restriction digest analysis of recombinant pGEM-T Easy/Repm 
colonies. Lanes ( 1) 1 kb marker; (2-7) pGEM-T Easy/Repm plasmids digested by Eco 
RI, show all of the six colonies are positive; (8) linearised pGEM-T Easy plasmid 
DNA. 
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3.4 Part 4: The development of four CMV CP transgenes 
3.4.1 Introduction 
In this part, the development of four CMV-L Y CP resistance genes is presented. Virus 
CP genes have been the most common viral sequence used for PDR. The strategy 
used here was similar to that used for other published CP genes. The main difference 
is the inclusion of a truncated native 3' UTR, which was included to examine whether 
a mutation in this region will specifically induce RNA-mediated resistance. 
Three of the resistance genes were based on the CP sequence of the sg II CMV-L Y 
isolate and one on the CP sequence of a Western Australian sg I CMV isolate, 
originally found infecting banana (Singh et al., 1995). A flow chart outlining the 
procedures used for cloning is given in Figure 3.28 and a schematic illustration 
showing the cloned resistance genes in Figure 3.29. Four CMV CP resistance gene 
constructs were developed in the project. 
(1) CPl - contains a translatable CMV-LY ORF 3b coding sequence truncated at the
C-terminal end by 12 amino acids.
(2) CP2 - contains a full-length translatable CMV-Banana ORF 3b coding sequence
and the native 3' UTR minus 121 nucleotides.
(3) CP3 - contains a full-length translatable CMV-L Y ORF 3b coding sequence and
the native 3' UTR minus 103 nucleotides.
(4) CP4 - contains a full-length translatable CMV-LY ORF 3b coding sequence with




RNA3 5'UIR ORF3a ORF3b 
/RT-PCR 
l 
CPI (CMV-LY) CP2 (banana) CP3 (CMV-LY) 
I 
Clone into pGEM-T 
• 
pGEM-T/CPI I I pGEM-T/CP2 11 pGEM-T/CP3
\ l I 
EcoRI 
mutation 
p YR2-CP 1 sense 
p YR2-CP 1 anti sense 
p YR2-CP2 sense 
p YR2-CP2 antisense 
p YR2-CP4 sense 
p YR2-CP4 antisense 
Clone into pYR2 and pART27/7-4 I ◄ 
/ � 
pAR T -CPI sense 
pAR T-CP 1 antisense 
pAR T-CP2 sense 
pAR T -CP2 antisense 




pAR T-CP3 antisense 
Figure 3.28. A flow diagram outlining the procedure used in the development of 
CMV CP resistance genes.
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Figure 3. 29 Schematic illustration off our different CP resistance gene. 
The primers used for RT-PCR amplification of the CMV CP genes have arrows above 
them depicting the direction of synthesis (see also Table 3.1 J). 
CP 1 is comprised of 625 bp of the CMV-LY CP gene. 
CP2 is comprised of the entire CMV-LY CP coding region and partial 3' UTR 
sequence (777 nt). 
CP 3 is comprised of the entire CMV-banana CP coding region and partial 3' UTR 
sequence (786 nt). 
CP4 is comprised of the entire CMV-LY CP coding region and partial 3' UTR 
sequence, but mutation of an internal Eco RI site has resulted in a 12-amino acid 
extension of the ORF (790 nt). 
3.4.2.1 Design of primers and RT-PCR of CMV CP gene sequences 
Design of primers 
Six primers were synthesised for RT-PCR amplification of CMV CP sequences (Table 
3.11, Fig. 3.30). The primers were designed from conserved regions in the CP 
sequences of twenty-two sg I and four sg II CMV isolates found at the GenBank 
database. The primers had either Eco RI or Hind III restriction sites added at the 5' 





Table 3.11 Oligonucleotide primers used/or RT-PCR o/CMV CP genes. 
CPl 5'CTAGGAATTCATGGACAAATCTGGCTCTCCC 
CP2 5'ATATAGAATTCCATCCGTGAGATAGGAATTCG 
CP3 5' GAATTCATGGACAAATCTGGATCTC 
CP4 5' GAA TTCGT AAGCTGGATGGACAACCC 
CP5 5' AAGCTTATGGACAAATCTGGCTCTCCC 
CP6 5'AAGCTTGTAAGCTGGATGGACAACC 
Eco RI and Hind III restriction sites are underlined. 
RT-PCR of CMV CPl, CP2 and CP3 transgenes 
The CPl, CP2 and CP3 genes were amplified directly from genomic CMV RNA by 
RT-PCR. CMV-LY and CMV-banana RNA were extracted from infected leaves of N.
glutinosa host plants as described in Chapter 2. Following optimisation of the RT­
PCR reaction, the reagents and volumes given in Table 3.12 were used for production 
of first-strand cDNA. The reaction was incubated in a thermal cycler at 42°C for 30 
min, and then 99°C for 5 min to denature the reverse transcriptase enzyme. 
Table 3.12 First-strand cDNA synthesis from CMV-LY CP RNA 
Reagent Stock Cone. Volume (µI) 
MgCh 25 mM 1.6 
PCR buffer lOX 1.0 
dNTPs l0mM 1.0 
Rnase Inhibitor 20 U/µl 0.25 
M-MuLV RT 50 U/µl 0.25 
3' CP primer 20 pmol/µl 0.5 
RNA extract 1.0 
H20 to 10µ1 
The PCR step was done by adding. the reagents given in Table 3.13 as a master mix 
directly to the tube containing the completed RT reaction. The reaction was then 
heated to 94°C for 3 min for initial denaturation followed by 30 cycles of 94°C for 30 
sec, 60°C for 30 sec; 72°C for 2 min, with a final extension cycle of 72°C for 10 min. 











5' CP primer 




Stock Cone. Volume (ul) 
25 mM 6.4 
lOX 4.0 
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Figure 3.30 RT-PCR amplification of three CMV CP gene sequences. 
Lanes (1) 100 bp marker; (2) CP positive control (truncated CP gene) (3) negative 
control (H20); (4) CPI; (5) CP2; (6) CP3; (7) 1 kb marker. 
3.4.2.2 Cloning of CPl, CP2 and CP3 PCR products into pGEM-T 
The CPl, CP2 and CP3 PCR products were purified with the BresaClean DNA 
Purification Kit, fluorometrically quantified and cloned into pGEM-T in a 3: 1 ratio 
(insert:vector). 5 µl of the ligation mix was transformed into chemical competent E.
coli DH5a cells and incubated overnight at 37°C on LB plates (containing lO0µg/ml 
ampicillin) coated with 20 µI of 50 mg/ml X-Gal and 100 µl of 100 mM IPTG. 
Following plasmid purification, six single white colonies were screened for positive 
recombinants by Eco RI digestion (for the CPl and CP2 genes) and Hind III (for the 
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Figure 3.31 Restriction digest analysis of recombinant pGEM-TICPl plasmids. 
Lane (1) 1 kb marker; (2-7) recombinant pGEM-T/CP 1 plasmids digested by Eco RI, 
show all of the six colonies are positive; (8) linearised pGEM-T Easy plasmid DNA. 
3kb � 
770bp � 
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Figure 3.32 Restriction digest analysis of recombinant pGEM-T/CP2 plasmids 
Lane ( 1) 1 kb marker; (2-7) recombinant pGEM-T/CP2 plasmids digested by Eco RI, 
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Figure 3.33 Restriction analysis of recombinant pGEM-TCP3 plasmids 
Lane(]) 1 kb marker; (2-7) recombinant pGEM-T/CP3 plasmids digested by Hind III, 
show all of the six colonies are positive; (8) non-recombinant pGEM-T plasmid DNA. 
3.4.2.3 Development of a c-terminal extended mutant CP gene 
The site used for cloning genes into the pYR2 binary vector was Eco RI. However, 
there is an Eco RI restriction site in the C-terminal end of CMV-L Y 3b gene. In order 
to clone the full length CP gene into pYR2 binary vector, the Eco RI site in CP3 was 
mutated, and used to develop a C-terminal extended mutant CP gene. 
The pGEM-T/CP3 recombinant plasmid was linearised by Eco RI restriction 
digestion, gel purified and the ends filled-in using Kienow DNA polymerase as 
previously described. The reaction was extracted with phenol/chloroform to remove 
the enzyme and the plasmid re-circularised with T4 DNA ligase. 5 µl of the ligation 
mix was transformed into chemical competent E. coli DH5a cells and incubated 
overnight at 37
°C on LB plates containing 100 µg/ml ampicillin. Six colonies were 
screened for the correct mutation by Eco RI and Hind III restriction digestion, using 
the buffer supplied for Eco RI. All six colonies were found to contain a plasmid with 
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Figure 3.34 Restriction digest analysis of a mutated CMV-LY CP 3 gene. 
Lanes (1) 1 kb marker; (2) pGEM-T/CP3 digested by Eco RI; (3-5) mutated pGEM­
T/CP3 digested by Eco RI, show the uncut plasmids. 
3.4.2.4 Preparation of CP4 gene for cloning into binary vectors 
The CP4 gene was excised from pGEM-T plasmid DNA by Hind III restriction 
digestion, the gel fragment purified and then treated with Taq DNA polymerase to add 
a single adenosine base to the 3' ends (as previously described). The DNA was 
electrophoresed in a 0.8% (w/v) LMP gel, gel quantified and ligated into pGEM-T 
Easy. 5 µl of the ligation mix was transformed into chemical competent E. coli DH5a 
cells and incubated overnight at 37°C on LB plates (containing 100 µg/ml ampicillin) 
coated with 20 µl of 50 mg/ml X-Gal and 100 µl of 100 mM IPTG. Following 
plasmid purification, sixsingle white colonies were screening for positive 
recombinants by Eco RI digestion (Fig. 3.35). 
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Figure 3.35 Restriction digest analysis of recombinant pGEM-T Easy/CP4 
colonies. Lanes (1) 1 kb marker; (2-7) recombinant pGEM-T easy/CP4 plasmids 
digested by Eco RI, show all of the six colonies are positive; (8) linearised pGEM-T 
Easy plasmid DNA. 
3.4.2.5 Sequencing of CPl, CP2, CP3 and CP4 resistance genes 
The CMV CP resistance genes were sequenced to ensure that they remained in-frame 
and had not undergone mutation during the RT-PCR processes. The genes were 
sequenced directly from plasmid DNA using T7 and SP6 primers as previously 
described. A nucleotide and amino acid alignment for the genes is given in Figs. 3.36 
and 3.37, respectively. The results show that the correct nucleotide sequence was 
maintained in the CP2, CP3 and CP4 sequences, even though a nucleotide difference 
(C➔T) was observed at position 388 of the CPl sequence. All four CP genes are in­
frame and the predicted polypeptide regions of CPl, CP3 and CP4 are 205, 218 and 
230 amino acids in length, respectively. The mutated Eco RI site in CP4 is expected 
to result in the addition of twelve amino acids at the C-terminal end. The protein 
translated from CP2 gene is predicted to be 218 amino acids. 
CPl includes 645 nt and is shorter than the ORF3b (657nt) by 12nt. CP3 contains 
786nt including 657nt of ORF3b and 129nt of the 3'UTR. The CP4 (790nt) is longer 
than the CP3 in four nucleotides due to the mutated Eco RI site. It is composed of 
690nt ORF and lO0nt of the 3'UTR (Fig. 3.36). The sequences of CPl, CP3 and CP4 






and 120nt of the 3'UTR. CP2 was amplified from CMV-Banana isolate RNA (sg I), it 
has 76% homology with CP3 at the nucleotide level, and the sequence of CP2 






































































































CAATGCTAGT AGAACCTCCC GGCGTCGTCG 
CAATGCTAGT AGAACCTCCC GGCGTCGTCG 
CAATGCTAGT AGAACCTCCC GGCGTCGTCG 
CAGTGCTGGT CGCAACCGTC GACGTCGTCC 
**-****-** -*-*-**--* *-*******-
100 
CCGCTTCTGG TGCGGATGCA GGGTTGCGTG 
CCGCTTCTGG TGCGGATGCA GGGTTGCGTG 
CCGCTTCTGG TGCGGATGCA GGGTTGCGTG 
CCTCCTCCTC CGCGGATGCT AACTTTAGAG
****-**--- -********- ---**--*-* 
150 
AGACTCAATA AAACCCTCGC CATTGGTCGT 
AGACTCAATA AAACCCTCGC CATTGGTCGT 
AGACTCAATA AAACCCTCGC CATTGGTCGT 
CGACTTAATA AGACGTTAGC AGCTGGTCGT 
-********* *-***-*-** ---******* 
200 
CTTCGTGGGT AGAGAAAGTT GTAAACCCGG 
CTTCGTGGGT AGAGAAAGTT GTAAACCCGG 
CTTCGTGGGT AGAGAAAGTT GTAAACCCGG 
CTTTGTAGGG AGTGAACGCT GTAGACCTGG 
******-*** **-***-*** ***-***-** 
250 
CCCTGAAACC GCCTGAAATT GAGAAAGGTT 
CCCTGAAACC GCCTGAAATT GAGAAAGGTT 
CCCTGAAACC GCCTGAAATT GAGAAAGGTT 
CCCTAAAGCC ACCAAAAATA GACCGTGGGT 
****-**-** -**--****- **----**-* 
300 
TCTTTGCCAG ATTCAGTCAC GGACTATGAT 
TCTTTGCCAG ATTCAGTCAC GGACTATGAT 
TCTTTGCCAG ATTCAGTCAC GGACTATGAT 
TTATTACCTG ATTCAGTCAC GG TATGAT 
*--**-**-* ********** ***-****** 
350 
TCAAATCAGG ATTAATCCTT TGCCGAAATT 
TCAAATCAGG ATTAATCCTT TGCCGAAATT 
TCAAATCAGG ATTAATCCTT TGCCGAAATT 
TCAAATTCGA GTTAATCCTT TGCCGAAATT 
******--** -********* ********** 
400 
CAGTTCGGAA AGTACCTTCA TCATCCGATC 
CAGTTCGGAA AGTACCTTCA TCATCCGATC 
CAGTTCGGAA AGTACCTTCA TCATCCGATC 
CAGTTCGTAA AGTTCCTGCC !'CCTCGGACT 
********** ***-***-** **-**-**-* 
450 
GCCATGTTTG GCGATGGTAA TTCACCGGTT 
GCTATGTTTG GCGATGGTAA TTCACCGGTT 
GCTATGTTTG GCGATGGTAA TTCACCGGTT 







cpl TTGGTTTATC AGTATGCTGC GTCCGGAGTT CAGGCCAACA ATAAGTTACT 
cp3 TTGGTTTATC AGTATGCTGC GTCCGGAGTT CAGGCCAACA ATAAGTTACT 
cp4 TTGGTTTATC AGTATGCTGC GTCCGGAGTT CAGGCCAACA ATAAGTTACT 
cp2 CTGGTTTATC AGTACGCTGC ATCTGGAGTC CAAGCTAACA AC TTGTT 
Consensus -********* ****-***** -**-*****- *****-**** *-**-**--* 
501 550 
cpl TTATGACCTG TCCGAGATGC GTGCTGATAT CGGCGACATG CGTAAGTACG 
cp3 TTATGACCTG TCCGAGATGC GTGCTGATAT CGGCGACATG CGTAAGTACG 
cp4 TTATGACCTG TCCGAGATGC GTGCTGATAT CGGCGACATG CGTAAGTACG 
cp2 GTATGATCTT TCGGCGATGC GCGCTGATAT AGGTGATATG AGAAAGTACG 
Consensus -*****-**- ****-***** *-******** -**-**-*** -*-******* 
551 600 
cpl CCGTCCTGGT TTATTCGAAA GACGACAAAC TAGAGAAGGA TGAGATTGTA 
cp3 CCGTCCTGGT TTATTCGAAA GACGACAAAC TAGAGAAGGA TGAGATTGTA 
cp4 CCGTCCTGGT TTATTCGAAA GACGACAAAC TAGAGAAGGA TGAGATTGTA 
cp2 CCGTCCTCGT GTATTCAAAA GACGATGCAC TCGAGACGGA CGAGCTAGTA 
Consensus ********** -*****-*** *****---** *-****-*** -***-*-*** 
601 650 
cpl CTTCATGTCG ACGTCGAGCA TCAACG .... AATTCCTATC TCACGGATG. 
cp3 CTTCATGTCG ACGTCGAGCA TCAACG .... AATTCCTATC TCACGGATGC 
cp4 CTTCATGTCG ACGTCGAGCA TCAACGAATT AATTCCTATC TCACGGATGC 
cp2 CTTCATGTTG ACATCGAGCA CCAACG .... CATTCCCACA TCTGGGGTGC 






TCCCGACTTA GTCCGTGTGT TTACCGGCGT CCGAAGACGT TAAACTACAC 
TCCCGACTTA GTCCGTGTGT TTACCGGCGT CCGAAGACGT TAAACTACAC 
TCCC ...... ..... AGTCT GATTCCGTAT TCCCAGAACC CTCCCTCCGA 






TCTCAATCGC GAGTGCTGAG TTGGTAGTAT TGCTTTAAAC TGCCTGAGGT 
TCTCAATCGC GAGTGCTGAG TTGGTAGTAT TGCTTTAAAC TGCCTGAGGT 
TTTCTGTGGC GGGAGCTGAG TTGGCAGTTC TGCTATAAAC TGTCTG GT 






CCCTAAACGT GTTGTTGCGC GGGGAACGGG TTGTCCTTCC 
CCCTAAACGT GTTGTTGCGC GGGGAACGGG TTGTCCTTCC 
CACTAAACGT TTT ..... AC GGTGAACGGG TTGTCCATCC AGCTTA
Consensus ---------- ---------- ---------- ---------- ------
Figure 3.36. cDNA sequence alignment of CMV CP resistance genes. 
A consensus sequence is given at the bottom of each frame. The start codons are 
shown in bold type, and the stop codons of CP 2, CP 3 and CP 4 are underlined. The 
nucleotide differences in CP 2 are given in red type. The nucleotide alignment and 
consensus sequence were generated using the GCG 'PileUp' and 'Pretty' programs, 
respectively. The Eco RI mutation in CP4 is in bold and underlined. 
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cp1 OK'-;:;6 ·
cp3 0 K 0 6 1 
cp4 . D K .:: 6 ·, 
cp2 . D S 6 :·
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Consensus RP TL NH Pl F V 6 -ES CK P 6 V l Fr SIT L KP PE IE K 6 S VF 6 RR LS LP OS VT 0 V 
cp1 OKKL\JHRIQIRIN L KFDSTYWV VRKV 5SSDLSVAAISA F606NS�
cp3 0 K K L \J S R I O I R I t� L K F D S T V W ',) T V R K V .., S S D L S V A A I S A ti F 6 0 6 N S 
cp4 0 K K L \J S R I Q I R I N L K F O S T Y W V T V R K \) S S S D L S Y A R r S A fi F 6 0 6 N \:, 
cp2OKKL\JSRIQIRVN L KFDSTVWVTVRKV ASSOLSVAAISANFADSAS
Consensus OK KL \JSR IQ IR IN PL PK F OST Y WV f V R KVP S S SD LS VA A IS AN F 6 0 6 NS P 




Consensus V L V Y Q Y A A S 6 � Q A N N K L L Y D L S E M R A D I 6 D n R K Y A V L V Y S K D D K L E K D E I 
,:p 1 V L H V O V E H Q R l - - - - - - --□I S R i'l - -----
-
,:p3 V L H V O V E H r, R l -------- I S R I ,m T ----
,:p4VLHVDVEHQRINSYLTDA DLVRVFT6VRRR 
,:p2VLHVOIEHQRl--------0TB6VL V----
Co ra sens us 10) L H V O V E H Q R I -- - ---- - P - S R -L - - - -- -
Figure 3.3 7 Amino acid sequence alignment of CMV CP resistance genes. 
Conserved residues are boxed The amino acid alignment and consensus sequence 
were generated using the GCG Pile Up' and PrettyPlot' programs, respectively. 
3.5 Part 5: Transgene cloning into plant binary vectors 
3.5.1 Introduction 
In this part, the cloning of CMV MP, Rep and CP resistance genes into the plant 
binary vectors, pYR2 and pART27/7-4 is given. In all, a total of nine different 
potential resistance genes were developed during the project. Each of the resistance 
genes were excised from their respective pGEM-T Easy hosts with Eco RI and 
transferred into the corresponding site in the plant expression cassette of the plant 
binary vectors. 
3.5.2 Methods and Results 
3.5.2.1 Dephosphorylation of the linear plant binary vector DNA 
Linearised plasmid DNA was electrophoresed in a 1 % LMP gel, the bands excised 
from the gel, purified with the BresaClean DNA Purification Kit and fluorometrically 
quantified. Following quantification, the linear DNA was dephosphorylated with 
CIAP. The reaction mix consisted of lX CIAP reaction buffer (0.5 M Tris-HCl 
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pH9.3, 10 mM MgC}z, 1 mM ZnC}z, 10 mM spermidine), 1 µl CIAP (1 U/µl), 1 µg 
plasmid DNA, made up to a final volume of 50 µl with sterile distilled water. The 
reaction was incubated at 37°C for 30 min, an additional 1 µl CIAP was added and the
reaction incubated at 56
°
C for 30 min. 2 µl 0.5 M EDTA was added to stop the 
reaction and heated to 75 
°
C for 15 min. The DNA was extracted by adding 1 volume 
of phenol:chloroform:isoamyalcohol (50:50: 1), vortexing and centrifuging 20,800 g 
for 1 min. The aqueous layer was extracted with chloroform/isoamyalcohol. The 
DNA was concentrated by ethanol precipitation, washed with 70% ethanol, and 
resuspended in 10 µl water. 
3.5.2.2 Preparing the CMV resistance genes 
Single pGEM-T colonies containing the CMV resistance genes were grown overnight 
in LB broth containing 100 µg/ml ampicillin and the plasmid DNA purified using 
QIAprep Spin Columns. The plasmids were digested with Eco RI restriction digestion 
(pGEM-T/CP3 was digested with Hind III), and the reaction mix electrophoresed in a 
0.8% LMP gel, the bands were excised from the gel, purified with the BresaClean 
DNA Purification Kit and gel quantified using SPP-1 molecular marker. 
3.5.2.3 Cloning CMV transgenes into pYR2 and pART27/7-4 
The CMV resistance genes were cloned into pYR2 and pART27/7-4 binary vectors 
with T4 DNA ligase in a 1:1 molar ratio and incubated at 14°C overnight. 5 µl of the
ligation mix was transformed into chemical competent E. coli JM109 cells. 
3.5.2.4 Analysis of the pYR2 and pART clones containing CMV 
trans genes 
Screening for positive colonies was done by Eco RI restriction digestion (CP3 m 
pART vector was digested with Hind III) of purified plasmid DNA extracted from 
single colonies grown overnight in LB broth containing either 50 µg/ml 
chloramphenicol (for pYR2 vector) or 50 µg/ml spectinomycin (for pART vector). 
Although the strategies used for determining the orientations of the CMV transgenes 
in the binary vectors were the same - specific restriction digestion. The different 
enzymes were used to determine the different CMV transgenes in the different binary 
vectors. The overnight broth from positive colonies were mixed with sterilized 
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glycerol {finally concentration of glycerol was 15% (v/v)}, snap frozen in liquid 
nitrogen and immediately put in an -80
°
C freezer for long term storage. 
l kb ___. 
2 3 4 5 6 7 
Figure 3.38 Restriction digestion of pART clones carrying the MP gene in order to 
determine orientation of the insert. Lane ( 1) 1 kb marker; (2) pART/MP plasmid 
digested by Eco RI, shows the 840 bp insert of MP gene; (3) PART/MP plasmid double 
digested by 
Sal I and Hind III, shows the insert in the antisense orientation; (4) PART/MP plasmid 
double digested by Sal I and Hind III, shows the insert in the sense orientation; ( 5) 
pARTIMPS plasmid digested by Eco RI, shows the 840 bp insert of MPS gene; (6) 
PART/MPS plasmid double digested by Sal I and Hind 111, shows the insert in the 
sense orientation; (7) PART/MPS plasmid double digested by Sal I and Hind Ill, 
shows the insert in the antisense orientation. 
800bp _. 
1 2 3 4 5 6 7 8 9 10 
Figure 3.39 Eco RV/Sma I restriction digests to determine the orientations of CP 
genes in p YR2 vector 
Lane (1) 1 kb marker; (2) pYR2/CP2 digested by Eco RI, shows the insert of CP2; 
(3)CP2 in sense orientation; (4) CP2 in antisense orientation; (5) pYR2/CP 1 digested
by Eco RI, shows the insert of CP 1; ( 6) CP 1 in sense orientation; (7) CP 1 in antisense
orientation; (8) pYR2/CP4 digested by Eco RI, shows the insert of CP4; (9) CP4 in
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Figure 3.49 Eco RV /Xho I restriction digests to determine the orientations of CP 
genes in pART vector 
a. wne (1) 100 bp marker; (2) CP 1 in sense orientation; ( 3) CP 1 in antisense
orientation.
b. wne (1) 1 kb marker; (2-3) CPI in sense orientation; (4) CP2 in sense
orientation; (5) CP2 in antisense orientation; (6) CP3 in sense orientation; (7)








1.95 kb � 
1 2 3 4 5 6 
1 2 3 4 5 6 7 
7 
Figure 3.41 Restriction digest to determine the orientations of Rep genes in p YR2 
and pART vectors 
a. Lane (]) SPP marker; (2-3) pART/Repf digested by Kpn I, show the inserts in
sense orientation; ( 4) pART/Repf digested by Kpn I, show the inserts in antisense
orientation; (5) pYR2/Repf double digested by Kpn I and Xho I, shows the insert in
sense orientation; (6-7) pYR2/Repf double digested by Kpn I and Xho I, show the
inserts in antisense orientation.
b. Lane (1) SPP marker; (2-3) pART/Repm digested by Kpn I, show the inserts in
antisense orientation; ( 4-5) pART/Repm digested by Kpn I, show the inserts in
sense orientation; (6-7) pYR2/Repm double digested by Kpn I and Xho I, show the
inserts in antisense orientation; ( 8) p YR2/Repm double digested by Kpn I and Xho
I, shows the insert in sense orientation.
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Table 3.8 CMV resistance gene constructs developed in this study 
No. Construct Gene Size (bp) Binary vector Orientation Selectable 
marker 
1 pYR-UNMPl UNMP 936 pYR2 sense bar 
2 pYR-UNMP2 UNMP 936 pYR2 antisense bar 
3 pYR-lMPl lMP 840 PYR2 sense bar 
4 pYR-lMP2 lMP 840 PYR2 antisense bar 
5 pYR-lMPSl lMPS 840 PYR2 sense bar 
6 pYR-lMPS2 lMPS 840 PYR2 anti sense bar 
7 pYR-Repml Repm 2666 PYR2 sense bar 
8 pYR-Repm2 Repm 2666 PYR2 antisense bar 
9 pYR-CPl-1 CPl 645 PYR2 sense bar 
10 pYR-CPl-2 CPl 645 PYR2 anti sense bar 
11 pYR-CP2-1 CP2 777 PYR2 sense bar 
12 pYR-CP2-2 CP2 777 PYR2 anti sense bar 
13 pYR-CP4-1 CP4 790 PYR2 sense bar 
14 pYR-CP4-2 CP4 790 PYR2 antisense bar 
15 pART-lMPl lMP 840 PART27/7 sense npt II 
16 pART-lMP2 lMP 840 PART27/7 antisense nptII 
17 pART-lMPSl lMPS 840 PART27/7 sense nptII 
.. 
18 pART-lMPS2 lMPS 840 PART27/7 anti sense nptII 
19 pART-Repfl Repf 2777 PART27/7 sense nptII 
20 pART-Repf2 Repf 2777 PART27/7 antisense nptII 
21 pART-Repml Repm 2666 PART27/7 sense nptII 
22 pART-Repm2 Repm 2666 PART27/7 anti sense nptII 
23 pART-CPl-1 CPl 645 PART27/7 sense npt II 
24 pART-CPl-2 CPl 645 PART27/7 anti sense nptII 
25 pART-CP2-1 CP2 777 PART27/7 sense nptII 
26 pART-CP2-2 CP2 777 PART27/7 antisense nptII 
27 pART-CP3-1 CP3 786 PART27/7 sense nptII 
28 pART-CP3-2 CP3 786 PART27/7 antisense nptII 
29 pART-CP4-1 CP4 790 PART27/7 sense nptII 





3.6.1 PYR2 and pART27/7-4 Binary vectors 
3.6.1.1 p YR2 binary vector 
Numerous binary vectors contain significant stretches of duplicated sequences as a 
consequence of driving transcription of both the genes of interest and the plant 
selectable marker with the same promoter. These duplicated sequences may be 
responsible for plasmid instability within the plant genome. During the construction of 
the p YR2 vector in this research, stretches of duplicated sequences were avoided to 
minimise the possibility of recombination events leading to deletions and/or 
rearrangements. The Sc4 promoter is originally from subterranean clover stunt virus, 
and should induce strong gene expression in legumes, such as lupins. 
3.6.1.2 pART27/7-4 binary vector 
Since the pART27/7-4 vector contains two different promoters for driving 
transcription of both the insert and the plant selectable marker, there was no problem 
with stability of the binary vector in either the bacterial hosts or in the plant genome 
(Gleave, 1992). The MCS in the 35S-mcs-9cs 3' cassette offered 7 unique restriction 
sites (Xho I, Eco RI, Kpn 1, Sma I, Hind III, Cla I, Barn HI and Xba I) for cloning the 
genes of interest. 
Both pYR2 and pART27/7-4 have been used in developing the genetic constructs for 
CMV resistance in this research. In addition, the two binary vectors were given to 
colleagues at the SABC. Ms K. Hoffmann used p YR2 to develop a construct for 
BYMV resistance based on the BYMV CP gene. Dr S. Wylie used pYR2 to produce a 
series of anti-fungal constructs. Ms S. Pons cloned a fish growth hormone gene into 
pYR2 for transformation into tobacco and narrow-leafed lupin. Ms S. Pons also 
introduced a fish growth hormone gene into pART27/7-4. 
3.6.2 Advantage of ELONGase in amplifying CMV-L Y Rep gene 
Amplification using Taq DNA polymerase has a nucleotide misincorporation rate of 
about 10-4 mutations per bp per cycle (Barnes, 1994). Tag-induced mismatches could 
be a problem if deleterious mutations arise in transgene products. This is less likely 
to be of concern in untranslatable constructs where there is no protein product; for 
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example, two unexpected point mutations were detected in the :MPS gene, which was 
an untranslatable version of CMV-LY MP. 
Amplification using Taq DNA polymerase is generally limited to DNA templates less 
than 5 kb. This limitation is believed to be largely due to the inability of Taq DNA 
polymerase, which lacks proof-reading (3' to 5' exonuclease) activity (Tindall and 
Kunkel, 1988), to correct nucleotide misincorporations and continue primer elongation 
(Innis et al., 1988). 
In order to minimise mismatches in amplifying the CMV-L Y Rep gene ELONGase 
was used. The ELONGase enzyme consists of a mixture of Taq and Pyrococcus 
species GB-D thermostable DNA polymerase, which edits the nascent strand to allow 
subsequent polymerization by the Taq. Because mismatches are removed, PCR 
products generated in this way should match the original template more accurately. 
This conclusion was further confirmed in this study when amplifying the CMV-L Y 
Rep gene. 
3.6.3 Inverse PCR mutagenesis .. · .. 
Site-directed mutagenesis is widely used in the field of molecular biology to introduce 
mutations in DNA (Callow et al., 1994). The development of inverse polymerase 
chain reaction mutagenesis (IPCRM) eliminated the need to clone DNA, therefore 
simplifying the technique and enabling the desired results to be achieved more 
quickly. It proved to be a rapid and convenient method for mutating the GDD motif in 
the CMV-L Y RNA 2 during development of the Repm resistance gene in this 
research. 
Although the method that was used in the development of mutated version of CMV­
Fny Rep gene by Anderson et al (1992) allowed reliable production of mutated DNA, 
the necessary steps in the protocol were laborious, moreover, suitable restriction 
enzymes for region-specific deletion are not always available. For CMV-L Y RNA 2, 
there were no suitable restriction enzymes for deleting the GDD motif. 
The only problem associated with IPCRM is the possible carryover of unmutated 
plasmid DNA into the transformation reaction, resulting in false positives. This 
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problem can be overcome by digesting away the plasmid DNA template with Dpn I, 




------------ ------ --I - -- - -a-�_-__ - -cc_--- -- -�-----,------OJ � -_-,---------_-__ -______ _  ccc�, -- ------ --- - ------------ ----- -----• �---- ---- -- ---- --- -- -- -- �-
I 
Chapter 4 
The complete nucleotide sequence of the Western 
Australian CMV-LY isolate 
106 
-_ I I 
! I --
Chapter 4 The complete nucleotide sequences of Western Australian 
CMV-L Y isolate
4.1 Introduction 
The complete nucleotide sequences of seven strains of CMV have been reported (see 
Appendix 1.1). In addition the nucleotide sequence of six RNA 2 and seventeen RNA 
3 sequences have been reported or directly submitted to the GenBank nucleotide 
database. Based on sequence differences, these CMV strains have been classified into 
two main subgroups (Owen and Palukaitis, 1988). 
The initial sequencing of CMV-L Y RNA 2 and RNA 3 was presented in Chapter 3 in 
which sequences required for making each CMV resistance construct were elucidated. 
In this chapter, the entire genomic sequence of the sg II CMV-LY isolate is presented. 
This includes the complete nucleotide sequences of RNAs 1, 2 and 3 and the deduced 
amino acid sequences of ORFla, ORF2a, ORF2b, ORF3a (MP) and ORF3b (CP). 
The regions that were not sequenced in Chapter 3 were determined in this chapter, and 
include: the complete nucleotide sequence of RNA 1, complete nucleotide sequence of 
RNA 2, 5' and 3' terminal regions of RNA 1, 2 and 3, intergenic region (IR) of RNA 3. 
A comparison of CMV-L Y nucleotide . and deduced amino acid sequences with those 
of the other CMV strains from sg I and II, is also provided. 
4.2 Materials and Methods 
4.2.1 Purification of CMV-LY virions 
The protocol for CMV-L Y virions purification was supplied by Dr M Prins, 
Wangengang Agricultural University, Netherlands (personal communication, 1998). 
200 g of CMV-L Y infected N. glutinosa leaves were ground in 200 ml of buffer A (0.5 
M sodium citrate, 5 mM Na-EDTA and 1 % 2-mercaptolethanol) and the extract 
filtered through two layers of cheesecloth. 100 ml chloroform and 100 ml carbon 
tetrachloride were added to the filtrate, the mixture stirred for 30 min at room 
temperature, followed by a 20 min centrifugation at 10,000 g and the supernatant 
transferred to a fresh tube. PEG 6000 and sodium chloride was added to the 
supernatant to a final concentration of 8% and 300 mM, respectively. The mixture 
stirred for 1 hr, and then centrifuged at 19,000 g for 20 min. The pellet was 
resuspended in 50 ml buffer B (5 mM sodium tetraborate and 5 mM Na-EDTA), 
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containing 2% Triton X-100, stirred for 30 min, centrifuged at 10,000 g for 10 min. 
The supernatant was applied to a cushion of 20% sucrose and centrifuged at 200,000 g 
for 90 min, and the pellet was resuspended in two volumes of buffer C (5 mM sodium 
tetraborate and 1 mM Na-EDT A). 
4.2.2 Preparation of total RNA from CMV-LY virions 
The protocol used for preparing the total RNA from CMV-L Y virions was based on 
Wylie (1996). Purified CMV virions were gently mixed with proteinase K (Sigma) to 
a final concentration of 50 µg/ml and 0.1 % SOS, and incubated at 37°C for 1 hr. 
_Following incubation, 1 volume of phenol:chloroform:isoamylalcohol (24:24:2) was 
added and mixed by inverting the tube several times. The phases were separated by 
centrifugation for 2 min at 20,800 g in a bench-top centrifuge. The aqueous phase was 
removed and the procedure repeated with chloroform:isoamylalcohol (24:1) to remove 
any residual phenol. The RNA was precipitated by adding 0.5 vol of 10 M ammonium 
acetate (pH 5.2) and 2 volumes of cold ethanol, incubated on ice for 15 min followed 
by centrifigation at 20,800 g for 15 min. The solution was carefully aspirated and the 
pellet washed with 70% ethanol, vacuum dried and resuspended in 10 µl RNase-free 
water. The RNA concentration was estimated by quantifying spectrophotometrically. 
RNA was stored under two volumes of absolute ethanol at -80°C and prior to use. 
4.3 RNA 1 
4.3.1 Primer design 
Two primers were designed for RT-PCR amplification of most of the CMV-LY RNA 
1 molecule. The primer sequences were based on the RNA 1 sequence of CMV-Q 
(Accession number: X02733). The upstream primer (RNA 1-1, 
5'CAAGAGCGT ACGGTTCAACCCCTGC) anneals at nucleotides 11 to 35 of CMV­
Q RNA 1, and the downstream primer (RNA 1-2, 5' TGGTCTCCTTATGGAGAACC) 
binds at the 3' end of CMV-Q RNA 1. 
4.3.2 RT-PCR 
First-strand cDNA synthesis was carried out using Superscript™ II RNase H. Reverse 
Transcriptase. An aliquot of CMV-LY RNA extract (100 ng) was incubated at 70°C 
for 10 min to denature the RNA and then quickly chilled on ice. A 2 µl aliquot was 
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immediately added to a fresh tube containing the first-strand reaction mixture (minus 
the polymerase) and incubated for 10 min at 25°C, and then for 2 min at 42°C to 
hybridise the random hexamers to template RNA. Superscript II RNase H- Reverse 
Transcriptase was added, the tube mixed gently and the reaction incubated at 42°C for 
50 min. The RT enzyme was heat inactivated at 70°C for 15 min. The RNA template 
was degraded by incubating the mixture at 37°C for 15 min in the presence of 1 µl 
RNaseH. 
Table 4.1 First-strand cDNA synthesis reagent mixture 
Reagent Stock Cone. Volume (µI) Final Cone. 
Reaction buff er 5X 4.0 lX 
OTT lOmM 1.0 0.5 mM 
dNTPs lOmM 1.0 0.5 mM 
Random hexamers 50pmol 1.0 2.5 pmol/µl 
Superscript 5 U 1.0 0.25U/µl 
CMV RNA extract 2.0 
H20 to 20 µI 
PCR amplification was done using the ELONGase® Enzyme Mix to minimise 
nucleotide misincorporation during DNA �ynthesis. 2 µl of cDNA from the first­
strand reaction was added to a mixture containing the PCR reagents given in Table 
4.2. The reaction mix was heated to 94 °C for 3 min for initial denaturation followed 
by 30 cycles of 94°C for 1 min, 60°C for 1 min, 72°C for 5 min, followed by a final 
extension cycle of 72°C for 7 min. 
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The PCR product was electrophoresed in a 1 % LMP gel, the cDNA band excised from 
the gel, purified with the BresaClean DNA purification Kit, cloned into pGEM-T Easy 
and transformed into E. coli DH5a chemical competent cells. The cells were incubated 
overnight at 37°C on LB plates containing 100 µg/ml ampicillin, coated with 20 µl of 
50 mg/ml X-Gal and 100 µl of 100 mM IPTG to facilitate blue/white screening. 
Screening for positive colonies was done by Eco RI restriction digestion of purified 
plasmid DNA extracted from single white colonies grown overnight in LB broth 
containing 100 µg/ml. Plasmid DNA was purified for sequencing by QIAprep spin 
columns as described in Chapter 2. 
4.3.4 Sequencing the cDNA of CMV-L Y RNA 1 
The T7 and SP6 primers were used to determine the 5'- and 3'- terminal sequences of 
the CMV-LY RNA 1 insert in pGEM-T Easy. The remaining region was sequenced 
using CMV-L Y RNA 1 specific primers designed from sequence data (Table 4.3 and 
Fig.4.1). 
Table 4.3 The primers used for sequencing the CMV-LY RNA 1 cDNA 
PrimerNo Primer .. Primer seauence 
1 T7 5' CTATGACCATGATTACGCCAAGC 
2 SP6 5' CGGCAGTGAATTGT AATACGAC 
3 RNA 1-3 5' GATGCGTCACACTGAAAGG 
4 RNA 1-4 5' TTCAACCT AACCAGGG 
5 RNA 1-5 5'ACGCTGGCGTGATGACTTAC 
6 RNA 1-6 5' TTGCACATGACAGCGCAC 
7 RNA 1-7 5' GAGACCGCGCGAGGAAAAG 
8 RNA 1-8 5' CTCCCAGT AGGAAA 
9 RNA 1-9 5' AAACTCTTT AGAGAG 
10 RNA 1-10 5' AACTCCTTTTCCTCGC 
11 RNA 1-11 5'ATGAAGTTGTTCTGTTGC 
12 RNA 1-12 5' TTCCAAT AGGTCAT ACC 
13 RNA 1-13 5' ATGCGACCCTGGTTAGG 
14 RNA 1-14 5' AACCTTTCAGTGTGACG 
RNA 1-3 RNA 1-5 RNA 1-7 RNA 1-9 RNA 1-11 RNA 1-13 
� _. _. _. _. _. _. 
... .,._ � .,._ � � 4-
RNA 1-14 RNA 1-12 RNA 1-10 RNA 1-8 RNA 1-6 RNA 1-4 
SP6 
Figure 4.1 A linear representation of CMV-LY RNA 1 insert in pGEM-T showing 
primer annealing positions. T7 and SP6 primers anneal to the plasmid DNA. The 
remaining primers were designed from primer walking experiment ( sequences given in 
Table 4.3). 
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4.4 RNA2 
A similar strategy to that used for sequencing CMV RNA 1 was applied for 
determining the nucleotide sequence of CMV-L Y RNA 2. The T7 and SP6 primers 
were used to determine the terminal sequences of the CMV-LY RNA 2 cDNA insert in 
pGEM-T/RNA 2. The remaining region was sequenced using CMV-LY RNA 2 
specific primers designed from sequence data obtained from primer walking 
experiments (Table 4.4 and Fig.4.2). 


































5' GCTGTT AAGACCTCC 
5' CTTCCTGATCTTCACGCGGAG 
5' GGTACTGCAGGTTCCATCACC 
5' TTGACAGT AGTGGTGTCGACC 















Figure 4.2 A linear representation of CMV-LY RNA 2 insert in pGEM-T showing 
primer annealing positions. T7 and SP6 primers anneal to the plasmid DNA. The 
remaining primers were designed from primer walking experiment ( sequences given in 
Table 4.4). 
4.5 RNA3 
Partial CMV-LY RNA 3 sequence was determined in Chapter 3 during the 
development of CMV resistance constructs based on CMV-L Y MP and CP genes. 
Therefore, only the IR of RNA 3 was amplified by RT-PCR with upstream primer, 
MP9 (5' GTCCGTCCGCGTCCCGTAAC) and downstream primer CP9 (5' 
GAGTCTCAGCATCTGCTGAG), the cDNA was cloned into pGEM-T and 





4.6 Determination of RNAs 1, 2 and 3 5' terminal sequences 
The 5'-tenninal sequence of RNAs 1, 2 and 3 was determined using rapid 
amplification of cDNA ends (5' RACE). 5' RACE is a procedure used to amplify 
nucleotide sequence from RNA template between a defined internal site and unknown 
sequence at the 5' -end of the mRNA (Frohman et al., 1988). The 5' RACE involves 
the synthesis of first strand cDNA, 5'-end homopolymer tailing, and preparation of 
target cDNA for subsequent amplification by PCR. First strand cDNA synthesis was 
primed using a gene-specific oligonucleotide (GSPl). Following cDNA synthesis, the 
RNA was degraded by RNase Mix, and the first strand product was purified from 
unincorporated dNTPs and GSPl. Terminal deoxynucleotidyl transferase (TdT) and 
dTCP were used to add homopolymeric tails to the 3' ends of the first strand cDNA. 
Tailed cDNA was then amplified by PCR using a nested gene-specific primer (GSP2) 
and a complementary homopolymer-containing abridged anchor primer (AAP) 
4.6.1 Design of 5' RACE primers 
Two gene-specific primers (GSPl and GSP2) for each RNAs (1, 2 and 3) were 
synthesised from 5' regions of RNAs 1, 2 and 3 {Table 4.5). An AAP containing 
sequences complementary to the homopolymer tail was supplied by Life Technologies. 
Table 4.5 List ofGSP and anchor primer sequences used for 5' RACE 
RNA Name of primer 
Sequence 
RNAl GSPl RNA 1-13 5'AACCTTTCAGTGTGACG 
GSP2 RNA 1-14 5 'T AGACCTT AAGGCCTCT AGC 
RNA2 GSPl ReplO 5'TCGCGGCCACAAGGTC 
GSP2 Rep12 5 'ACGT AAAGCCGCCTCAGCATC 
RNA3 GSPl 3'MP 5' GCTGGATCCCTAAAGACCGTTAACCACC 
GSP2 3'MP2 S'GGAACGAGAGGTCTGACAGAG 
AAP 5'GGC CAC GCG TCG ACT AGT ACG GGI IGG Gil GGG IIG 
4.6.2 First strand cDNAs synthesis from total RNA 
First strand cDNA of the 5' terminal regions of RNAs 1, 2 and 3 were synthesised 
using Superscript™ II RNase H- RT as described in Chapter 3 and specified GSPl, 
downstream primers. CDNA was purified using GlassMax DNA isolation spin 




4.6.3 TdT tailing of cDNA 
Purified first-strand cDNA was tailed with TdT according to the manufacturer's 
instructions. The following components were added to each tube and mixed gently: 
6.5 µl RNase-free water, 2 mM dCTP 2.5 µl, and 10.0 µl purified cDNA sample. The 
tubes were incubated for 2 to 3 min at 94 °C and chilled for 1 min on ice. The contents 
of the tube were collected by brief centrifugation and placed on ice. 1 µl TdT added, 
the tube mixed gently and incubated for 10 min at 37°C. The tubes were then heated 
for 10 min at 65°C to inactivate the TdT. The contents of the reaction were collected 
by brief centrifugation and placed on ice. 
4.6.4 PCR of dC-tailed cDNA 
For PCR amplification of dC-tailed cDNA, 2 mM MgCh, 1 X PCR Buffer II, 0.2 mM 
dNTP, 20 pmol GSP2 primer, 20 pmol AAP, 5 µI dC-tailed cDNA and sterile-distilled 
water was added to 49.75 µI. The thermal cycler was equilibrated to 80°C and 0.25 µl 
of Taq DNA polymerase (5 U/µl) added to the tubes. The PCR cycling conditions 
consisted of an initial denaturation period of 3 min at 94 °C followed by 30 cycles of 
94 °C for 30 sec, 60°C for 30 sec, 72°C for 2 min, followed by a final extension cycle 
of 72°C for 10 min. 10 µI aliquots of the 5' RACE products were analyzed in a 1 % 
agarose gel electrophoresis. 
The PCR products were gel purified, ligated into pGEM-T Easy, and transformed into 
E. coli JM 109 competent cells as described in Chapter 2. Screening for positive
colonies was done by Eco RI restriction digestion of purified plasmid DNA extracted 
from single colonies. Single pGEM-T Easy clones containing the 5' ends of CMV-LY 
RNAs 1, 2 and 3 were sequenced in both directions using T7 and SP6 primers. 
4.7 Determination of the 3' terminal regions of RNAs 1, 2 and 3 
4.7.1 Polyadenylation of the 3' ends of CMV-LY RNAs 
The procedure used for poly (A)-tailing of the 3' ends of CMV-LY RNAs was based 
on the protocol supplied by the manufacturers (Life Technlogies). The reaction 
consisted of 10 µI 5X Poly(A) polymerase buffer (20 mM Tris HCI, pH 8, 50 mM 
MgCh, 12.5 mM MnC}z, 1.25 M NaCl), 15 µg CMV-LY RNA, 1.5 µ1 10 mM ATP, 5 
U Poly (A) polymerase and sterile-distilled water to 50 µI. The reaction tube was 




incubated at 37°C for 30 min. The reaction was stopped by adding 2 µI 0.5 M EDTA 
and heated to 75°C for 10 min. 
4.7.2 cDNA synthesis and cloning of the 3' end of CMV-LY RNAs 1, 2 
and3 
The 3' terminal regions of CMV-LY RNAs 1, 2 and 3 were amplified by RT-PCR 
using the poly A tailed RN As as the template with the standard conditions as described 
in Chapter 2. The gene specific primers are listed in Table 4.6. 
Table 4.6 Primers used for RT-PCR amplification of the 3' terminal region of CMV 
RNAs 1,2 and 3 
RNA 5' upstream primer 3' downstream primer 




The PCR reactions were carried out using the standard protocol described in Chapter 
2. The PCR products were gel purified using the BresaClean DNA Purification Kit,
cloned into pGEM-T, and sequenced with T7 and SP6 primers in both directions as 
previously described. 
4.8 Results and Discussion 
4.8.1 Amplification of the cDNA of 5' ends of RNAs 1, 2 and 3 
The 5' ends of CMV-LY RNA 1, 2 and 3 were successfully amplified using the 5' 
RACE system. The exepcted size fragments of RT-PCR are shown in Fig. 4.3 (120 bp 
of RNA 1 's; 280 bp of RNA 2's and 240 bp of RNA 3's). These three cDNAs were 





2 3 4 5 6 7 
280 bp 
240 bp 
Figure. 4.3 PCR products of the 5' ends of CMV-LY RNAs 1, 2 and 3. Lane 1 1 kb 
marker; lane 2 positive control (CMV-CP); lane 3 negative control (H2O); lane 4 RNA 
l; lane 5 RNA 2; lane 6 RNA 3.and lane 7 pUC72 marker. 
4.8.2 Amplifying the cDNA of the 3' ends of RNA 1, 2 and 3 
The 3' ends of RNAs 1, 2 and 3 were successfully tailed with poly (A) polymerase, and 
amplified by RT-PCR (Fig. 4.4). 
310 bp 
1 2 3 4 5 
._ 380bp 
6 7 8 
Figure. 4.4 PCR of the 3' ends of CMV-LY RNA 1, 2 and 3 and IR of RNA 3. 
Lane 1 1 kb marker; Lane 2 RNA 1; Lane 3 RNA 2; Lane 4 RNA 3, lane 5 negative 
control, lane 6 IR of RNA 3; lane 7-8 positive control. 
4.8.3 cDNA synthesis of the IR of CMV-L Y RNA 3 
The IR of CMV-LY RNA 3 was successfully amplified by RT-PCR (Figure 4.4). The 
PCR product was purified by Bresa-clean DNA purification kit and ligated into 
pGEM-T vector for sequencing with T7 and SP6 primers. The sequence result will be 




4.8.4 RNA 1 
4.8.4.1 Complete nucleotide sequence of CMV-L Y RNA 1 
The complete nucleotide sequence and deduced amino acid sequence of CMV-L Y 
RNA 1 are given in Figure 4.5. The RNA 1 molecule is 3391 nt in length. Following 
the 5' non-coding region of 95 nt, the first ATG occurs at positions 96-98, followed by 
a large ORF of 2979 nt. The length of the 3' non-coding region is 317 nt. The 
predicted ORFla protein translated from RNA 1 is a polypeptide of 932 amino acids 
and encodes a protein with a Mr of 111 kDa. 
i I 
9TTTTATTTACAAGAGCGTACGGTTCAACCCCTGCCCCCTCTGTAAAACTACCCTTTGAA 
1 ---------+---------+---------+---------+---------+---------+ 60 
CAAAATAAATGTTCTCGCATGCCAAGTTGGGGACGGGGGAGACATTTTGATGGGAAACTT 
TTCTTCTTCTCGACTTTTCTTAGTTTAAAATTCCTATGGCAACGTCCTCATTCAACATCA 
61 ---------+---------+---------+---------+---------+---------+ 120 
AAGAAGAAGAGCTGAAAAGAATCAAATTTTAAGGATACCGTTGCAGGAGTAAGTTGTAGT 
M A T S S F N I N 
ATGAACTGGTAGCCTCCCACGGCGATAAAGGACTACTTGCGACAGCCCTCGTTGATAAAA 
121 ---------+---------+---------+---------+---------+---------+ 180 
TACTTGACCATCGGAGGGTGCCGCTATTTCCTGATGAACGCTGTCGGGAGCAACTATTTT 
E L V A S H G D K G L L A T A L V D K T 
CAGCTCATGAACAGCTGGAGGAGCAACTTCAACATCAACGTAGAGGCCTTAAGGTCTACA 
181 ---------+---------+---------+---------+---------+---------+ 240 
GTCGAGTACTTGTCGACCTCCTCGTTGAAGTTGTAGTTGCATCTCCGGAATTCCAGATGT 
A H E Q L E E Q L Q H Q R R G L K V Y I 
TCCGTAATGTTTTGGATGTAAAGGACTCCGAAGTCATTCGGACTCGGTATGGTGGTAAGT 
241 ---------+---------+---------+---------+---------+---------+ 300 
AGGCATTACAAAACCTACATTTCCTGAGGCTTCAGTAAGCCTGAGCCATACCACCATTCA 
R N V L D V K D S E V I R T R Y G G K Y 
ACGACCTCCATCTCACCCAGCAGGAATTAGCTCCCCATGGCCTCGCTGGTGCCCTCCGCT 
301 ---------+---------+---------+---------+---------+---------+ 360 
TGCTGGAGGTAGAGTGGGTCGTCCTTAATCGAGGGGTACCGGAGCGACCACGGGAGGCGA 
D L H L T Q Q E L A P H G L A G A L R L 
TGTGTGAAACTCTCGATTGTCTAGACTTTTTCCCTCGTTCAGGTCTGCGGCAGGACCTCG 
361 ---------+---------+---------+---------+---------+---------+ 420 
ACACACTTTGAGAGCTAACAGATCTGAAAAAGGGAGCAAGTCCAGACGCCGTCCTGGAGC 
C E T L D C L D F F P R S G L R Q D L V 
TCTTAGACTTCGGAGGAAGTTGGGTCACACACTATCTTCGCGGACACAACGTACATTGCT 
421 ---------+---------+---------+---------+---------+---------+ 480 
AGAATCTGAAGCCTCCTTCAACCCAGTGTGTGATAGAAGCGCCTGTGTTGCATGTAACGA 





481 ---------+---------+---------+---------+---------+---------+ 540 
CGAGGGGTACAAACCCATAGGCACTGTTCTACGCAGTGTGACTTTCCAACTACTCGTACG 
S P C L G I R D K M R H T E R L M S M R 
GCAAGGTCATTTTAAACGATCCACAGCAGTTTGATGGCCGCCAGCCGGACTTTTGCACTA 
541 ---------+---------+---------+---------+---------+---------+ 600 
CGTTCCAGTAAAATTTGCTAGGTGTCGTCAAACTACCGGCGGTCGGCCTGAAAACGTGAT 
K V I L N D P Q Q F D G R Q P D F C T K 
AGTCTGCAGCTGAATGCAAAGTTCAAGCCCACTTTGCTATTTCTATACACGGAGGATATG 
601 ---------+---------+---------+---------+---------+---------+ 660 
TCAGACGTCGACTTACGTTTCAAGTTCGGGTGAAACGATAAAGATATGTGCCTCCTATAC 
S A A E C K V Q A H F A I S I H G G Y D 
ATATGGGCTTTAGAGGTTTATGTGAGGCAATGAACGCTCACGGAACTACGATTTTGAAAG 
661 ---------+---------+---------+---------+---------+---------+ 720 
TATACCCGAAATCTCCAAATACACTCCGTTACTTGCGAGTGCCTTGATGCTAAAACTTTC 
M G F R G L C E A M N A H G T T I L K G 
GGACGATGATGTTCGACGGCGCTATGATGTTTGACGACCAAGGCTTTATTCCTGAACTTA 
721 ---------+---------+---------+---------+---------+---------+ 780 
CCTGCTACTACAAGCTGCCGCGATACTACAAACTGCTGGTTCCGAAATAAGGACTTGAAT 
T M M F D G A M M F D D Q G F I P E L K 
AATGTCAGTGGCGAAAAGTTAAATCCGCCTTCTCTGAGGAGGAGGATGCCACTTGTTTAG 
781 ---------+---------+---------+---------+---------+---------+ 840 
TTACAGTCACCGCTTTTCAATTTAGGCGGAAGAGACTCCTCCTCCTACGGTGAACAAATC 
C Q W R K V K S A F S E E E D A T C L A 
CAGCTAAACTCAATTCTAGTGGTTTTTCACGCGTGCGAAATGGGAAAACCTTAATCGCAT 
841 ---------+---------+---------+---------+---------+---------+ 900 
GTCGATTTGAGTTAAGATCACCAAAAAGTGCGCACGCTTTACCCTTTTGGAATTAGCGTA 
A K L N S S G F S R V R N G K T L I A F 
TTGACTTCGTTGAGGAATCCACGATGTCTTATGTTCACGATTGGGATAATATACAATCGT 
901 ---------+---------+---------+---------+---------+---------+ 960 
AACTGAAGCAACTCCTTAGGTGCTACAGAATACAAGTGCTAACCCTATTATATGTTAGCA 
D F V E E S T M S Y V H D W D N I Q S F 
TTATGACAGATCAAACGTACTCTTTCAATGGTATGACCTATGGAATTGAGCGTTGTGTCA 
961 ---------+---------+---------+---------+---------+---------+ 1020 
AATACTGTCTAGTTTGCATGAGAAAGTTACCATACTGGATACCTTAACTCGCAACACAGT 
M T D Q T Y S F N G M T Y G I E R C V I 
TTTACGCTGGCGTGATGACTTACAAGATTGTTGGCGTGCCTGGTATGTGTCCGCCCGAAC 
1021 ---------+---------+---------+---------+---------+---------+ 1080 
AAATGCGACCGCACTACTGAATGTTCTAACAACCGCACGGACCATACACAGGCGGGCTTG 
Y A G V M T Y K I V G V P G M C P P E L 
TCATTCGACATTGTATCTGGTTCCCCTCTATGAAGGACTATGTTGGTCTTAAGATTCCCG 
1081 ---------+---------+---------+---------+---------+---------+ 1140 
AGTAAGCTGTAACATAGACCAAGGGGAGATACTTCCTGATACAACCAGAATTCTAAGGGC 
I R H C I W F P S M K D Y V G L K I P A 
CGTCTGATGACTTGGTTAAATGGAAAACAGTCCGTATTTTACTGTCAACATTACGTGAGA 





S D D L V K W K T V R I L L S T L R E T 
CTGAAGAAATAGCTATGCGTTGTTATAACGACAAGAAGAATTGGATGGATCAATTCAAGA 
1201 ---------+---------+---------+---------+---------+---------+ 1260 
GACTTCTTTATCGATACGCAACAATATTGCTGTTCTTCTTAACCTACCTAGTTAAGTTCT 
E E I A M R C Y N D K K N W M D Q F K I 
TTATTCTCGGTGTTTTATCATCGAAGTCCTCCACGATCGTTATCAATGGTATGTCTATGC 
1261 ---------+---------+---------+---------+---------+---------+ 1320 
AATAAGAGCCACAAAATAGTAGCTTCAGGAGGTGCTAGCAATAGTTACCATACAGATACG 
I L G V L S S K S S T I V I N G M S M Q 
AATCCGGTGAACGTATTGATCTCAATGATTATCATTACATCGGTTTTGCTATCCTTCTCC 
1321 ---------+---------+---------+---------+---------+---------+ 1380 
TTAGGCCACTTGCATAACTAGAGTTACTAATAGTAATGTAGCCAAAACGATAGGAAGAGG 
S G E R I D L N D Y H Y I G F A I L L H 
ACACGAAGTTAAAATACGAACAACTTGGGAAAATGTACGATATGTGGAATGCTTCCTTCA 
1381 ---------+---------+---------+---------+---------+---------+ 1440 
TGTGCTTCAATTTTATGCTTGTTGAACCCTTTTACATGCTATACACCTTACGAAGGAAGT 
T K L K Y E Q L G K M Y D M W N A S F I 
TTTGGAAGTGGTTTGCGTCTATGTCTAGACCATTCCGTGTTTTCTTTTCCACTGTTGTTA 
1441 ---------+---------+---------+---------+---------+---------+ 1500 
AAACCTTCACCAAACGCAGATACAGATCTGGTAAGGCACAAAAGAAAAGGTGACAACAAT 
W K W F A S M S R P F R V F F S T V V K 
AGACTTTGTTTCCGACTTTGAGACCGCGCGAGGAAAAGGAGTTTTTGGTCAAACTTTCCA 
1501 ---------+---------+---------+---------+---------+---------+ 1560 
TCTGAAACAAAGGCTGAAACTCTGGCGCGCTCCTTTTCCTCAAAAACCAGTTTGAAAGGT 
T L F P T L R P R E E K E F L V K L S T 
CTTTCGTCACCTTTAACGAGGAGTGCTCTCTTGACGGAGGGAAAGAATGGGACGTGATAT 
1561 ---------+---------+---------+---------+---------+---------+ 1620 
GAAAGCAGTGGAAATTGCTCCTCACGAGAGAACTGCCTCCCTTTCTTACCCTGCACTATA 
F V T F N E E C S L D G G K E W D V I S 
CATCAGCGGCTTTCGTAGCCGCTCAGGCTGTTGCAGATGGTACTATTCTGGCCGAGGAGA 
1621 ---------+---------+---------+---------+---------+---------+ 1680 
GTAGTCGCCGAAAGCATCGGCGAGTCCGACAACGTCTACCATGATAAGACCGGCTCCTCT 
S A A F V A A Q A V A D G T I L A E E K 
AAGCTAAGAAATTAGCTGATCGTCTGGCCGTGCCTGTTGAAGAAGTATCTGCTATTCCTG 
1681 ---------+---------+---------+---------+---------+---------+ 1740 
TTCGATTCTTTAATCGACTAGCAGACCGGCACGGACAACTTCTTCATAGACGATAAGGAC 
A K K L A D R L A V P V E E V S A I P E 
AGGTGTCTCCTACACCTGTTGATCAGGGCACTGCTTGTGGACTGGAAACAGAAACATCGG 
· 1741 ---------+---------+---------+---------+---------+---------+ 1800
TCCACAGAGGATGTGGACAACTAGTCCCGTGACGAACACCTGACCTTTGTCTTTGTAGCC 
V S P T P V D Q G T A C G L E T E T S E 
AACTGGATTCTCTGTCTGCCCAAACACGTTCCCCCATCACACGGATCGCTGAAAGAGCGA 
1801 ---------+---------+---------+---------+---------+---------+ 1860 
TTGACCTAAGAGACAGACGGGTTTGTGCAAGGGGGTAGTGTGCCTAGCGACTTTCTCGCT 
L D S L S A Q T R S P I T R I A E R A T 
118 
-�---� �-�- ---1 
I 1 
CCGCTATGCTTGAATATTCAGCTTATGAGAAACAATTGCACGATACCACCGTTTCAAATC 
1861 ---------+---------+---------+---------+---------+---------+ 1920 
GGCGATACGAACTTATAAGTCGAATACTCTTTGTTAACGTGCTATGGTGGCAAAGTTTAG 
A M L E Y S A Y E K Q L H D T T V S N L 
TTCAACGAATTTGGTGCATGGCAGGTGGCGACAACAAGAGAAACTCTTTAGAGAGTAATT 
1921 ---------+---------+---------+---------+---------+---------+ 1980 
AAGTTGCTTAAACCACGTACCGTCCACCGCTGTTGTTCTCTTTGAGAAATCTCTCATTAA 
Q R I W C M A G G D N K R N S L E S N L 
TGAAATTTGTGTTTGACACTTATTTTTCTGTTGACGCCCTGGTGAATGTTCACTTTCCTA 
1981 ---------+---------+---------+---------+---------+---------+ 2040 
ACTTTAAACACAAACTGTGAATAAAAAGACAACTGCGGGACCACTTACAAGTGAAAGGAT 
K F V F D T Y F S V D A L V N V H F P T 
CTGGGAGGTGGATGCACCCTGTGCCTGAGGGCGTGGTATACTCTGTTGGTTATAACGAGA 
2041 ---------+------- -+---------+---------+---------+---------+ 2100 
GACCCTCCACCTACGTGGGACACGGACTCCCGCACCATATGAGACAACCAATATTGCTCT 
G R W M H P V P E G V V Y S V G Y N E K 
AGGGTCTTGGTCCTAAACTGGATAGTGAGTTGTACATAGTTAATGGTGATTGTGTGATTT 
2101 ---------+---------+---------+---------+---------+---------+ 2160 
TCCCAGAACCAGGATTTGACCTATCACTCAACATGTATCAATTACCACTAACACACTAAA 
G L G P K L D S E L Y I V N G D C V I S 
CGAACAGTCATGATTTGTTTTCAATCACTAAATCTTTGTTAGCTCCCACCGGAACCATCA 
2161 ---------+---------+---------+---------+---------+---------+ 2220 
GCTTGTCAGTACTAAACAAAAGTTAGTGATTTAGAAACAATCGAGGGTGGCCTTGGTAGT 
N S H D L F S I T K S L L A P T G T I S 
GCCAAGTCGATGGTGTAGCTGGGTGCGGAAAAACCACTGCTATAAAATCCATGTTTAATC 
2221 ---------+---------+---------+---------+---------+---------+ 2280 
CGGTTCAGCTACCACATCGACCCACGCCTTTTTGGTGACGATATTTTAGGTACAAATTAG 
Q V D G V A G C G K T T A I K S M F N P 
CTTCCACAGATATAATTGTCACAGCCAACAAGAAATCTGCTCAAGATGTGCGTTATGCGC 
2281 ---------+---------+---------+---------+---------+---------+ 2340 
GAAGGTGTCTATATTAACAGTGTCGGTTGTTCTTTAGACGAGTTCTACACGCAATACGCG 
S T D I I V T A N K K S A Q D V R Y A L 
TGTTTAAATCTACTGACTCCAAAGAAGCTTGTGCTTTTGTTAGGACCGCTGATTCCATAT 
2341 ---------+---------+---------+---------+---------+---------+ 2400 
ACAAATTTAGATGACTGAGGTTTCTTCGAACACGAAAACAATCCTGGCGACTAAGGTATA 
F K S T D S K E A C A F V R T A D S I L 
TACTCAATGATTGCCCTACGGTGTCTCGAGTGCTTGTGGATGAAGTTGTTCTGTTGCACT 
2401 ---------+---------+---------+---------+---------+---------+ 2460 
ATGAGTTACTAACGGGATGCCACAGAGCTCACGAACACCTACTTCAACAAGACAACGTGA 
L N D C P T V S R V L V D E V V L L H F 
TTGGTCAGTTGTGCGCTGTCATGTCGAAACTTCATGCTGTCAGAGCTTTGTGTTTCGGAG 
2461 ---------+---------+---------+---------+---------+---------+ 2520 
AACCAGTCAACACGCGACAGTACAGCTTTGAAGTACGACAGTCTCGAAACACAAAGCCTC 
G Q L C A V M S K L H A V R A L C F G D 
ACTCCGAACAGATAGCCTTCTCCTCTCGTGACGCTTCGTTCGACATGCGTTTCTCTAAGC 




S E Q I A F S S R D A S F D M R F S K L 
TTATTCCGGATGAGACCAGTGATGCGGACACAACTTTCCGTAGCCCACAAGATGTAGTAC 
2581 ---------+---------+---------+---------+---------+---------+ 2640 
AATAAGGCCTACTCTGGTCACTACGCCTGTGTTGAAAGGCATCGGGTGTTCTACATCATG 
I P D E T S D A D T T F R S P Q D V V P 
CACTTGTGCGTTTGATGGCTACGAAGGCTCTACCGAAAGGGACCCGTACGAAATACTCAA 
2641 ---------+---------+---------+---------+---------+---------+ 2700 
GTGAACACGCAAACTACCGATGCTTCCGAGATGGCTTTCCCTGGGCATGCTTTATGAGTT 
L V R L M A T K A L P K G T R T K Y S R 
GATGGGTGTCCCAATCTAAAGTGAGGAAGTCTGTTACTTCGCGTGCTGTTGCTAGTGTAT 
2701 ---------+---------+---------+---------+---------+---------+ 2760 
CTACCCACAGGGTTAGATTTCACTCCTTCAGACAATGAAGCGCACGACAACGATCACATA 
W V S Q S K V R K S V T S R A V A S V S 
CTCTAGTTGAACTGGACCCCACCAGATTCTATATTACGATGACGCAAGCTGATAAAGCCT 
2761 ---------+---------+---------+---------+---------+---------+ 2820 
GAGATCAACTTGACCTGGGGTGGTCTAAGATATAATGCTACTGCGTTCGACTATTTCGGA 
L V E L D P T R F Y I T M T Q A D K A S 
CACTAATCACTAGAGCTAAGGAACTGAACCTACCCAAGGCATTCTACACTGATAGGATAA 
2821 ---------+---------+---------+---------+---------+---------+ 2880 
GTGATTAGTGATCTCGATTCCTTGACTTGGATGGGTTCCGTAAGATGTGACTATCCTATT 
L I T R A K E L N L P K A F Y T D R � 
AGACTGTCCATGAATCTCAAGGTATTTCAGAAGATCATGCGACCCTGGTTAGGTTGAAGA 
2881 ---------+---------+---------+---------+---------+---------+ 2940 
TCTGACAGGTACTTAGAGTTCCATAAAGTCTTCTAGTACGCTGGGACCAATCCAACTTCT 
T V H E S Q G I S E D H A T L V R L K S 
GTACTAAATGCGACCTGTTCAAGAAATTTTCCTACTGCTTAGTTGCAGTTACTCGACACA 
2941 ---------+---------+---------+---------+---------+---------+ 3000 
CATGATTTACGCTGGACAAGTTCTTTAAAAGGATGACGAATCAACGTCAATGAGCTGTGT 
T K C D L F K K F S Y C L V A V T R H K 
AGGTCACCTTCCGCTATGAGTACTGTGGTGTGTTAGGTGGGGACCTAATCGCTACTTGTA 
3001 ---------+---------+---------+---------+---------+---------+ 3060 
TCCAGTGGAAGGCGATACTCATGACACCACACAATCCACCCCTGGATTAGCGATGAACAT 
V T F R Y E Y C G V L G G D L I A T C I 
TTCCGTTAGTCTGAACGCGGAAGGTCCGAAGACGTTAAACTACACTCTCTTTATTGCGAG 
3061 ---------+---------+---------+---------+---------+---------+ 3120 
AAGGCAATCAGACTTGCGCCTTCCAGGCTTCTGCAATTTGATGTGAGAGAAATAACGCTC 
P L V * 
TGCTGAGTTGGTAGTTTTGCTTTAAACTATCTGAAGTCGCTAAATCCAGTATTGGTTGCG 
3121 ---------+---------+---------+---------+---------+---------+ 3180 
ACGACTCAACCATCAAAACGAAATTTGATAGACTTCAGCGATTTAGGTCATAACCAACGC 
AACGGGTTGTCCATCCAGCTTACGGCTAAAATGGTCAGTCATGCCCCAAAGGCATGCCGA 
3181 ---------+---------+---------+---------+---------+---------+ 3240 
TTGCCCAACAGGTAGGTCGAATGCCGATTTTACCAGTCAGTACGGGGTTTCCGTACGGCT 
CATCTTACAAGGTTGTCGAGGTACCCTTGAAATCATCTCCTAGATTTCTTCGGAAGGGCT 





3301 ---------+---------+---------+---------+---------+---------+ 3360 
AGCACTCTTCGAGCACGTGCCATTATGTGACTATAATGGTTCTCACGCCCATAGCGGACA 
GGTTTTCCACAGGTTCTCCATAAGGAGACCA 
3361 ---------+---------+---------+- 3391 
CCAAAAGGTGTCCAAGAGGTATTCCTCTGGT 
Figure 4.5 cDNA sequence of CMV-LY RNA 1. The predicted ORFla protein 
sequences are given below the cDNA coding sequence. The underlined amino acid 
sequence closest to the N-terminus of the protein represents a conserved putative 
methyltransferase domain (Mi et al., 1989). The six-underlined amino acid domains 
near the C-terminus represent conserved domains associated with RNA helicase 
activity (Habili & Symons, 1989). The 40 nt RNA sequence in red in the 3' 
untranslated region represents a 40-nucleotide sequence domain that is conserved in 
all cucumovirus sequences ( see Fig. 4.15 ). 
4.8.4.2 CMV RNA 1 and ORFla sequence comparison 
The complete nucleotide and predicted amino acid sequences of CMV-L Y RNA 1 
were compared with the nucleic acid and amino acid sequences of one CMV sg II 
(CMV-Q) and six sg I RNA 1/0RFla sequences (Table 4.7). CMV-L Y RNA 1 was 
found to be most identical to the CMV-Q strain, both at the nucleic acid level (99%) 
and amino acid level (99%). This equates to a difference of only 38 nt over the entire 
RNA molecule and 16 amino acid residues in the coding region. In contrast, the 
Japanese isolate CMV-Y, shares the least homology with only 77% identity at the 
nucleotide level and 84% identity at the amino acid level (Table 4.7). A visual 
comparison of the isolates with the least amino acid identity showed that many of the 
differences occur at the same site in the ORF, and that the residues involved were often 
the same or had similar properties (Fig. 4.6). There is a difference between CMV-L Y 
and CMV-Q from position 869 to 872 of the amino acid sequence (Fig. 4.6). When 
comparing the ORFla sequence of CMV-LY with those of other sg I strains in this 
region, all the sequences are identical, so that this difference between CMV-L Y and 
CMV-Q maybe caused by the sequence errors in the sequence of CMV-Q (Fig. 4.6).
The CMV-L Y ORFla coding sequence was found to contain six conserved domains 
nearer the C-terminus and a conserved domain near the N-terminus (Fig. 4.6). These 
domains correspond to those found in other tripartite plant viruses e.g. BMV, TAV, 
and PSV (Goldbach, 1988; Bernal et al., 1991). The seven conserved domains were 
121 
I 1 
Table 4.7 Comparative sequence analysis of CMV-LY RNA 1 and ORFl with six 
CMV sg I and one sg II strains 
CMV Sub- RNAl 
Strain group 
LY II 100 
Q II 99 
Fny I 77 
Ix I 77 
L I 76 
NT9 I 78 
SD I 76 
y I 76 










ORF 3'UTR ORFla RNAl 
(la) length 
s I (nt) 
100 100 100 100 3391 
99 99 99 99 3389 
77 77 92 85 3357 
77 67 91 84 3361 
77 63 91 85 3359 
78 65 92 85 3358 
77 64 92 85 3379 
77 65 91 84 3361 
also found to be highly conserved within the CMV group of ORFla sequence, with the 
exception of N-terminal domain, which had three differences (Fig. 4.6). The amino 
acid differences are present in the outmost position of the domains and involve 
residues that have similar properties. For example, the last residue position of the N­
terminal domain contains either a glutamine residue (E) in CMV sg II strains or an 
aspartate residue (D) in CMV sg I strains. Both D and E are polar and charged. The 
N-terminal domain contains a serine residue (S) in sg II strains or a proline residue (P)
in sg I at the fourth last residue position, both S and P are small amino acids. There is 
a lysine residue (K) or a histidine (H) or a glutamine (Q) at the fifth last residue 
position of the N-terminal domain, both K and H are hydrophobic and have a positive 
charge, all three residues belong to the polar amino acids. 
1 50 
CMV-LY MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGLKVYIR 
Q MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGLKVYIR 
IX MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGRKVYIR 
NT9 MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGRKVYIR 
Fny MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGRKVYIR 
I MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGRKVYIR 
SD MATSSFNINE LVASHGDKGL LATALVDKTA HEQLEEQLQH QRRGRKVYIR 
Y MATSSFNINE LVASHGDKGL LATALVDKTT HEQLEEQLQH QRRGRKVYIR 
Consensus ********** ********** *********- ********** ****-*****
51 100 
CMV-LY NVLDVKDSEV IRTRYGGKYD LHLTQQELAP HGLAGALRLC ETLDCLDFFP 
Q NVLDVKDSEV IRTRYGGKYD LHLAQQELAP HGLAGALRLC ETLDCLDFFP 
IX NVLGVKDSEV IRNRYGGKYD LHLTQQEFAP HGLAGALRLC ETLDCLDSFP 
NT9 NVLGVKDSEV IRNRYGGKYD LHLTQQEFAP HGLAGALRLC ETLDCLDSFP 
Fny NVLGVKDSEV IRNRYGGKYD LHLTQQEFAP HGLAGALRLC ETLDCLDSFP 
I NVLGVKDSEV IRNRYGGKYD LHLTQQEFAP HGLAGVLRLC ETLDCLDSFP 
SD NVLGVKDSEV IRNRYGGKYD LHLTQQEFAP HGLAGALRLC ETLDCLDSFP 
Y NVLGVKDSEV IRNRYGGKYD LHLTQQEFAS QGLAGALRLC GTLDCLDSFP 




CMV-LY RSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HTERLMSMRK 
Q RSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HTE�SMRK 
IX SSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HAERLMNMRK
NT9 SSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HAERLMNMRK 
Fny SSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HAERLMNMRK 
I SSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HAERLMNMRK 
SD SSGLRQDLVL DFEGSWVTHY LRGHNVHCCS PCLGIRD:KMR HAERLMNMRK 
y SSGLRQDLVL DFGGSWVTHY LRGHNVHCCS PCLGIRD:KMR HSERLMNMRK 
Consensus ********** ********** ********** ********** ********** 
151 200 
CMV-LY VILNDPQQFD GRQPDFCTKS AAECKVQAHF AISIHGGYDM GFRGLCEAMN
Q VILNDPQQFD GRQPDFCTKS CKVQAHF AISIHGGYDM GFRGLCEAMN 
IX IILNDPQQFD GRQPDFCTHP AAECDVQAHF AISIHGGYDM GFRGLCEAMN 
-1 
NT9 IILNDPQQFD GRQPDFCTHP AADCKVQAHF AISIHGGYDM GFRGLCEAMN 
Fny IILNDPQQFD GRQPDFCTQP AADCKVQAHF AISIHGGYDM GFRGLCEAMN 
I IILNDPQQFD GRQPDFCTQP AEDCKVQAHF AISIHGGYDM GFRGLCEAMN 
SD IILNDPQQFD GRQPDFCTHP AADCKVQAHF AISIHGGYDM GFRGLCEAMN 
y IILNDPQQFD GRQPDFCTQP AADCKVQAHF AISIHGGYDM GFRGLCEAMN 
Consensus -********* ********-- **-******* ********** ********** 
201 250 
CMV-LY AfIGTTILKGT MMFDGAMMFD DQGFIPELKC QWRKVKSAFS EEEDATCLAA
Q AHGTTILKGT MMFDGAMMFD DQGFIPELKC QWRKIKSAFS EEEDATCSAA
IX AHGTTILKGT MMFDGAMMFD DQGVIPELNC QWRKlRSAFS ETEDVTPLSG
NT9 AHGTTILKGT MMFDGAMMFD DQGVIPELNC QWRKIRTAFS ETEDATPLSE
Fny AHGTTILKGT MMFDGAMMFD DQGVIPELNC QWRKIRSAFS ETEDVTPLVG
I AHGTTILKGT MMFDGAMMFD DQGVIPELNC QWRKIRSAFS ETEDVTPLSG 
SD AHGTTILKGT MMFDGAMMFD DQGVIPELNC QWRKIRSAFS ETEDVTPLTE 
y AHGTTILKGT MMFDGAMMFD DQGVIPELNC QWRKIRSAFS ETEDVTPLVG 
Consensus ********** ********** ***-****-* *****-**** *-**-*----
251 300 
CMV-LY KLNSSGFSRV RNGKTLIAFD FVEESTMSYV HDWDNIQSFM TDQTYSFNGM
Q KLNSSVFSRV RNGKTLIAFD FVEESTMSYV HDWDNIKSFM TDQTYSFNGM 
IX KLNSTVFSRV RKFKTMVAFD FINESTMSYV HDWENIRSFL TDQTYSYRGM 
NT9 KLNSTIFSHV RKFKTMVAFD FINESTMSYV HDWENIKSFL TDQTYSYRGM 
Fny KLNSTVFSRV RKFKTMVAFD FINESTMSYV HDWENIKSFL TDQTYSYRGM 
I KLNSTVFSRV RKFKTMVAFD FINESTMSYV HDWENIKSFL TDQTYSYRGM 
SD KLNSTIFSRV RKFKTMVAFD FINESTMSYV HDWENIKSFL TDQTYSYRGM 
y KLNSTVFSRV RKFKTMVAFD FINESTMSYV HDWENIKSFL TDQTYSYRGM 
Consensus ****--**** *--**--*** *--******* ***-**-**- ******--** 
301 350 
CMV-LY TYGIERCVIY AGVMTYKIVG VPGMCPPELI RHCIWFPSMK DYVGLKIPAS
Q TYGIERCVIY AGVMTYKIVG VPGMCPPELI RHCIWFPSMK DYVGLKIPAS 
IX TYGIERCVIH AGIMTYKIIG VPGMCPPELI RHCIWFPSIK DYVGLKIPAS 
NT9 TYGIERCVIH AGIMTYKIIG VPGMCPPELI RHCIWFPSIK DYVGLKIPAS 
Fny TYGIERCVIH AGIMTYKIIG VPGMCPPELI RHCIWFPSIK DYVGLKIPAS 
I TYGIERCVIH AGIMTYKIIG VPGMCPPELI RHCIWFPSIK DYVGLKIPAS 
SD TYGIERCVIH AGIMTYKIIG VPGMCPPELI RHCIWFPSIK DYVGLKIPAS 
y TYGIERCVIH AGIMTYKIIG VPGMCPPELI RHCIWFPSIK DYVGLKIPAS 
Consensus *********- **-*****-* ********** ********-* ********** 
351 400 
CMV-LY DDLVKWKTVR ILLSTLRETE EIAMRCYNDK KNWMDQFKII LGVLSSKSST
Q DDLVKWKTVR ILLSTLRETE EIAMRCYNDK KNWMDLFKII LGVLSSKSST 
IX QDLVEWKTVR YLTSTLRETE EIAMRCYNDK KAWMEQFKVI LGVLSAKSST 
NT9 QDLVEWKTVR ILTSTLRETE EIAMRCYNDK KAWMEQFKVI LGVLSAKSST 
Fny QDLVEWKTVR ILTSTLRETE EIAMRCYNDK KAWMEQFKVI LGVLSAKSST 
I QDLVEWKTVR ILMSTLRETE EIAMRCYNDK KAWMEQFKVI LGVLSAKSST 
SD QDLVEWKTVR ILTSTLRETE EIAMRCYNDK KAWMEQFKVI LGVLSAKSST 
y QDLVEWKTVR ILTSTLRETE EIAMRCYNDK KAWMEQFKVI LGVLSAKSST 
Consensus -********* -*-******* ********** *-**--**-* *****-**** 
401 450 
CMV-LY IVINGMSMQS GERIDLNDYH YIGFAILLHT KLKYEQLGKM YDMWNASFIW 
Q IVINGMSMQS GERIDLNDYH YIGFAILLHT KLKYEQLGKM YDMWNASFIW 
IX IVINGMSMQS GERIDINDYH YIGLAILLHT KMKYEQLGKM YDMWNASSIS 
NT9 IVINGMSMQS GERIDINDYH YIGFAILLHT KMKYEQLGKM YDMWNASYIS 
FnY IVINGMSMQS GERIDINDYH YIGFAILLHT KMKYEQLGKM YDMWNASSIS 
I IVINGMSMQS GERIDINDYH HIGFAILLHT KMKYEQLGKM YDMWNASSIS 
SD IVINGMSMQS GERIDINDYH YIGFAILLHT KMKYEQLGKM YDMWNASSIS 
y IVINGMSMQS GERIDINDYH YIGFAILLHT KMKYEQLGKM YDMWNASSIS 
Consensus ********** ********** -**-****** *-******** *******-*-
123 
451 
CMV-LY KWFASMSRPF RVFFSTWKT 
Q KWFASMSRPF RVFFSTWKT 
IX KWFAALTRPL RVFFSSVVHA 
NT9 KWFAALTRPL RVFFSSVVHA 
Fny KWFAALTRPL RVFFSSVVHA 
I KWFAALTRPL RVFFSSVVHA 
SD KWFAALTRPL RVFFSGVVHA 




Q GGKEWDVISS 'AAFVATQAVA 
IX GGEEWDVISS AAYVATQAVT 
NT9 GGEEWDVISS AAYVATQAVT 
Fny GGEEWDVISS AAYVATQAVT 
I GGEEWDVISS AAYVATQAVT 
SD GGEEWDVISS AAYVATQAVT 
y GGEEWDVISS AAYVATQAVT 
Consensus **-******* **-**-***-
551 
CMV-LY .SPTPVDQGT ACGLETETSE 
Q .SPTPVDQGT ACGLETETSE 
IX PSPTPDDPAD VCGKEQEVSE 
NT9 PSSTPDDTAD VCGKEQEVSE 
Fny SSQTPDDTAD VCGREREVSE 
I SSQTPDDTAE VCGKEREVSE 
SD SSQTPDDTAD VCGREQEVSE 
y SSQTPDDTAD VCGKEREVSE 
Consensus -*-**-*--- -**-*-*-** 
601 
CMV-LY QLHDTTVSNL QRIWCMAGGD 
Q QLHDTTVSNL QRIWCMAGGD 
IX QLHDTTVSNL KRIWNMAGGD 
NT9 QLHDTTVSNL KRIWNMAGGD 
Fny QLHDTTVSNL KRIWNMAGGD 
I QLHDTTVSNL KRIWNMAGGD 
SD QLHDTTVSNL RRIWNMAGGD 
y HLHDTTVSNL KRIWNMAGGD 
Consensus -********* -***-***** 
651 
CMV-LY GRWMHPVPEG VVYSVGYNEK 
Q GRWMHPVPEG VVYSVGYNEK 
IX GKWMRPVPEG IVYSVGFNEH 
NT9 GRWMRPVPEG IVYSVGFNER 
Fny GRWMRPVPEG IVYSVGYNER 
I GRWMRPVPEG VVYSVGYNER 
SD GRWMRPVPEG IVYSVGYNER 
y GRWVRPVPEG IVYPVGYNER 
Consensus ***--***** -**-**-**-
701 
CMV-LY KSLLAPTGTI SQVDGVAGCG 
Q KSLLAPTGTI SQVDGVAGCG 
IX RSLQAPTGTI SQVDGVAGCG 
NT9 RSLQAPTGTI SQVDGVAGCG 
Fny RSLQAPTGTI SQVDGVAGCG 
I RSLQAPTGTI SQVDGVAGCG 
SD RSLQAPTGTI SQVDGVAGCG 
y RSLQTPTGTI SQVDGVAGCG 
Consensus -***-***** ********** 
751 
CMV-LY LFKSTDSKEA CAFVRTADSI 
Q LFKSTDSKEA CAFVRTADSI 
IX LFKSSDSKEA CTFVRTADSV 
NT9 LFKSSDSKEA CTFVRTADSV 
Fny LFKSSDSKEA CTFVRTADSV 
I LFKSSDSKEA CTFVRTADSV 
SD LFKSSDSKEA CAFVRTADSV 























DGTILAEEKA KKLADRLAVP VEEVSAIPEV 
DGTILAEEKA KKLADRLAVP VEEVTAIPEV 
DGKVLAAQKA EKLAEKLAQP VIEVSDRPEA 
DGKVLAAQKA EKLAEKLAQP VIEVSDRPEA 
DGKILAAQKA EKLAEKLAQP VSEVSDSPET 
DGKILAAQKA EKLAEKLAQP VIEVSDSPEA 
DGKVLAAQKA EKLAEKLAQP VIEVSDRPEA 
DGKILAAQKA EKLAEKLAQP VSEV-DSPET 
**--**--** ****--**-* *-**---**-
600 
LDSLSAQTRS PITRIAERAT AMLEYSAYEK 
LDSLSAQTRS PIARIAERAT AMLEYSAYEK 
LDSLSAQTRS PITRVAERAT AMLEYAAYEK 
LDSLSAQTRS PITRVAERAT AMLEYAAYEK 
LDSLSAQTRS PITRVAERAT AMLEYAAYEK 
LDSLSAQTRS PITRVAERAT AMLEYAAYEK 
LDSLSAQTRS PITRVAERAT AMLEYAAYEK 
LDSLSAQTRS PITRVAERAT AMLEYAAYEK 
********** **-*-***** ********** 
650 
NKRNSLESNL KFVFDTYFSV DALVNVHFPT 
NKRNSLESNL KFVFDTYFSV DALVNVHFPT 
DKRNSLEGNL KFVFDTYFTV DPMVNIHFST 
DKRNSLEGNL KFVFDTYFTV DPMVNIHFST 
DKRNSLEGNL KFVFDTYFTV DPMVNIHFST 
DKRNSLEGNL KFVFDTYFTV DPMVNIHFST 
DKRNSLEGNL KFVFDTYFTV DPMVNIRFST 
DKRSFLEGNL KFVFDSYFTV DPMVNIHFST 
-***-**-** *****-**-* *---*--*-* 
700 
GLGPKLDSEL YIVNGDCVIS NSHDLFSI.T 
GLGPKLDSEL YIVNGDCVIS NSHDLFSI.T 
GLGPKSDGEL YIVNSECWC NNESLSNV.T 
GLGPKSDGEL YIVNSECVIC NSESLSTV.T 
GLGPKSDGEL YIVNSECVIC NSESLSTV.T 
GLGPKSDGEL YIVNSECVIC NSESLSTV.T 
GLGPKSDGEL YIVNSECVIC NSESLSAV.T 
GLGPKSDGEL YIVNSECVIC NSESLSTVYG 
*****-*-** ****--**-- *---*-----
750 
KTTAIKSMFN PSTDIIVTAN KKSAQDVRYA 
KTTAIKSMFN PSTDIIVTAN KKSAQDVRYA 
KTTAIKSIFE PSTDMVVTAN KKSAQDVRMA 
KTTAIKSIFE PSTDMIVTAN KKSAQDVRMA 
KTTAIKSIFE PSTDMIVTAN KKSAQDVRMA 
KTTAIKSIFE PSTDMIVTAN KKSAQDVRMA 
KTTAIKSIFD PSTDMIVTAN KKSAQDVRMA 
KTMPIKSIFE PSTDMIVTAN KKSAQDVRMA 
***-***--- ****--**** ********-* 
800 
LLNDCPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNDCPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNECPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNECPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNECPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNECPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNECPTVSR VLVDEVVLLH FGQLCAVMSK 
LLNECPTVSR VLEDEVVLLH FGQLCAVMSK 





CMV-LY LHAVRALCFG DSEQIAP'SSR DASFDMRFSK LIPDETSDAD 'l'TP'RSPQDVV 
Q LHAVRALCFG DSEQIAFSSR DASFDMRFSK LIPDETSDAD 'l'TP'RSPQDVV 
IX LKAVRAICFG DSEQIAP'SSR DASFDMRFSK IIPDETSDAD 'l'TP'RSPQDVV 
NT9 LKAVRAICFG DSEQIAFSSR DASFDMRFSK IIPDETSDAD 'l'TP'RSPQDVV 
Fny LKAVRAICFG DSEQIAFSSR DASFDMRFSK IIPDETSDAD 'l'TP'RSPQDVV 
I LKAVRAICFG DSEQIAP'SSR DASFDMRFSK IIPDETSDAD 'l'TP'RSPQDVV 
SD LKAVRAICFG DSEQIAFSSR DASFDMRFSK IIPDETSDAD 'l'TP'RSPQDVV 
Y LKAVRAICFG DAEQIAFSSR DASFDMRFSK IIPDETSDAD 'l'TP'RSPQDVV 
Consensus *-******** *-******** **�******* -********* ********** 
851 900 
CMV-LY PLVRLMATKA LPKGTRTKYS GWVSQSKVRK SVTSRAVASV SLVELDPTRF 
Q PLVRLMATKA LPKGTRTKYS D.GAQSKVRK SVTSRAVASV SLVELDPTRF 
IX PLVRLMATKA LPRGTHSKYT KWVSQSKVKR SVTSRAISSV TLVDLDSSRF 
NT9 PLVRLMATKA LPKGTHSKYT KWVSQSKVKR SVTSRAIASV TLVDLDSSRF 
Fny PLVRLMATKA LPKGTHSKYT KWVSQSKVKR SVTSRAIASV TLVDLDSSRF 
I PLVRLMATKA LPKGTHSKYT KWVSQSKVTR SVTSRAIVSV TLVDLDSSRF 
SD PLVRLMATKA LPKGTHSKYT KWVSQSKVRR SVTSRAIASV TLVDLDPSRF 
y PLVRLMATKA LPKGTHSKYT KWVSQSKVRR SVTSRAIASV TLVDLDSSRF 
Consensus ********** **-**--**- -----***-- ******--** -**-**--**
901 950 
CMV-LY YITMTQADKA SLITRAKELN LPKAFYTDRI KTVHESQGIS EDHATLVRLK 
Q YITMTQADKA SLITRAKELN LPKAFYTDRI KTVHESQGIS EDHVTLVRLK
IX YITMTQADKA SLISRAKEMN LPKTFWNERI KTVHESQGIS EDHVTLVRLK
NT9 YITMTQADKA SLISRAKEMN LPKTFWNERI KTVHESQGIS EDHVTLVRLK 
Fny YITMTQADKA SLISRAKEMN LPKTFWNERI KTVHESQGIS EDHVTLVRLK
I YITMTQADKA SLISRAKEMN LPKTFWNERI KTVHESQGIS EDHVTLVRLK 
SD YITMTQADKA SLISRAKEMN LPKTFWDERI KTVHESQGIP EDHVTLVRLK 
y YITMTQADKA SLISRAKEMN LPKTFWNERI KTVHESQGIS EDHVTLVRLK 
Consensus ********** ***-****-* ***-*---** *********- **********
951 995 
CMV-LY STKCDLFKKF SYCLVAVTRH KVTFRYEYCG VLGGDLIATC IPLV
Q STKCDLFKKF SYCLVAVTRH KVTFRYEYCG VLGGDLIANC IPLV
IX STKCDLFKQF SYCLVALTRH KVTFRYEHCG ILNGDLIAEC IARA
NT9 STKCDLFKQF SYCLVALTRH KVTFRYEHCG VLNGDLIAEC IARA
Fny STKCDLFKQF SYCLVALTRH KVTFRYEYCG VLNGDLIAEC VARA
I STKCDLFKQF SYCLVALTRH KVTFRYEYCG VLNGDLIAEC VARA 
SD STKCDLFKKF SYCLVALTRH KVTFRYEYCG VLNGDLVAEC IARA 
y STKCDLFKQF SYCLVALTRH KVTFRYEYCG VLNGDLIA.S VARA 
Consensus ********-* ********** *******-** -*-***-*-- ----
Figure 4.6 Multiple sequence alignment of eight CMV ORFla sequences. 
Conserved residues are indicated by an asterisk and where there are differences from 
the consensus by a dash (-). Bold residues designate relatively conserved domains and 
the different residues in the N-terminal domain are in red. The multiple sequence 
alignment was done using the GCG 'Pileup' program and the consensus sequence 
calculated and displayed using the GCG 'Pretty' program. 
4.8.5 RNA 2 
4.8.5.1 Complete nucleotide sequence of CMV-L Y RNA 2 
The RNA 2 of CMV-LY is 3, 038 nt in length. The first ATG occurs at positions 19-21 
(Fig. 4.7) and is preceded by -5 AGCGT1 • It is presumably not functional since it is 
followed by two downstream in-frame stop codons (TGA) at positions 43-45 and 63-
65. The second start codon ATG, at position 93-95, has the preceding sequence -
5TI ACT 1 and is followed by the large ORF (2a). This is considered a functional 
initiation triplet since it has the critical A in position -3 and a consensus C residue in 
125 
I I 
position -2. Two additional ATG codons occur just down stream at positions 136-138 
and 145-147. Translation initiation from these codons would only result in 
polypeptides of 86 and 83 amino acids. The 3' non-coding region of RNA 2 is 423 nt 
(excluding the stop codon). 
CMV-LY RNA 2 is predicted to contain two ORFs, ORF 2a and ORF 2b (Fig. 4.7)
The N-terminal ORF 2a contains 2, 523 nt (including the stop codon), encoding an 840 
amino acid polypetide with a calculated Mr of 97 kDa. The C-terminal ORF 2b starts 
at nucleotides 2, 410 to 2, 412, encoding a protein with a predicted Mr of 11.3 kDa 
(Fig. 4.7), which is translated from subgenomic RNA 4A. The small ORF overlaps the 
C-terminal portion (69 amino acid) of ORF 2a (Fig. 4.7).
. I 
GTTTATTCTCAAGAGCGTATGGTTCAACCCCTGCCTCCTCTGTGAAATTACCCTAGTTTT 
1 ---------+---------+---------+---------+---------+---------+ 60 
CAAATAAGAGTTCTCGCATACCAAGTTGGGGACGGAGGAGACACTTTAATGGGATCAAAA 
ATTGATCTACTTCTAGTCTCTTTTCTGTTACTATGACAAGTCCTCCACCCACTTTCTCAT 
61 ---------+---------+---------+---------+---------+---------+ 120 
TAACTAGATGAAGATCAGAGAAAAGACAATGATACTGTTCAGGAGGTGGGTGAAAGAGTA 
M T S P P P T F S F 
TCGCCAATCTGTTGAATGGCTCCTATGGTGTTGACACTCCCGAGGAAGTGGAACGCGTTA 
121 ---------+---------+---------+---------+---------+---------+ 180 
AGCGGTTAGACAACTTACCGAGGATACCACAACTGTGAGGGCTCCTTCACCTTGCGCAAT 
A N L L N G S Y G V D T P E E V E R V R 
GACGTGAACAACGCGAAGATGCTGAGGCGGCTTTACGTAATTATAAGCCTTTACCCACTG 
181 ---------+---------+---------+---------+---------+---------+ 240 
CTGCACTTGTTGCGCTTCTACGACTCCGCCGAAATGCATTAATATTCGGAAATGGGTGAC 
R E Q R E D A E A A L R N Y K P L P T V 
TGGATGTCAGTGAGAGTGTCCCTAGAGACGAACCTATTGTCTCGCAAACCGTCACTACAG 
241 ---------+---------+---------+---------+---------+---------+ 300 
ACCTACAGTCACTCTCACAGGGATCTCTGCTTGGATAACAGAGCGTTTGGCAGTGATGTC 
D V S E S V P R D E P I V S Q T V T T A 
CTCCTGTTACATCAGCCGTTGACGCGTTTGTTTCTTTTGGTGCTGAGGACTACCTTGAAA 
301 ---------+---------+---------+---------+---------+---------+ 360 
GAGGACAATGTAGTCGGCAACTGCGCAAACAAAGAAAACCACGACTCCTGATGGAACTTT 
P V T S A V D A F V S F G A E D Y L E M 
TGTCCCCATCTGAGCTGCTTTCCGCTTTTGAGTTGATGGTCAAACCCTTGCGTATCGGTG 
361 ---------+---------+---------+---------+---------+---------+ 420 
ACAGGGGTAGACTCGACGAAAGGCGAAAACTCAACTACCAGTTTGGGAACGCATAGCCAC 
S P S E L L S A F E L M V K P L R I G E 
AAGTGTTGTGCCCGAATTTTGATCGTTCGCTATTCATCTCCAGCGTCGCTATGGCTAGGA 




V L C P N F D R S L F I S S V A M A R T 
CGTTGTTGTTGGCACCACTCACATCCACCCGAACGTTGAAGCGTTTTGAAGACCTTGTGG 
481 ---------+---------+---------+---------+---------+---------+ 540 
GCAACAACAACCGTGGTGAGTGTAGGTGGGCTTGCAACTTCGCAAAACTTCTGGAACACC 
L L L A P L T S T R T L K R F E D L V A 
CCGCGATCTATCTAAAAACTGATTTTTTTTTAGAAGACGATGGGCCCCAGACTGATGTCT 
541 ---------+---------+---------+---------+---------+---------+ 600 
GGCGCTAGATAGATTTTTGACTAAAAAAAAATCTTCTGCTACCCGGGGTCTGACTACAGA 
A I Y L K T D F F L E D D G P Q T D V S 
CCCAAAGCGATGTGCCCGGTTATACCTTCGAACCAGGGCAACACTCATCCGGTTTTGAAC 
601 ---------+---------+---------+---------+---------+---------+ 660 
GGGTTTCGCTACACGGGCCAATATGGAAGCTTGGTCCCGTTGTGAGTAGGCCAAAACTTG 
Q S D V P G Y T F E P G Q H S S G F E P 
CCCCCCCTATTTGTGCTAAATGTGACTTGATTTTGTATCAATGTCCGTGTTTCGATTTTA 
661 ---------+---------+---------+---------+---------+---------+ 720 
GGGGGGGATAAACACGATTTACACTGAACTAAAACATAGTTACAGGCACAAAGCTAAAAT 
P P I C A K C D L I L Y Q C P C F D F N 
ACGCACTTCGTGAGTCTTGCGCAGAGAAAACATTCTCTCACGACTATGTTATCGAGGGTC 
721 ---------+---------+---------+---------+---------+---------+ 780 
TGCGTGAAGCACTCAGAACGCGTCTCTTTTGTAAGAGAGTGCTGATACAATAGCTCCCAG 
A L R E S C A E K T F S H D Y V I E G L 
TCGATGGTGTCATTGATAACGCTACGCTGTTATCAAATTTGGGACCATTTTTGTTACCTG 
781 ---------+---------+---------+---------+---------+---------+ 840 
AGCTACCACAGTAACTATTGCGATGCGACAATAGTTTAAACCCTGGTAAAAACAATGGAC 
D G V I D N A T L L S N L G P F L L P V 
TCCATTGTTCTTATTCAAAGACCGAGGACCCCGATTTCGTCGTTGATCCTAGTCTTGCGC 
841 ---------+---------+---------+---------+---------+---------+ 900 
AGGTAACAAGAATAAGTTTCTGGCTCCTGGGGCTAAAGCAGCAACTAGGATCAGAACGCG 
H C S Y S K T E D P D F V V D P S L A R 
GACCTACTGATAGGGTTGATGCACATGTAGTTCAAGCCGTTTGCGATACCACTCTGCCCA 
901 ---------+---------+---------+---------+---------+---------+ 960 
CTGGATGACTATCCCAACTACGTGTACATCAAGTTCGGCAAACGCTATGGTGAGACGGGT 
P T D R V D A H V V Q A V C D T T L P T 
CCTATGTTAACTACGATGATTCCTTTCATCAAGTCTTTGTGGACTCTGCTGATTATTCCA 
961 ---------+---------+---------+---------+---------+---------+ 1020 
GGATACAATTGATGCTACTAAGGAAAGTAGTTCAGAAACACCTGAGACGACTAATAAGGT 
Y V N Y D D S F H Q V F V D S A D Y S I 
TTGACATGGATCACGTTCGGTTACGTCAATCCGATTTAGTAGCAAAAATTCCGGATGGTG 
1021 ---------+---------+---------+---------+---------+---------+ 1080 
AACTGTACCTAGTGCAAGCCAATGCAGTTAGGCTAAATCATCGTTTTTAAGGCCTACCAC 
D M D H V R L R Q S D L V A K I P D G G 
GGCATATGTTACCGGTGTTGAATACCGGGAGTGGTCACAAGAGAGTAGGTACTACGAAGG 





H M L P V L N T G S G H K R V G T T K E 
AGGTCTTAACAGCAATAAAGAAAAGAAATGCTGATGTCCCTGAGCTTGGTGACTCTGTTA 
1141 ---------+---------+---------+---------+---------+---------+ 1200 
TCCAGAATTGTCGTTATTTCTTTTCTTTACGACTACAGGGACTCGAACCACTGAGACAAT 
V L T A I K K R N A D V P E L G D S V N 
ATCTGTCACGCCTGAGCAAAGCAGTAGCCGAACGGCTTCGTCTCTCGTATATGAATGTTG 
1201 ---------+---------+---------+---------+---------+---------+ 1260 
TAGACAGTGCGGACTCGTTTCGTCATCGGCTTGCCGAAGCAGAGAGCATATACTTACAAC 
L S R L S K A V A E R L R L S Y M N V D 
ACGCTTTGGCTAAAAGTAACTTTGTTAATGTTGTCGGTAATTTTCACGCTTACATGCAAA 
1261 ---------+---------+---------+---------+---------+---------+ 1320 
TGCGAAACCGATTTTCATTGAAACAATTACAACAGCCATTAAAAGTGCGAATGTACGTTT 
A L A K S N F V N V V G N F H A Y M Q K 
AATGGCAATCTTCTGGACTTTCTTATGATGATCTTCCTGATCTTCACGCGGAGAATTTAC 
1321 ---------+---------+---------+---------+---------+---------+ 1380 
TTACCGTTAGAAGACCTGAAAGAATACTACTAGAAGGACTAGAAGTGCGCCTCTTAAATG 
W Q S S G L S Y D D L P D L H A E N L Q 
AGTTTTATGATCACATGATTAAGTCCGATGTTAAGCCAGTTGTCACCGACACGTTGAACG 
1381 ---------+---------+---------+---------+---------+---------+ 1440 
TCAAAATACTAGTGTACTAATTCAGGCTACAATTCGGTCAACAGTGGCTGTGCAACTTGC 
F Y D H M I K S D V K P V V T D T L N V 
TCGACAGACCTGTCCCAGCTACTATTACATTTCACAAAAAGACCATAACATCCCAGTTCT 
1441 ---------+---------+---------+---------+---------+---------+ 1500 
AGCTGTCTGGACAGGGTCGATGATAATGTAAAGTGTTTTTCTGGTATTGTAGGGTCAAGA 
D R P V P A T I T F H K K T I T S Q F S 
CACCGTTGTTTATATCTCTGTTTGAGAGATTCCAGAGATGCCTTCGGGAACGTATTGTTC 
1501 ---------+---------+---------+---------+---------+---------+ 1560 
GTGGCAACAAATATAGAGACAAACTCTCTAAGGTCTCTACGGAAGCCCTTGCATAACAAG 
P L F I S L F E R F Q R C L R E R I V L 
TGCCCGTTGGTAAGATTTCCTCCCTTGAGATGACTGATTTTTCAGTCTTGAACAAACATT 
1561 ---------+---------+---------+---------+---------+---------+ 1620 
ACGGGCAACCATTCTAAAGGAGGGAACTCTACTGACTAAAAAGTCAGAACTTGTTTGTAA 
P V G K I S S L E M T D F S V L N K H C 
GTCTTGAAATTGATTTATCTAAATTCGACAAATCTCAAGGTGAGTTCCACCTTATGATTC 
1621 ---------+---------+---------+---------+---------+---------+ 1680 
CAGAACTTTAACTAAATAGATTTAAGCTGTTTAGAGTTCCACTCAAGGTGGAATACTAAG 
L E I D L S K F D K S Q G E F H L M I Q 
AAGAGCACATTCTCAACGATCTTGGTTGCCCAGCACCCGTCACCAAATGGTGGTGTGACT 
1681 ---------+---------+---------+---------+---------+---------+ 1740 
TTCTCGTGTAAGAGTTGCTAGAACCAACGGGTCGTGGGCAGTGGTTTACCACCACACTGA 
E H I L N D L G C P A P V T K W W C D F 
TTCATAGGTTTTCCTATATTAAAGACAAACGTGCTGGGGTTGGAATGCCCATCAGCTTTC 
1741 ---------+---------+---------+---------+---------+---------+ 1800 
AAGTATCCAAAAGGATATAATTTCTGTTTGCACGACCCCAACCTTACGGGTAGTCGAAAG 




1801 ---------+---------+---------+---------+---------+---------+ 1860 
TTGCGGCATGACCACTGCGAAAGTGGATAAAACCGTTATGATAACAGTGCTACCGACTCA 
R R T G D A F T Y F G N T Z V T M A E F 
TTGCTTGGTGTTATGACACTGACCAATTTGACCGATTGCTCTTTTCTGGTGATGATTCTC 
1861 ---------+---------+---------+---------+---------+---------+ 1920 
AACGAACCACAATACTGTGACTGGTTAAACTGGCTAACGAGAAAAGACCACTACTAAGAG 
A W C Y D T D Q F D R L L F S G D D S L 
TGGCTTTTTCTAAGCTCCCACCTGTTGGAGATCCCAGTAAGTTTACAACTTTATTCAACA 
1921 ---------+---------+---------+---------+---------+---------+ 1980 
ACCGAAAAAGATTCGAGGGTGGACAACCTCTAGGGTCATTCAAATGTTGAAATAAGTTGT 
A F S K L P P V G D P S K F T T L F N M 
TGGAAGCTAAGGTGATGGAACCTGCAGTACCTTATATTTGTTCGAAGTTTCTACTCTCTG 
1981 ---------+---------+---------+---------+---------+---------+ 2040 
ACCTTCGATTCCACTACCTTGGACGTCATGGAATATAAACAAGCTTCAAAGATGAGAGAC 
E A K V M E P A V P Y I C S K F L L S D 
ATGAGTTTGGTAATACGTTTTCAGTCCCCGACCCACTACGTGAAATCCAGCGGTTAGGTA 
2041 ---------+---------+---------+---------+---------+---------+ 2100 
TACTCAAACCATTATGCAAAAGTCAGGGGCTGGGTGATGCACTTTAGGTCGCCAATCCAT 
E F G N T F S V P D P L R E I Q R L G T 
CCAAGAAGATACCGTACTCGGACAACAACGATTTCTTGTTCGCTCATTTTATGAGTTTTG 
2101 ---------+---------+---------+---------+---------+---------+ 2160 
GGTTCTTCTATGGCATGAGCCTGTTGTTGCTAAAGAACAAGCGAGTAAAATACTCAAAAC 
K K I P Y S D N N D F L F A H F M S F V 
TTGACAGGCTGAAGTTTATGGACAGGATGTCGCAGTCCTGTATTGATCAATTGTCCATTT 
2161 ---------+---------+---------+---------+---------+---------+ 2220 
AACTGTCCGACTTCAAATACCTGTCCTACAGCGTCAGGACATAACTAGTTAACAGGTAAA 
D R L K F M D R M S Q S C I D Q L S I F 
TCTTCGAGTTGAAATACAAGAAGTCCGGGAACGAAACCGCCCAAGTTTTGGGCGCGTTTA 
2221 ---------+----------+---------+---------+---------+---------+ 2280 
AGAAGCTCAACTTTATGTTCTTCAGGCCCTTGCTTTGGCGGGTTCAAAACCCGCGCAAAT 
F E L K Y K K S G N E T A Q V L G A F K 
AGAAGTACACCGCTAATTTTAACGCCTATAAGGAGCTTTATTACTCTGACCGTCAACAAT 
2281 ---------+---------+---------+---------+---------+---------+ 2340 
TCTTCATGTGGCGATTAAAATTGCGGATATTCCTCGAAATAATGAGACTGGCAGTTGTTA 
K Y T A N F N A Y K E L Y Y S D R Q Q C 
GTGACTTGATCAATACGTTTTGTATATCTGAGTTCCAGGTGATTCGTCGCACTACCGTTA 
2341 ---------+---------+---------+---------+---------+---------+ 2400 
CACTGAACTAGTTATGCAAAACATATAGACTCAAGGTCCACTAAGCAGCGTGATGGCAAT 
D L I N T F C I S E F Q V I R R T T V K 
AGAAGAAGAAGAATGGACGTGTTGACAGTAGTGGTGTCGACCGCCGACCTCCACCTAGCC 
2401 ---------+---------+---------+---------+---------+---------+ 2460 
TCTTCTTCTTCTTACCTGCACAACTGTCATCACCACAGCTGGCGGCTGGAGGTGGATCGG 
ORF2b M D V L T V V V S T A D L H L A 




2461 ---------+---------+---------+---------+---------+---------+ 2520 
GTAAACGTCCTCCACTTTGCAGCTTCTGCTTCCAGAGTGCAGTTTTTGGCCGCTCGCTCC 
H L Q E V K R R R R R S H V K N R R A R 
F A G G E T S K T K V S R Q K P A S E G 
GGTTACAAAAGTCCCAGCGAGAGAGCGCGATCTATAGCGAGATTTTTCCAGATGTTACCA 
2521 ---------+---------+---------+---------+---------+---------+ 2580 
CCAATGTTTTCAGGGTCGCTCTCTCGCGCTAGATATCGCTCTAAAAAGGTCTACAATGGT 
G Y K S P S E R A R S I A R F F Q M L P 
L Q K S Q R E S A I Y S E I F P D V T I 
TTCCACGGAGTAGATCCCGTGGATTGGTTTCCTGATGTCGTTCGCTCTCCGTCCGTTACC 
2581 ---------+---------+---------+---------+---------+---------+ 2640 
AAGGTGCCTCATCTAGGGCACCTAACCAAAGGACTACAGCAAGCGAGAGGCAGGCAATGG 
F H G V D P V D W F P D V V R S P S V T 
P R S R S R G L V S * 
AGCCTTGTTTCTTGTGAATCTTTTGATGATACCGATTGGTTTGCTGGTAACGAATGGGCC 
2641 ---------+---------+---------+---------+---------+---------+ 2700 
TCGGAACAAAGAACACTTAGAAAACTACTATGGCTAACCAAACGACCATTGCTTACCCGG 
S L V S C E S F D D T D W F A G N E W A 
GAAGGGTCGTTTTGATTTCCGACCCTTCGTCGTCCGAAGACGTTAAATTACACTCTCTTT 
2701 ---------+---------+---------+---------+---------+---------+ 2760 
CTTCCCAGCAAAACTAAAGGCTGGGAAGCAGCAGGCTTCTGCAATTTAATGTGAGAGAAA 
E G S F * 
ATTGCGAGTGCTGAGTTGGTAGTTTTCCTCTAAACTATCTGAAGTCGCTAAATCCATTAC 
2761 ---�-----+---------+---------+---------+---------+---------+ 2820 
TAACGCTCACGACTCAACCATCAAAAGGAGATTTGATAGACTTCAGCGATTTAGGTAATG 
TGGTTGCGAACGGGTTGTCCATCCAGCTTACGGCTAAAATGGTCAGTATGCCCCAAAGGC 
2821 ---------+---------+---------+---------+---------+---------+ 2880 
ACCAACGCTTGCCCAACAGGTAGGTCGAATGCCGATTTTACCAGTCATACGGGGTTTCCG 
ATGCCGACACCCTACAGGGTTGTCGAGGTACCCTTGAAATCATCTCCTAGATTTCTTCGG 
2881 ---------+---------+---------+---------+---------+---------+ 2940 
TACGGCTGTGGGATGTCCCAACAGCTCCATGGGAACTTTAGTAGAGGATCTAAAGAAGCC 
AAGGGCGTCGTGAGAAGCTCGTGCACGGTAGTACCCTGATATTACCAAGAGTGCGGGTAT 
2941 ---------+---------+---------+---------+---------+---------+ 3000 
TTCCCGCAGCACTCTTCGAGCACGTGCCATCATGGGACTATAATGGTTCTCACGCCCATA 
CGCCTGTGGTTTTCCACAGGTTCTCCATAAGGAGACCA 
3001 ---------+---------+---------+-------- 3038 
GCGGACACCAAAAGGTGTCCAAGAGGTATTCCTCTGGT 
Figure 4. 7 cDNA nucleotide sequence of CMV-LY RNA 2. The amino acid 
sequences of ORF2a and ORF2b are shown below their coding sequences (The 
ORF2b is underlined). Three amino acid sequences in the 2a protein represent 
conserved domains associated with RNA polymerase activity (Habili &Symons, 1989) 
are in bold The RNA sequence at the 3' untranslated region in red represents a 40-




Table 4.8 Comparative sequence analysis of CMV-LY RNA 2 and its encoded 
proteins with 14 published CMV strains 
CMV 
RNA2 S'UTR 3'UTR 
ORF2a RNA2in 
strain (Identity) lemrth (nt) 
Fny 73 77 67 82 3050 
y 70 78 67 84 3051 
IX 73 74 64 82 3060 
Kor 74 77 66 82 3049 
B 72 79 67 82 3049 
SD 73 76 66 82 3048 
L 73 79 59 83 3047 
0 74 80 66 84 3049 
:rvm8 73 79 63 83 3048 
K 73 76 65 82 3048 
NT9 74 7 66 82 3042 
AS 72 76 64 83 3047 
Q 98 99 95 94 3035 
Trk7 99 100 97 96 3039 
LY 100 100 100 100 3038 
4.s.s:t RNA 2, ORF2a and ORF2b sequence comparisons
CMV-LY RNA 2 shares 98-99% homology to CMV sg II strains and 76-78% to CMV
sg I strains at the nucleotide level (Table 4.8). The homology is closest between CMV­
L Y and CMV-Trk7 (originally from Hungary, a CMV sg II strain), and lowest 
between CMV-LY and CMV-Y (originally from Japan, a sg I strain). The regions 
showing homology are distributed over the entire molecule in every case. The highest 
homology between CMV-LY and other CMVs was found in the 5' untranslated region, 
from 73% to 80% (with sg I strains) and from 99% to 100% (with sg II strains). The 
lowest homology was found in the 3' untranslated region, from 59% to 68% (with sg I 
strains) and from 95% to 97% (with sg II strains). 
CMV-LY ORF2a sequence shares 94-96% homology with CMV sg II strains (CMV-Q
and CMV-Trk7) and 82-84% homology with CMV sg I strains (Table 4.8). 
1 50 
Trk7 MTSPPPTFSF ANLLNGSYGA DTPEEVERVR REQREDAEAA LRNYKPLPTV 
LY MTSPPPTFSF ANLLNGSYGV DTPEEVERVR REQREDAEAA LRNYKPLPTV 
Q MISPPPTFSF ANLLNGSYGV DTPEEVERVR REQREDAEAA LRNYKPLPAV 
0 MASPAPAFSL ANLLNGSYGV DTPEDVERLR SEQREEAAAA CRNYRPLPAV 
Y MAFPAPAFSL ANLLNGSYGV DTPEDVERLR SEQREEAAAA CRNYRPLPAV 
Fny MAFPAPAFSL ANLLNGSYGV DTPEDVERLR SEQREEAAAA CRNYRPLPAV 
Kor MASPAPAFSL ANLLNGSYGV DTPEDVERLR SEQREEAAAA CRNYRPLPAV 
Ii MAFPAPAFSL ANLLNGSYGV DTPEDVERLR SEQREEAAAA CRNYRPLPAV 
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MAFPAPAFSL ANLLNGSYGV DTPEDMERLR SEQREEAAAA CRNYRPLPAV 
MAFPAPAFSL ANLLNGSYGV DTPEEVERVR SEQREEAAAA CRNYRPLPAV 
MAFPAPAFSL ANLLNGSYGV DTPEEVERVR SEQREEAAAA CRNYRPLPAV 
MAFPAPAFSL ANLLNGSYGV DTPEEVERVR SEQRDEAAAA CRNYRPLPAV 
MAFSAPTFSL ANLLNGSYGV DTPEEVERVR SEQREEAAAA CRNYRPLPAV 





































AIYLKTDFFL .... EDDGPQ 
AIYLKTDFFL .... EDDGPQ 







































































































































AEKTFSHDYV IEGLDGVIDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPI 
AERTFADDYV IEGLDGVVNN ATLSSNLGPF 
AERTFADDYV IEGLDGVVDN ATLLSNLGPF 
132 
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CNMIMYQCPC FDFNALKKSC AERTFADDYV IEGLDGWDN ATLLSNLGPF 
*--*--**** ******---* **-**--*** *******--* ***-*****-
251 300 
LLPVHCSYSK TEDPDFVVDP SLARPTDRVD AHVVQAVCDT TLPTHVNYDD 
LLPVHCSYSK TEDPDFVVDP SLARPTDRVD AHVVQAVCDT TLPTYVNYDD 
LLPVHCSYSK TEDPDFVVDP SLARPTDRVD VHVVQAVCDT TLPTHGNYDD 
LVPVKCQYEK CPTPTIAIPP DLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTIAIPP DLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTIAIPP DLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEN CPTPTLAIPP DLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTIAIPP NLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPPIAIPP NLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTIAIPP NLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTVANPP SLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTVANPP SLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCPYEK CPTPVGEIPP DLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYEK CPTPTVAIPP SLNRATDRVD INLVQSICDS TLPTHSNYDD 
LVPVKCQYKQ YPTPTVAIPP SLNRATDRVD INLVQSICDS TLPTHSNYDD 
*-**-*-*-- ---*-----* -*-*-***** ---**--**- ****--**** 
301 350 
SFHQVFVDSA DYSTDMDHVR LRQSDLVAKI PDGGHMLPVL NTGSGHKRVG 
SFHQVFVDSA DYSIDMDHVR LRQSDLVAKI PDGGHMLPVL NTGSGHKRVG 
SFHQVFVDSA DYSTDMDHVR LRQSDLVAKI PDGGHMLPVL NTGSGHQRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL STGSGHKRVG 
SFHQVFVESA DYSIDLDHVR LRQSDLIAKI PDSGHMIPVL NTGSGHKRVG 
*******-** ***-*-**** ******-*** **-***-*** -*****-*** 
351 400 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFRLSY MNVDALAKSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERLRLSY MNVDALAKSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFRLSY MNVDALAKSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGDSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLSRLSK AVAERFFISY INGNSLASSN 
TTKEVLTAIK KRNADVPELG DSVNLPRLSK AVAERFFIAY INGNSLATSN 
********** ********** *****-**** *****----* -*---**-** 
401 450 
FVNVVGNFHA YMQKWQSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPVVTD 
FVNVVGNFHA YMQKWQSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPVVTD 
FVNVVSNFHA YMQKWPSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPVVTD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA EKLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
FVNVVSNFHD YMEKWKSSGL SYDDLPDLHA ENLQFYDHMI KSDVKPWSD 
*****-***- **-**-**** ********** *-******** ********-* 
451 500 
TLNVDRPVPA TITFHKKTIT SQFSPLFTSL FERFQRCLRE RIVLPVGEIS 
133 
LY TLNVDRPVPA TITFHKKTIT SQFSPLFISL FERFQRCLRE RIVLPVGKIS 
Q TLNVDRPVPA TITFHKKTIT SQFSPLFISL FERFQRCLRE RWLPVGKIS 
0 TLNIDRPVPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
y TLNIDRPVPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
'j 
Fny TLNIDRPVPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
Kor TLNIDRPVPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
Ii TLNIDRPVPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
MBB TLNIDRPIPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
B TLNIDRPVPA TITYHKKSIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
K TLNIDRPVPA TITYHKKGIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
SD TLNIDRPVPA TITYHKKGIT SQFSPLFTAP FERFQRCLRE RIILPVGKIS 
AS TLNIDRPVPA TITYHKKGIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
NT9 TLNIDRPVPA TITYHKKGIT SQFSPLFTAL FERFQRCLRE RIILPVGKIS 
Ix TLNIDRPVPA TITYHKKGIT SQFSPLFTAL FERFQRCLRE RVILPVGKIS 
Consensus ***-***-** ***-***-** *******--- ********** *--****-** 
501 550 
Trk7 SLEMTGFSVL NKHCLEIDLS KFDKSQGEFH LMIQEHILND LGCPAPVTKW 
LY SLEMTDFSVL NKHCLEIDLS KFDKSQGEFH LMIQEHILND LGCPAPVTKW 
Q SLEMTGFSVL NKHCLEIDLS KFDKSQGEFH LMIQEHILND LGCPAPITKW 
0 SLEMAGFDVK NKHCLEIDLS KFDKSQGEFH LLIQEHILNG LGCPAPITKW 
y SLEMAGFDVK NKHCLEIDLS KFDKSQGEFH LLIQEHILNG LGCPAPITKW 
Fny SLEMAGFDVK NKHCLEIDLS KFDKSQGEFH LLIQEHILNG LGCPAPITKW 
Kor SLEMAGFDVK NKHCLEIDLS KFDKSQGEFH LLIQEHILNG LGCPAPITKW 
Ii SLEMAGFDVK SKYCLEIDLS KFDKSQGEFH LLIQEHILNG LGCPAPITKW 
MBB SLEMAGFDVK NKYCLEIDLS KFDKSQGEFH LLIQEHILNG LGCPAPITKW 
B SLEMAGFDVK NKYCLEIDLS KFDKSQGEFB LLIQEHILNG LGCPAPITKW 
K SLEMAGFDVK NKHCLEIDLS KFDKSQGEFH LMIQEHILNG LGCPAPITI<W 
SD SLEMAGFDVK NKHCLEINLS KFDKSQGEFH LMIQEHILNG LGCPAPITKW 
AS SLEMAGFDVK NKHCFEIDLS KFDKSQGEFP FKIQEHILNG LGCPAPITKW 
NT9 SLEMAGFDVK NKHCLEIDLS KFDKSQGEFH LMIQEHILNG LGCPAPITKW 
Ix SLEMSGFDVK NKYCLEIDLS KFDKSQGEFH LMIQEHILNG LGCPAPITKW 
Consensus ****--*-*- -*-*-**-** *********- --*******- ******-*** 
551 600 
Trk7 WCDFHRFSYI KDKRAGVGMP ISFQRRTGDA �TYFGNTIVT MAEFAWCYDT 
LY WCDFHRFSYI KDKRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
Q WCDFHRFSYI KDKRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
0 WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
y WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
Fny WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA LTYFGNTIVT MAEFAWCYDT 
Kor WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
Ii WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
MBB WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
B WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
K WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
SD WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFPWCYDT 
AS WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
NT9 WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
Ix WCDFHRFSYI RDRRAGVGMP ISFQRRTGDA FTYFGNTIVT MAEFAWCYDT 
Consensus ********** -*-******* ********** -********* ****-***** 
601 650 
Trk7 DQFDRLLFSG DDSLAFSKLP PVGDPSKFTT LFNMKAKVME PAVPYICSKF 
LY DQFDlU.LFSG DDSLAFSKLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
Q DQFD LFSG DDS SKLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
0 DQFEKLLFSG DDSLGFSLLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
y DQFERLLFSG DDSLGFSLLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
Fny DQFElCLLFSG DDSLGFSLLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
Kor DQFE LFSG DDSLGFSLLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
Ii DQFERLLFSG DDSLGFSLLP PVGDPSKFTT LYNMEAKVME PSVPYICSKF 
MBB DQFERLLFSG DDSLGFSLLP PVGDSSKFTT LYNMEAKVME PSVPYICSKF 
B DQFEKLLFSG DDSLGFSQLP PVGDSSKFTT LYNMEAKVME PSVPYICSKF 
K DQFEKLLFSG DDSLGFSVLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
SD DQFEKLLFSG DDSLGFSVLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
AS DQFEKLLFSG DDSLGFSVLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
NT9 DQFEKLLFSG DDSLGFSVLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
Ix DQFEKLLFPG DDSLGFSVLP PVGDPSKFTT LFNMEAKVME PAVPYICSKF 
Consensus ***--***-* ****-**-** ****-***** *-**-***** *-********
651 700 
Trk7 LLSDEFGNTF SVPDPLREIQ RLGTKKIPYS DNNDFLFAHF MSFVDRLKFM 
LY LLSDEFGNTF SVPDPLREIQ RLGTKKIPYS DNNDFLFAHF MSFVDRLKFM 
Q YSLMSLVTRF QSP.TIREIQ RLGTKKIPYS DNNDFLFAHF MSFVDRLKFM 
0 LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
y LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
Fny LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
134 
- - - - - - L _ _  - - ..: - -
Kor LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
Ii LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
MB8 LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
B LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MQFVDRLKFL 
K LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
SD LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
AS LLSDEFGNTF SVPDPLREVQ RLGTKKIPCS DNDEFLFAHF MSFVDRLKFL 
NT9 LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL· 
Ix LLSDEFGNTF SVPDPLREVQ RLGTKKIPYS DNDEFLFAHF MSFVDRLKFL 
Consensus ---------* --*---**-* ********-* **--****** *-*******-
701 750 
Trk7 DRMSQSCIDQ LSIFFELKYK KSGNEAAQVL GAFKKYTANF NAYKELYYSD 
LY DRMSQSCIDQ LSIFFELKYK KSGNETAQVL GAFKKYTANF NAYKELYYSD 
Q DRMSQSCIDQ LSIFFELKYK KSGNEAALVL GAFKKYTANF NAYKELYYSD 
0 DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
y DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
Fny DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
Kor DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
Ii DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
MB8 DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
B DRMSQSCIDQ LSIFFELKYK KSGEEAALML GAFKKYTANF QSYKELYYSD 
K DRMTQSCIDQ LSLFFELKYR KSGAEAALML GAFKKYTANF QSYKELYYSD 
SD DRMTQSCIDQ LSLFFELKYR KSGAEAALML GAFKKYTANF QSYKELYYSD 
AS DRMTQSCIDQ LSLFFELKYR KSGEEAALML GAFKKYTANF QSYKELYYSD 
NT9 DRMTQSCIDQ LSLFFELKYR KSGAEAALML GAFKKYTANF QSYKELYYSD 
Ix DRMTQSCIDQ LSLFFELKYR KSGAEAALML GAFKKYTANF QSYKELYYSD 
Consensus ***-****** **-******- ***-*-*--* ********** --******** 
751 800 
Trk7 RQQCDLVNI'F CISEFQVIRR TTVK .. KKKN GCVDSSGVDR RPPPSPFAGG 
LY RQQCDLINTF CISEFQVIRR TTVK .. KKKN GRVDSSGVDR RPPPSPFAGG 
Q RQQCDLVNI'F CISEFRVIRR TTVK .. KKKN GCVDSSGVDR RPPLSQFAGG 
0 RRQCELINSF CSTEFRVERV NSNKQR.KKY GIERRCNDKR RTPTGSYGGG 
y RRQCELINSF CSTEFRVERV NSNKQR.KKY GIERRCNDKR RTPTGSYGGG 
Fny RRQCELINSF CSTEFRVERV NSNKQR.KNY GIERRCNDKR RTPTGSYGGG 
Kor RRQCELINSF CSTEFRVERV NSNKQR.KKY GIERRCNDKR RTPTGSYGGG 
Ii RRQCELINSF CSTEFRVERV NSNKLR.KKY GIERRCDDKR RTPTGSYGGG 
MB8 RHQCELINSF CSTEFRVERV NSNKQR.KKY GIERRCDDKR RTPTGSYGGG 
B RRQCELINSF CISEFRVERV NSNKQR.KKH GIERRCNDKR RTPTGSYGGG 
K RRQCELINSF SCVELRIERS SSTKQRKKKD GIERRRDDKR RTPTGSYGGG 
SD RRQCELINSF SCVELRIERS SSTKQRKKKD GIERRRNDKR RTPTGSYSGG 
AS RRQCELINSF SCVELRIERS SSTKQREKKD GIERRRNDKR RTPTGSYGGG 
NT9 RRQCELINSF SCVELRIERS SSTKQRKKKD GIERRRSDKR RTPTGSYGGG 
Ix RRQCELINSF SCVELRIERS SFIKQRKKKD GIERRRNDKR RTPTSPHGGG 
Consensus *-**-*-*-* ---*----*- ---*---*-- *--------* *-*-----** 
801 850 
Trk7 ETSKTKVSRQ KPASEGLQKS QRESAIYSET FPDVTIPRSR SRGLVS .... 
LY ETSKTKVSRQ KPASEGLQKS QRESAIYSEI FPDVTIPRSR SRGLVS .... 
Q ETSKTKVSRQ KPASEGLQKS QRESAIYSET FPDVTIPRSR SRGLVS .... 
0 EETETKVSQT ESTGTRSQKS QRESAFKSQT VPLPTVLSSR WFGTDRVIPP 
y EEAETKVSQT ESTGTRSQKS QRESAFKSQT VPLPTVLSSR WFGTDRVMPP 
Fny EEAETKVSQT ESTGTRSQKS QRESAFKSQT IPLPTVLSSG WFGTDRVMPP 
Kor EEAETKISQA ESTGTRSQKS QRESAFKSQT VPLPTVLSSR WFGTDRVEPP 
Ii EEAETKVSQT KSTGTRSQKS QRESAFKSQT VPLPTVLSSG WSGTDRWPP 
MB8 EEAETKVSQT KSTGTRSQKS QRESAFESQT VPLPTVLSSG WSGTDRWPP 
B EEAETKVSQT ESTGTRSQKS QRESAFKSQT VPLPTVLSSG RSGTDRVIPP 
K EEAETKVSQA ESTGTRSQKS QREGAFKSQA VPLPTILSSR WFGTDRDVPP 
SD EEAETKVSQA ESTGTRSQKS QREGAFKSQA VPLPTILSSR WFGTDRDVPP 
AS EEAETKVSQA ESTGTRSQKS QREGAFKSQA VPLPTILSSR WFGTDRDVPP 
NT9 EKTETKVSHE ESTGTRSQKS QREGAFKSQI VPLPTILSGG WSGTDRA.PP 
Ix EETETKVSQE ESTGTMLQKS QRESAFKSQT IPFPTVLSSR RFGIDRDVPP 
Consensus *---**-*-- -------*** ***-*--*-- -*--*----- --*-------
851 
Trk7 . . . . . . . . .
















Figure 4.8 Multiple sequence alignment of fifteen CMV ORF2a amino acid 
sequences. Conserved residues are indicated by an asterisk and where there are 
differences from the consensus by a dash (-). Bold residues designate conserved 
motifs and the different residues in the GDD motif are in red color. The multiple 
sequence alignment was done using the GCG 'Pileup' program and the consensus 
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Figure 4.9 Alignment of CMV-LY 2a with the other two CMV sg II strains (Q and 
Trk7). The consensus sequence is presented at the bottom of each block. The multiple 
sequence alignment was done by the GCG 'Pileup' program and the consensus 





An alignment of CMV-L Y ORF2a with two published CMV sg II strains (CMV-Q and 
CMV-Trk7) are presented in Figure 4.9. There are 4, 7 and 24 amino acid differences
between CMV-Trk7, CMV-LY and CMV-Q, respectively. From positions 647 to 662 
(a total of sixteen amino acids), there are fourteen amino acid differences between 
CMV-Q and the consensus sequence. Interestingly, when checking the alignment of
all of the CMV ORF2a sequences in Figure 4.8, it was found that all of the CMV 
strains except CMV-Q had an identical sequence in this region. It is, therefore, 
possible that the differences could have been caused by sequencing errors for the 
CMV-Q isolate.
The CMV-L Y ORF2a gene coding sequence was found to contain three conserved 
domains associated with RNA polymerase activity (Habili & Symons, 1989). The 
three domains were found to be highly conserved within the CMV group, with the 
exception of the third conserved domain, which had three differences (Fig. 4.8). The 
amino acid differences are present in the outmost positions of the domains and involve 
residues that have similar properties. For example, the last residue position of third 
domain contains either an alanine residue (A) in CMV sg II strains or a glycine residue 
(G) in CMV sg I strains. Both A and
_G are small and hydrophobic amino acid
residues. 
Comparison of the nucleotide and amino acid sequences of the CMV-L Y 2b gene of 
CMV-LY with thirteen other CMV strains (eleven from sg I, and two from sg II)
shows that it has less conservation than any of the other four genes (la, 2a, 3a and 3b). 
Between CMV-L Y and sg I strains, there was only 62-65% homology and 49-56% 
identity at the nucleotide and protein levels, respectively. There was good 
homology/identity between CMV-LY and sg II strains, with 97-98% at the nucleotide 
level, and 95-96% at amino acid level, respectively (Table 4.9). 
Alignment of the amino acid sequence of ORF2b of CMV-L Y with thirteen CMV 
strains using the Prettyplot program in GCG is shown in Fig. 4.10. It was found that 
except the ORF2b of CMV-IX (sg I) which encodes a polypeptide 134 amino acids in 
length, the ORF2b of the other ten CMV sg I strains encode 110 to113 amino acids, 
and the ORF2b of sg II strains (LY, Q and Trk7) encode a protein of 100 amino acids 




the N-terminal region and a 12 amino acid long gap is present near the C-terminal 
region. All of these differences result in the low identity of ORF2b between sg I and II 
(Fig. 4.9) 
Table 4.9 Homology (%) of CMV-LY lb and encoded proteins of ORF2b with those 
of other thirteen published CMV strains 
CMV strain Nucleotide Protein Protein ORF2b 
homology identity similarity location in 
RNA2 
AS 63 53 71 2414-2749 
B 63 53 68 2416-2753 
Fny 63 53 67 2419-2761 
IX 64 49 67 2432-2836 
K 62 53 71 2414-2749 
Kor 62 53 66 2419-2751 
MB8 65 53 66 2418-2750 
NT9 66 56 73 2415-2747 
0 63 53 68 2418-2750 
SD 64 52 70 2414-2749 
y 62 46 62 2420-2762 
Q 98 96 100 2411-2713 
Trk7 97 95 99 2413-2715 
CMV-LY 100 100 100 2413-2715 
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Figure 4.10 Multiple alignment of ORF2b of 14 CMV strains ( eleven sg I and three 
sg II strains). The multiple sequence alignment was done by the GCG 'Pileup' 
program and the consensus sequence calculated and displayed by the GCG 
'Prettyplot 'program. 
4.8.6 RNA 3 
4.8.6.1 Complete nucleotide sequence of CMV-LY RNA 3 
The complete nucleotide sequence and the deduced amino acid sequences of CMV-L Y 
RNA 3 is given in Figure 4.11. It is 2,203 nt long and has two large ORFs separated 
by an IR of 288 nt. The 5'-proximal ORF contains 840 nt and encodes a protein with a 
predicted Mr of 30 kDa. The 3'- proximal ORF starts at nucleotides 1,125 to 1,127 
and contains 657 nt. It encodes a protein with a predicted Mr of 24 kDa. The 30 kDa 
protein is the translation product of RNA 3, but the 24 kDa protein is translated from 
the subgenomic RNA 4, which is colinear with the 3' end of RNA 3 (Palukaitis et al.,
1992) 
GTAATCTTACCACTTTCTTTCACGTCGTGTCGCGTCAGTCCACGCTGTGTGTGTGCGTGT 
1 ---------+---------+---------+---------+---------+---------+ 60 
CATTAGAATGGTGAAAGAAAGTGCAGCACAGCGCAGTCAGGTGCGACACACACACGCACA 
GTTAGTTAGTGTGTCGTGTTTAGATTACCGAAGGTTATGGCTTTCCAAGGTACCAGTAGG 
61 ---------+---------+---------+---------+---------+---------+ 120 
CAATCAATCACACAGCACAAATCTAATGGCTTCCAATACCGAAAGGTTCCATGGTCATCC 
M A  F Q  G T  S R
ACGTTAACTCAACAGTCCTCGGCGGCGTCGTCTGACGACTTACAGAAGATATTATTCAGC 
121 ---------+---------+---------+---------+---------+---------+ 180 
TGCAATTGAGTTGTCAGGAGCCGCCGCAGCAGACTGCTGAATGTCTTCTATAATAAGTCG 
T L T Q Q S S A A S S D D L Q K I L F S 
CCCGATGCCATCAAGAAGATGGCTACTGAGTGTGACCTAGGTCGACATCATTGGATGCGC 
181 ---------+---------+---------+---------+---------+---------+ 240 
GGGCTACGGTAGTTCTTCTACCGATGACTCACACTGGATCCAGCTGTAGTAACCTACGCG 
P D A I K K M A T E C D L G R H H W M R 
GCGGATAACGCCATCTCTGTCAGACCTCTCGTTCCCCAAGTAACCAGTAACAATTTATTG 
241 ---------+---------+---------+---------+---------+---------+ 300 
CGCCTATTGCGGTAGAGACAGTCTGGAGAGCAAGGGGTTCATTGGTCATTGTTAAATAAC 




301 ---------+---------+---------+---------+---------+---------+ 360 
AGAAAGAAATTTAGACCCATACTACGGCCACTTAACGCGAGATTTCCGATATACTCGCAA 
S F F K S G Y D A G E L R S K G Y M S V 
CCTCAAGTGCTGTGTGCCGTTACCAGGACGGTTTCTACGGATGCTGAGGGTTCTTTGAAA 
361 ---------+---------+---------+---------+---------+---------+ 420 
GGAGTTCACGACACACGGCAATGGTCCTGCCAAAGATGCCTACGACTCCCAAGAAACTTT 
P Q V L C A V T R T V S T D A E G S L K 
ATTTATTTGGCTGACCTAGGTGATAAAGAATTATCCCCAATTGATGGGCAATGTGTTACT 
421 ---------+---------+---------+---------+---------+---------+ 480 
TAAATAAACCGACTGGATCCACTATTTCTTAATAGGGGTTAACTACCCGTTACACAATGA 
I Y L A D L G D K E L S P I D G Q C V T 
TTACATAATCATGAGCTCCCTGCTTTGATATCTTTCCAACATACCTACGATTGCCCCATG 
481 ---------+---------+---------+---------+---------+---------+ 540 
AATGTATTAGTACTCGAGGGACGAAACTATAGAAAGGTTGTATGGATGCTAACGGGGTAC 
L H N H E L P A L I S F Q H T Y D C P M 
GAATTAGTTGGCAATCGGCATCGATGTTTCGCGGTAGTCGTTGAGAGACATGGTTATATT 
541 ---------+---------+---------+---------+---------+---------+ 600 
CTTAATCAACCGTTAGCCGTAGCTACAAAGCGCCATCAGCAACTCTCTGTACCAATATAA 
E L V G N R H R C F A V V V E R H G Y I 
GGTTACGGTGGTACCACTGCTAGCGTGTGTAGTAACTGGCAAGCTCAGTTTTCTTCAAAG 
601 ---------+---------+---------+---------+---------+---------+ 660 
CCAATGCCACCATGGTGACGATCGCACACATCATTGACCGTTCGAGTCAAAAGAAGTTTC 
G Y G G T T A S V C S N W Q A Q F S S K 
AATAATAATTACACACACGCCGCTGCTGGTAAGACTCTTGTGTTGCCTTACAACAGATTA 
661 ---------+---------+---------+---------+---------+---------+ 720 
TTATTATTAATGTGTGTGCGGCGACGACCATTCTGAGAACACAACGGAATGTTGTCTAAT 
N N N Y T H A A A G K T L V L P Y N R L 
GCTGAGCATTCGAAACCGTCAGCCGTCGCTCGCCTGTTGAAGTCGCAGTTAAACAACGTT 
721 ---------+---------+---------+---------+---------+---------+ 780 
CGACTCGTAAGCTTTGGCAGTCGGCAGCGAGCGGACAACTTCAGCGTCAATTTGTTGCAA 
A E H S K P S A V A R L L K S Q L N N V 
AGCTCATCGCGCTATCTTTTGCCGAACGTTGCTCTTAATCAAAATGCGTCTGGGCACGAG 
781 ---------+---------+---------+---------+---------+---------+ 840 
TCGAGTAGCGCGATAGAAAACGGCTTGCAACGAGAATTAGTTTTACGCAGACCCGTGCTC 
S S S R Y L L P N V A L N Q N A S G H E 
TCCGAGATTTTAAACGAAAGCCCTCCCATCGCTATAGGGAGTCCGTCCGCGTCCCGTAAC 
841 ---------+---------+---------+---------+---------+---------+ 900 
AGGCTCTAAAATTTGCTTTCGGGAGGGTAGCGATATCCCTCAGGCAGGCGCAGGGCATTG 
S E I L N E S P P I A I G S P S A S R N 
AATAGCTTCAGATCGCAGGTGGTTAACGGTCTTTAGTGTTTTGTTACGTTGTACCTATGT 
901 ---------+---------+---------+---------+---------+---------+ 960 
TTATCGAAGTCTAGCGTCCACCAATTGCCAGAAATCACAAAACAATGCAACATGGATACA 
N S F R S Q V V N G L * 
ATATATATACTACGTTTATCTTCCGTATGTAAATACATGTGAGTCTATAGTCCCGTGTGA 
961 ---------+---------+---------+---------+---------+---------+ 1020 
TATATATATGATGCAAATAGAAGGCATACATTTATGTACACTCAGATATCAGGGCACACT 
GTTGTAACGGTAGACATCTGTGACGCGAAGCCGCTTGAAGATTTCCCATCTGGGGTTAGT 
1021 ---------+---------+---------+---------+---------+---------+ 1080 
CAACATTGCCATCTGTAGACACTGCGCTTCGGCGAACTTCTAAAGGGTAGACCCCAATCA 
AAGTCCACGTCACAGTTTTAAGGTTCAATTCCTTTTGCTCCCTGTTGGGCCCCCTTACTT 






1141 ---------+---------+---------+---------+---------+---------+ 1200 
AGAGTACCTACGAAGAGGCGCTCAATCGCAAATCAACAAGTGGACTCAGCACAAACAGAA 
TGTATTTTGCGTCTTAATGTGCCTATGGACAAATCTGGATCTCCCAATGCTAGTAGAACC 
1201 ---------+---------+---------+---------+---------+---------+ 1260 
ACATAAAACGCAGAATTACACGGATACCTGTTTAGACCTAGAGGGTTACGATCATCTTGG 
M D K S G S P N A S R T 
TCCCGGCGTCGTCGCCCGCGTAGAGGTTCTCGGTCCGCTTCTGGTGCGGATGCAGGGTTG 
1261 ---------+---------+---------+---------+---------+---------+ 1320 
AGGGCCGCAGCAGCGGGCGCATCTCCAAGAGCCAGGCGAAGACCACGCCTACGTCCCAAC 
S R R R R P R R G S R S A S G A D A G L 
CGTGCTTTGACTCAGCAGATGCTGAGACTCAATAAAACCCTCGCCATTGGTCGTCCCACT 
1321 ---------+---------+---------+---------+---------+---------+ 1380 
GCACGAAACTGAGTCGTCTACGACTCTGAGTTATTTTGGGAGCGGTAACCAGCAGGGTGA 
R A L T Q Q M L R L N K T L A I G R P T 
CTTAACCACCCAACCTTCGTGGGTAGAGAAAGTTGTAAACCCGGTTACACTTTCACATCT 
1381 ---------+---------+---------+---------+---------+---------+ 1440 
GAATTGGTGGGTTGGAAGCACCCATCTCTTTCAACATTTGGGCCAATGTGAAAGTGTAGA 
L N H P T F V G R E S C K P G Y T F T S 
ATTACCCTGAAACCGCCTGAAATTGAGAAAGGTTCATATTTTGGTAGAAGGTTGTCTTTG 
1441 --- -----+---------+---------+---------+---------+---------+ 1500 
TAATGGGACTTTGGCGGACTTTAACTCTTTCCAAGTATAAAACCATCTTCCAACAGAAAC 
I T L K P P E I E K G S Y F G R R L S L 
CCAGATTCAGTCACGGACTATGATAAGAAGCTTGTTTCGCGCATTCAAATCAGGATTAAT 
1501 ---------+---------+---------+---------+---------+---------+ 1560 
GGTCTAAGTCAGTGCCTGATACTATTCTTCGAACAAAGCGCGTAAGTTTAGTCCTAATTA 
P D S V T D Y D K K L V S R I Q I R I N 
CCTTTGCCGAAATTTGATTCTACCGTGTGGGTTACAGTTCGGAAAGTACCTTCATCATCC 
1561 ---------+---------+---------+---------+---------+---------+ 1620 
GGAAACGGCTTTAAACTAAGATGGCACACCCAATGTCAAGCCTTTCATGGAAGTAGTAGG 
P L P K F D S T V W V T V R K V P S S S 
GATCTTTCCGTCGCCGCCATCTCTGCTATGTTTGGCGATGGTAATTCACCGGTTTTGGTT 
1621 ---------+---------+---------+---------+---------+---------+ 1680 
CTAGAAAGGCAGCGGCGGTAGAGACGATACAAACCGCTACCATTAAGTGGCCAAAACCAA 
D L S V A A I S A M F G D G N S P V L V 
TATCAGTATGCTGCGTCCGGAGTTCAGGCCAACAATAAGTTACTTTATGACCTGTCCGAG 
1681 ---------+---------+---------+---------+---------+---------+ 1740 
ATAGTCATACGACGCAGGCCTCAAGTCCGGTTGTTATTCAATGAAATACTGGACAGGCTC 
Y Q Y A A S G V Q A N N K L L Y D L S E 
ATGCGTGCTGATATCGGCGACATGCGTAAGTACGCCGTCCTGGTTTAT�CGAAAGACGAC 
1741 ---------+---------+---------+---------+---------+---------+ 1800 
TACGCACGACTATAGCCGCTGTACGCATTCATGCGGCAGGACCAAATAAGCTTTCTGCTG 
M R A D I G D M R K Y A V L V Y S K D D 
AAACTAGAGAAGGATGAGATTGTACTTCATGTCGACGTCGAGCATCAACGAATTCCTATC 
1801 ---------+---------+---------+---------+---------+---------+ 1860 
TTTGATCTCTTCCTACTCTAACATGAAGTACAGCTGCAGCTCGTAGTTGCTTAAGGATAG 
K L E K D E I V L H V D V E H Q R I P I 
TCACGGATGCTCCCGACTTAGTCCGTGTGTTTACCGGCGTCCGAAGACGTTAAACTACAC 
1861 ---------+---------+---------+---------+---------+---------+ 1920 
AGTGCCTACGAGGGCTGAATCAGGCACACAAATGGCCGCAGGCTTCTGCAATTTGATGTG 
S R M L P T *
TCTCAATCGCGAGTGCTGAGTTGGTAGTATTGCTTTAAACTGCCTGAGGTCCCTAAACGT 
1921 ---------+---------+---------+---------+---------+---------+ 1980 
AGAGTTAGCGCTCACGACTCAACCATCATAACGAAATTTGACGGACTCCAGGGATTTGCA 
GTTGTTGCGCGGGGAACGGGTTGTCCATCCAGCTTACGGCTAAAATGGTCAGTCGTGTCT 





2041 ---------+---------+---------+---------+---------+---------+ 2100 
AAGTGTGCGGCTACAGAATGTTCCACAGCTCCATGGGTATCTTTAGTAGAGGATCTAAAG 
TTCGGAAGGGCTTCGTGAGAAGCTCGTGCACGGTAATACACTGATATTACCAAGAGTGCG 
2101 ---------+---------+---------+---------+---------+---------+ 2160 
AAGCCTTCCCGAAGCACTCTTCGAGCACGTGCCATTATGTGACTATAATGGTTCTCACGC 
GGTATCGCCTGTGGTTTTCCACAGGTTCTCCATAAGGAGACCA 
2161 ---------+---------+---------+---------+--- 2203 
CCATAGCGGACACCAAAAGGTGTCCAAGAGGTATTCCTCTGGT 
Figure 4.11 Nucleotide sequence of CMV-LY RNA 3. The sequences of the 279
amino acid 3a protein and the 218 amino acid 3b protein are shown below their RNA 
coding sequence. The stop codons of these reading frames are identified as asterisks. 
The red colour RNA sequence in the 3' untranslated region represents a 40- nucleotide 
sequence domain conserved in all cucumovirus RNA sequences ( see Fig. 4.15 ). 
4.8.6.2 RNA 3, ORF 3a and ORF 3b sequence comparisons 
The results of comparing the sequence of CMV-L Y RNA 3 with 12 published CMV 
strains at the nucleotide level is given in Table 4.10. As predicted, CMV-L Y RNA 3 
shows significant identity to the CMV sg II strains, with 99%, 99% and 98% between 
CMV-Trk7, CMV-Kin and CMV-Q, respectively. The identity between CMV-LY
RNA 3 and nine sg I strains ranges from· 71 % to 74%. The homology between CMV­
LY and CMV sg II strains (CMV-Kin, CMV-Q, and CMV-Trk7) in all regions are 
very high, especially, between CMV-LY and CMV-Trk7. The lowest is from 94% to 
95% in 5' UTR, the homology in other regions are very similar, from 97% to 99%. 
The values of homology between CMV-L Y RNA 3 and the nine CMV sg I strains in 
different regions are also given in Table 4.10. The highest homology is in 3a (77-
78%), 3b is the second (74-78%), the lowest value is only from 41 % to 51 % in the 5' 
UTR, the second lowest is in 3'UTR (64-68% ), and the IR has intermediate homology 
(66-71 %). 
The identity and similarity of ORF3a and ORF3b between CMV-L Y and other CMV 
strains is given in Table 4.11. There are higher homologies at the protein level than at 
the nucleotide level. The similarity between ORF3b of CMV-L Y and CMV sg I 
strains is higher than those of ORF3a between CMV-L Y and the other sg I strains, but 
the identities between ORF3b of CMV-L Y and those of the other CMV sg I strains are 
lower than those in ORF3a. Both ORF3a and ORF3b of CMV-L Yhave high identifies 




four 3a amino acid sequences, there are two and three amino acid differences between 
the consensus sequence and CMV-Kin and CMV-Q, respectively, the ORF3a 
sequences of CMV-LY and CMV-Trk7 both are identical to the consensus sequence 
(Fig. 4.12). Among the four ORF3b amino acid sequences, there are five differences 
between the consensus sequence and CMV-Trk7, and one each difference between the 
consensus sequence and CMV-L Y and CMV-Kin, the ORF3b sequence of CMV-Q is 
identical to the consensus sequence (Fig. 4.13). 
Table 4.10 Nucleotide sequence homology of CMV-LY RNA 3 with those of other 
12 published CMV strains 
CMV RNA3 5' 3a Intergenic 3b 3'UTR RNA3 in 
strain UTR ORF Region ORF length (nt) 
Fny 73 51 78 66 75 64 2,216 
IX 71 48 77 60 74 66 2,216 
KM 74 39 79 71 78 66 2,210 
Kor 73 46 79 65 74 62 2,225 
M 72 48 78 65 74 66 2,215 
NT9 74 48 78 65 78 68 2,214 
0 73 41 78 68 74- ---·-66 2,216 
Sny 73 51 78 65 75 64 2,216 
y 73 40 78 68 75 65 2,217 
Kin 99 95 99 97 99 98 2,199 
Q 98 95 99 97 99 98 2,197 
Trk7 99 94 99 96 98 99 2,209 
LY 100 100 100 100 100 100 2,203 
Table 4.11 Percentage identity and similarity between CMV-LY ORF3a and ORF3b 
proteins with 14 published CMV strains 
CMV CMV ORF3a 
subgroup strain identity 
I Fny 84 
I IX 83 
I KM 84 
I Kor 85 
I M 84 
I NT9 84 
I 0 84 
I Sny 83 
I y 84 
II Kin 99 
II Q 99 
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Figure 4.12. Alignment of CMV-LY 3a with those of the three CMV sg II strains 
(CMV-Trk7, -Kin and -Q). The consensus sequence is presented at the bottom of each 
block. The multiple sequence alignment was done by the GCG 'Pileup' program and 
the consensus sequence calculated and displayed by the GCG 'Prettyplot 'program. 
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Figure 4.13 Alignment of CMV-LY 3b (CP) with those of the three CMV sg II 
strains. The consensus sequence is presented at the bottom of each block. The 
multiple sequence alignment was done by the GCG 'Pileup' program and the 
consensus sequence calculated and displayed by the GCG 'Prettyplot 'program. 
4.8.7 5' Non-coding region of CMV-LY RNAs 
The determination of the entire genomic organization makes it possible to compare the 
5' non-coding regions of each RNA of CMV-L Y. Figure 4.14 shows the alignment of 
the 5' non-coding regions of CMV-L Y RNAs. The sequences of RNA 1 and 2 are 
very similar, whereas RNA 3 is somewhat different. In addition, an eleven nt 
(GGTTCGANTCC) in the IR of CMV-LY RNA 3, which is closely related to 
sequences detected in the 5'-untranslated region of CMV-LY RNA 1 and 2, is found.
This conserved sequence is also found in the B box of the internal control regions of 
tRNA promoters (ICR2), and acts as a promoter for plus-strand synthesis in viral 
replication (Pogue et al., 1990). It has been reported for CMV (Rezaian et al., 1985), 
BMV (Marsh et al., 1988) and PSV (Karasawa et al., 1992). It is proposed that this 
sequence interacts with the antisense sequence of CMV satellite RNA (satRNA), 
thereby regulating viral and satRNA replication (Rezaian et al., 1985). 
1 42 
CMV-LY RNA 1 GTTTUATTTACAAGAGCGTACGGTTCAACCCCTGCCCCCTCT 
Ill Ill 1111111111 111111111111111 11111 
CMV-LY RNA 2 ATTT ATTCTCAAGAGCGTATGGTTCAACCCCTGCCTCCTCT 
Partial IR of LY RNA 3 





Figure 4.14 Alignment of partial nucleotide sequences at the 5' end of CMV-LY 
RNA 1, 2 and IR of RNA 3. The sequences homologous to B box of the internal 
control regions of tRNA promoters are under! ined, and the consensus sequence for the 
tRNA B box is indicated. 
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4.8.8 3' Non-coding region of CMV-L Y RNAs 
Comparisons of the 3' untranslated ends of CMV-LY RNA 1, 2 and 3 with other 
cucumovirus RNAs revealed a very highly conserved RNA sequence domain of 40 nt 
in which all variation occurs at a single nucleotide (See Fig4.5, 4.7, 4.11, and 4.15). 
No structure or function for this sequence has been identified. However, such a degree 
of sequence conservation indicates an important function as a structural and/or binding 
5' GAACGGGUUGUCCAUCCAGCU(N)ACGGCUAAAAUGGUCAGU 3' 
(N) = U in all CMV-LY, CMV-Q, RNAs 2 and 3 ofCMV-Fny, CMV-Y, CMV-B, CMV-O, CMV-K, 
CMV-RNAs 1 and 3 ofCMV-Ix, RNA 1 of CMV-NT9, RNA 2 of CMV-Kor.
(N) = A in all TAV RNAs, RNAs 1 and 3 of PSV, RNA 1 ofCMV-Fny, CMV-Y, RNA 2 of CMV­
Ix, RNA 3 ofCMV-Kor.
(N) = G in all PSV RNA 2. 
Figure 4.15. A 40-nucleotide RNA sequence domain found in the 3' untranslated 
regions of all cucumovirus RNA sequences examined. 
domain. The conserved sequence may prove useful as a diagnostic signature sequence 
for cucumoviruses. Boccard and Baulcombe (1993) noted the high degree of 
conservation in sequences that overlap this domain in comparisons of the RNA 3 
components of cucumovirus. They also showed that deletions that included this region 
prevented detectable RNA 3 accumulation in protoplasts. The analogous region in 
BMV shows no obvious sequence similarity to this domain and contains putative stem­
loop structures which have been shown to have a role in RNA replication in 
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Chapter 5. Transformation and analysis of transgenic plants 
5.1 Overview of this chapter 
In this chapter, results of A. tumefaciens transformation of N. benthamiana with the 
resistance constructs developed in Chapter 3 are presented. The chapter deals with 
Agrobacterium transformation of tobacco and analysis of transgenic material using 
PCR, Southern blots, virus challenge and ELISA assays. Because of time limitations, 
not all of the putative transgenic plants were analysed using every test. 
In addition, some of the constructs developed here have been given to other 
researchers to generate genetically transformed lines of narrow-leafed and yellow 
lupins, chickpeas, lentils and faba beans. For example, Ms Liu Li (SABC, Murdoch 
University) has been transforming CMV-LY Rep-based constructs into narrow-leafed 
lupin (cv. Kalya). At CLIMA, Ms Simone Chapple has been transforming CMV 
resistance constructs based on CMV-L Y Rep and MP genes into narrow-leafed lupins. 
The preliminary results from these experiments are also given in this chapter. 
5.2 Introduction 
5.2.1 Agrobacterium species as plant pathogens 
A. tumefaciens and A rhiwgenes are Gram-negative, soil-borne bacteria responsible
for crown gall and hairy root diseases of plants, respectively. These phytopathogenic 
bacteria are found in abundance in the soil and infect plant cells via wounds, usually at 
the crown of the root at the soil surface. Although the phytopathogenic properties of 
these bacteria were recognized over 90 years ago (Smith and Townsend, 1907), the 
nature of the infection process has been elucidated and modified for use in plant 
transformation more recently (Hooykaas and Schilperoort, 1984). 
5.2.1.1 Characterisation of cells infected by Agrobacterium species 
Crown galls of A. tumefaciens infection show various morphological characteristics, 
ranging from disorganised masses of cells to the production of roots and shoots. By 
contrast, A. rhiwgenes usually produces 'hairy roots' which are capable of growing in 
a negatively geotropic fashion. In some species, these hairy roots can be induced to 
produce shoots and intact plants. However, crown galls and hairy roots share certain 
characteristics, such as the ability to grow in culture without the addition of plant 
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hormones and the production of unusual amino acids. These opines are utilised by the 
bacterium as a source of carbon and nitrogen. The types of opines produced are 
determined by the bacterial strain, or more precisely by the particular plasmid carried 
by the strain. Strains of A. tumefaciens usually produce octopine or nopaline, whereas 
those of A. rhizogenes mainly produce either agropine or mannopine. 
5.2.1.2 Structure of the Ti plasmid 
Both species of bacteria contain large plasmids (about 200 Kb) known as tumour 
inducing (Ti) plasmids in A. tumefaciens and root inducing (Ri) plasmids in A. 
rhizogenes. Both Ti and Ri plasmids include two major parts: the T-DNA (transferred 
DNA) and the backbone of the plasmid. The vir region and genes for opine catabolism 
reside on the backbone of the plasmid native T-DNA that contains the genes for opine 
metabolism and phytohormone synthesis is mobilized during infection. The T-DNA is 
about 23 Kb in size, and is flanked by 25 bp directly repeated sequences known as the 
right border (RB) and left border (LB). The vir region is composed of at least six 
essential operons (vir A, vir B vir G vir C, vir D, vir E) and two non-essential operons 
(virF, virH). 
5.2.1.3 A. tumefaciens T-DNA transfer process 
A current model for plant infection by Agrobacterium involves five steps, (1) bacterial 
colonisation, (2) induction of the bacterial virulence system, (3) generation of T-DNA 
transfer complex, (4) T-DNA transfer and (5) integration of T-DNA into the plant 
genome. 
Bacterial colonisation is the earliest step in tumour induction and it takes place when 
A. tumefaciens attaches to the plant cell surface (Matthysse, 1986). Acetosyringone
and other compounds released from wounded cells stimulate the virD2 gene to 
transcribe site-specific single-strand nicks at the lower strands of the RB and LB. A 
single-stranded molecule ( called the T-strand) is produced. The virD2 protein attaches 
to the RB (5') terminus of the T-strand covalently by a phosphotyrosine bond. The 
virD2 protein may also act as a pilot to direct the T-strands to the nucleus of the host 
plant cell, since it contains nuclear targeting sequences. A single-stranded DNA­
binding protein (69-kDa) encoded by the second ORF of the virE operon coats the T-
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strands by cooperative binding, leading to long, thin nucleo-protein filaments 
(Citovsky et al., 1989). The ss-DNA/protein complex is translocated and integrated 
into the host genome (Zambryski, 1992). Inside the plant cell, the ssT-DNA complex 
is targeted to the nucleus and crosses the nuclear membrane. Two vir proteins ( virD2 
and virE2) have been found to be important in this step (Hooykaas and Schilperoort, 
1992). The process of T-DNA integration into the host genome has not been fully 
characterised, however it is considered that integration occurs by illegitimate 
recombination (Gheysen et al., 1993; Lehman et al., 1994; Puchta, 1998). 
5.2.2 Transfer of interesting genes 
The precision by which Agrobacterium transfers its DNA into the host plant's genome 
makes it an ideal vector for plant transformation. In A. tumefaciens, removal of the 
oncogenes from the T-DNA of the Ti plasmid allows this bacterium to be used as a 
gene vector to introduce new genes into host plant cells. After T-DNA transfer into 
host cells, transgenic shoots and plants can be regenerated by culture of these cells in 
the presence of suitable media with auxins and cytokinins. Foreign genes can be 
placed within the boundaries of the T-DNA, either in the original virulent, disarmed Ti 
plasmid, or in a separate, non-virulent plasmid. The advantage of separating the region 
containing the T-DNA borders from that containing the vir genes is that the former can 
be a small plasmid that is easily manipulated and has a high copy number in E. coli. 
Such a 'binary' plasmid system, in which the T-DNA and vir regions are in a trans 
arrangement, is the most widely used transformation system. 
Efficient methodologies for Agrobacterium-mediated gene transfer have been 
established successfully for a wide range of dicotyledonous plants and more recently 
some monocotyledonous plants such as rice and barley. 
The transformation of L. angustifolius using Agrobacterium as achieved by two 
Australian groups, who independently described successful Agrobacterium-mediated 
transformation of L. angustifolius (Molvig, 1992; Molvig et al., 1993 and 1994; Atkins 
et al., 1998). Molvig (1992) and Molvig et al. (1993; 1994) used thin slices of 
cotyledonary nodes of young seedlings or of developing embryonic axes of lupin as 
starting material. However, the success rate for this approach was poor with a very 
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low transgenic frequency ( < 0.01 % ). Pigeaire et al. (1994; 1995; 1997) developed an 
alternative approach using explants from germinating seeds and relied on gene transfer 
to the shoot apex with subsequent development of shoots from transformed axillary 
buds. The frequency of recovery of transgenic plants ranged from 1.5 to 6%. This 
method is more reproducible and is now the standard method used to produce 
genetically engineering lines of L. angustifolius (Atkins et al., 1998). It has also been 
modified and is being used at the SABC, Murdoch University and CLIMA to 
regenerate transgenic L. angustifolius plants. 
5.3. Materials and Methods 
5.3.1. Molecular constructs and Agrobacterium strain
Ten CMV-resistance constructs were used to transform N. benthamiana (Table 5.1). 
Two constructs were based on the CMV-LY MP gene (:rvfl>l and MPSl), four based on 
the CMV CP gene (CPl-1, CP2-1, CP3-1 and CP4-1) and four based on the CMV-LY 
Rep gene (Repfl, Repf2, Repml and Repm2). All of the resistance genes were driven 
by the 35S CaMV promoter in the pART binary vector, which carries the npt II gene 
as selectable marker for plants. 
Table 5.1 CMV-resistance constructs used in N. benthamiana transformation 
Resistance plant selectable bacterium selectable Trans gene 
construct marker marker orientation of 
pARTMPl Kanamycin Spectinomycin Sense 
pARTMPSl Kanamycin Spectinomycin Sense 
pARTCPl-1 Kanamycin Spectinomycin Sense 
pARTCP2-1 Kanamycin Spectinomycin Sense 
pARTCP3-l Kanamycin Spectinomycin Sense 
pARTCP4-1 Kanamycin Spectinomycin Sense 
pARTRepfl Kanamycin Spectinomycin Sense 
pARTRepf2 Kanamycin Spectinomycin Anti sense 
pARTRepml Kanamycin Spectinomycin Sense 
pARTRepm2 Kanamycin Spectinomycin Anti sense 
152 
! I 
- -_ - - __ - ---- --" _[ 
5.3.2 Transformation of N. benthamiana 
5.3.2.1 Plant materials 
N. benthamiana seeds were surf ace-sterilised by immersing in sterilised water for 2
min, transferred to 70% ethanol for 2 min and then in 12.1 % (v/v) sodium hypochlorite 
for 5 min. The seeds were then washed four times with sterile distilled water and 
plated onto MS medium with BS vitamins containing 2.5% sucrose, 0.5% glucose and 
2.7% phytagel. The pH of the medium was adjusted to 5.7-5.8 with NaOH and 
autoclaved for 25 min at 121 °C. Sterilised seeds were grown under cool-white 
fluorescent light with a day length of 11 hr and 25/20°C day/night temperatures, 
respectively. 
5.3.2.2 Transformation and regeneration 
In vitro regeneration of ·shoots from N. benthamiana explants was optimised using the 
stock solutions indicated in Table 5.2 and 5.3. 6-BAP/NAA was added to 1 L 
regeneration medium in the following ratios: 1 mg/0.1 mg, 0.5 mg/0.1 mg, 1 mg/0.2 
mg and 0.5 mg 6-BAP alone. Twenty leaf explants were grown on each medium. 
Three weeks later, the calli and shoots �ere scored. 
Transformation and regeneration of N. benthamiana was done using a modification of 
the procedure of Horsch et al. (1985). One cm leaf explants were cut with a sterile 
scalpel blade from young in vitro grown N. benthamiana leaves and soaked for 5 min 
in an overnight culture of A. tumefaciens. The ex plants were blotted dry on sterile 3 M 
filter paper and placed onto solidified co-cultivation medium in Petri dishes for two 
days. The explants were then transferred to selection medium (regeneration medium) 
which contained the same ingredients as the co-cultivation medium but with the 
addition of 150 mg/I Timentin and 100 mg/I of Kanamycin to kill Agrobacterium and 
select transgenic cells, respectively. 
After 2 weeks, explants with developing shoots were transferred to fresh selection 
medium. Finally, after another two weeks, young shoots were transferred onto rooting 
medium (MS0 plus 150 mg/I Timentin and 100 mg/I of Kanamycin). Plants with 
vigorous roots in the medium were transplanted into pots with potting mix. The plants 
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were fertilised with Thrive (Yates), and fungal diseases and insects were controlled by 
spraying as required. 
Table 5.2. Composition of stock solutions used to prepare media for in vitro culture 
of N. benthamiana 


















Citric acid 1 
Malic acid 1 
Sodium pyruvate 0.5 
FeSO4.EDTA (lO0X) 250.0mg/100ml 
MS Vitamins (l000X) ml?ll00ml 
Nicotinic acid 1000 
Thiamine hydrochloride 10000 
Pyridoxine hydrochloride 1000 
mvo-Inositol 100000 
Phytohormone mwml 
6-BAP (Sigma) 1.0 
NAA (Sigma) 1.0 
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Table 5.3 Composition of stock solutions used to prepare media for N. benthamiana 
trans/ onnation ( additives given per litre) 
Medium 
Component 
Co-cultivation Regeneration Rooting 
Macro nutrients 100ml 100 ml 100 ml 
Micro nutrients 10 ml 10ml 10 ml 
Vitamins 1 ml 1 ml 1 ml 
FeSO�DTA 10 ml 10 ml 10 ml 
Organic nutrients 1 ml 1 ml 1 ml 
Glucose 5g 5g 5g 
Sucrose 25 g 25 g 25 g 
Phytagel 2.7 g 2.7 g 2.7 g 
BAP 0.5 ml 0.5 ml -
Kanamycin - 100mg 100mg 
Timentin - 150mg 150mg 
5.3.2.3 PCR analysis to identifytransgenic plants 
PCR was used to verify the presence of transgenes in putative transgenic plants . The 
PCR reagents and conditions were the same as those used in Chapter 2. The templates 
were prepared by nucleon PHYTOpure PLANT DNA extraction kit (Amersham LIFE 
SCIENCE). The primers used to detect the transgenes are listed in Table 5.4. 
Table 5.4 The primers used to detect transgenes in putative transgenic plants 
Trans gene Primers Expected size_ 
(bp) 
Repfl Rep3: 5' GGATCCACTATGACAAGTCCTCCACC 
Rep:f2 
Repml Rep6: 5' AGGCATCTCTGGAATCTC 1450 
Repm2 
MPl S'MP: 5' TATGAATTCAACCATGGCTTTCCAAGG 840 
MP2 3'MP: 5' GCTGAATTCCTAAAGACCGTTAACCACC 
CPl-1 CPI: 5' CTAGGAATTCATGGACAAATCTGGCTCTC 615 
CP7: 5' GAATTCGTTGATGCTCGACGTCGA 
CP2-1 CP3: 5' GAATTCATGGACAAATCTGGATCTC 780 
CP3-l CP4: 5' GAATTCGTAAGCTGGATGGACAACCC 
CP4-1 
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5.3.2.4 Southern blots 
5.3.2.4.1 Preparation of plant genomic DNA for Southern blots 
Plant genomic DNA (15 µg) was digested overnight with Hind m a final volume of 
400 µI. 20 µl aliquots were run on a 1 % agarose gel to make sure the digests were 
complete and that no degradation had occurred. The digested DNA was precipitated 
using 1/10 vol. 3 M sodium acetate and 2.5 vol. absolute ethanol at - 80°C for 15 min, 
rinsed with 70% ethanol and resuspended in 100 µl TE. 
5.3.2.4.2 Gel separation of digested DNA 
DNA fragments were separated by agarose gel electrophoresis in a Bio-Rad Wide Mini 
Sub™ DNA cell apparatus, in 0.5 x TBE buffer (0.2 M Tris-acetate, 5 mM EDTA, pH 
8.0). Electrophoresis was carried out at a constant voltage (70 - 80 V) and 40 mA 
current until full separation of lambda Hind III molecular weight standard occurred. 
5.3.2.4.3 Capillary blotting 
The gel was denatured by soaking in 500 ml of 0.4 N NaOH with gentle agitation. The 
DNA was then transferred to a nylon membrane (Sambrook et al., 1989). A gel tray 
was wrapped in two pieces of 3 MM paper and placed, inverted as a support, in a 
shallow plastic box. The box was filled with 0.4 N NaOH transfer buffer until the 
level almost reached the top of the support. The gel was placed inverted on the 
support. A piece of nylon membrane, 1 mm larger than the gel, was placed on the gel 
and air bubbles removed. Two pieces of 3 MM paper, cut to the same size as the 
nylon membrane, were placed on the membrane. The gel was surrounded with plastic 
wrap to prevent paper towels touching the transfer buffer. A stack of absorbent paper 
towels and a weight were put on top of the 3 MM paper and transfer of DNA into the 
membrane was allowed to proceed overnight. Following transfer, the membrane was 
soaked in neutralisation buffer (0.5 M Tris, 1.0 M NaCl) for 15 min to remove any 
excess agarose, followed by blotting dry on a piece of 3 MM paper. 
5.3.2.4.4 Synthesis of a DNA probe 
A DNA probe, homologous to the target gene, was amplified by PCR as described 
previously. The PCR product was purified using a Wizard PCR Clean-up column 
(Promega), then quantified by a fluorometer. The probe was labeled with [32P]-dCTP 
I I 
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(Amrad Pharmacia Biotech) and with the 'Ready To Go' DNA labeling kit 
(Pharmacia) following manufacturers instructions. 50 ng of PCR product in 7 µl water 
was added in a 0.5 ml tube. The DNA was denatured by incubating at 95°C for 3 min 
then chilled on ice. Random primers were annealed to the denatured DNA and a 
complementary strand was extended with Kienow DNA polymerase. The radiolabeled 
cytosines were incorporated into the new strand as it extended. Following synthesis of 
the radiolabeled strand, the DNA strands were separated at 95°C for 10 min and then 
placed on ice. 
5.3.2.4.5 Hybridising the probe to DNA immobilised on a nylon 
membrane 
The nylon membrane containing the digested DNA was placed in a hybridisation 
bottle and soaked in 15 ml of prehybridisation buffer (2.5 mM EDTA, Na2HP04, pH 
7.0, 7% SOS) at 65°C for 5 hr, which was then removed. The radiolabeled probe was 
mixed with 10 ml hybridisation buffer [0.5 ml sterile nanopure H20, 3 ml 5x HBS, 3 
ml Denhardt's III, 3 ml dextran sulphate 25% and 0.5 ml denatured salmon sperm 
DNA (5 mg/ml)] and added to the bottle.. Hybridisation was carried out by slowly 
rotating the bottle (10 rpm) in a hybridisation oven at 65°C overnight. 
5.3.2.4.6 Washing and exposure of the membrane 
Following hybridisation, unincorporated probe and isotope were removed, and the 
membrane washed. This involved addition of 40 ml 2x SSC, 0.1 % SOS, returned to 
the oven for 20 min at 65°C, then removal of the membrane from the bottle and 
transfer to a lunch box. Here it was washed successively with 200 ml of the following 
buffers: lx SSC, 0.1 % SDS, 0.5x SSC, 0.1 % SOS and 0.2x SSC, 0.1 % SOS at 65°C 
for 20 min. The membrane was blotted dry on paper towels before wrapping in plastic 
wrap. It was then placed in an X-ray film cassette containing an intensifying screen 
and exposed to X-ray film (Fuji Super HR-S30) for 5 days at -86°C before 
development of the film. 
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5.3.2.5 CMV-L Y virus challenge and ELISA assays 
Transgenic T1 plants of N. benthamiana from self-pollinated primary transformants 
were mechanically inoculated with CMV-L Y virus at the three-leaf stage. lnocula 
were prepared by grinding CMV-inf ected N. glutinosa leaf tissue in PBS buff er (pH 7) 
containing a small amount of Celite as described in Chapter 2. Plants were scored as 
being systemically infected when any leaf younger than the inoculated leaves showed 
typical symptoms. An emerging leaf and an inoculated mature leaf were collected 
from each plant 14 and 28 days post-inoculation (pi), for monitoring the presence of 
CMV by DAS-ELISA with an antibody to the CP of CMV. (The DAS-ELISA assays 
were conducted by Ms Brenda Coutts and Ms Yvonne Cheng, Plant Pathology 
Department, Agriculture Western Australia). 
5.4 Results 
5.4.1 Optimisation of the conditions for shoot regeneration from N.
benthamiana 
Calli and shoots were induced on all of the media containing different concentrations 
of 6-BAP and NAA, but the medium containing 0.5 mg/I 6-BAP alone gave the most 
shoots (Table 5.5). 45 healthy shoots were produced on 20 explants after three weeks 
on this medium. In contrast a large amount of callus was produced on the medium 
containing 1 mg/I 6-BAP and 0.1 mg/I NAA, which is the usual phytohormone 
combination used for tobacco tissue culture (Horsch et al., 1985). The calli on the 
latter medium could differentiate to give shoots later (Table 5.5), but this process was 
slow. As a result, 0.5 mg/16-BAP was chosen as the medium to use in the following 
work to transform N. benthamiana. 
Table 5.5 N. benthamiana shoots regenerated from different media 
Type of medium Days after growing on the regeneration medium 
21 days 28 days 32 days 
Typel - - 74 
Type2 - - 63 
Type3 - 17 144 
Type4 45 123 164 
Type 1: MS+ 1 mg/16-BAP and 0.2 mg/I NAA, 
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Type 2: MS+ 1 mg/16-BAP and 0.1 mg/I NAA, 
Type 3: MS + 0.5 mg/16-BAP and 0.1 mg/I NAA, 
Type 4: MS+ 0.5 mg/16-BAP. 
5.4.2 N. benthamiana transformation 
A total of 80 N. benthamiana leaf explants per experiment were co-cultivated with A. 
tumefaciens containing one of each of the ten plasmids. Many adventitious shoots 
were produced (Fig 5.1), and of these, 50 shoots were randomly chosen for transfer to 
rooting medium. Most of these produced roots on selection medium and 16 plantlets 
for each construct were subsequently transferred to the glasshouse for collection of T 1 
generation seeds. The transgenic N. benthamiana plants were labeled with "Nb" 
followed by a gene identification name and a line number, for example "NbCP4. l-6" 
indicates a N. benthamiana plants transformed with pARTCP4.1, transformation event 
(line) 6. 
Most of the putative transformants were morphologically identical to the 
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(c) 
Plate 5.1. Transformation of N. benthamiana with CMVresistance constructs. 
(a) Negative control. It shows that no calli or shoots developed from the 
untransformed explants on 100 mgll knanamycin selection medium 
(b) Plate containing the transformed explants. It shows healthy shoots arising from,
calli on 100 mgll kanamycin selection medium.
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5.4.3 Analysis of transgenic plants 
5.4.3.1 PCR tests 
Results from PCR analysis of N. benthamiana T 1 transgenic plants are given in Table 
5.6 and Figures 5.2 to 5.6. One plant of each selected line for eight different 
constructs was analysed by PCR, except for two lines picked from NbRepml 
(NbRepml.2 and NbRepml.4). Because not all of the plants were tested from each 
line, analysis of genetic segregation based on CMV resistance could not be 
undertaken. 
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Figure 5.2 PCR products for Repm gene generated with primers Rep6 and Rep3 
(1.45 kb). 
Lane (1) 100 bp marker; (2) plasmid positive control; (3) N. benthamiana 
untransformed control; lanes 4, 5, 7, 8, 9, 11, 13, 14, 15, 16, 17, 18 transformed 
plants, containing Repm antisense gene, show positive PCR results; lanes 20, 21, 22, 
23, 24 and 25 transformed plants containing full-length Rep gene, show positive PCR 
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Figure 5.3 PCR products J or Repm gene generated with primers Rep6 and Rep3 
(1.45 kb). 
Lane ( 1) 1 kb marker; (2) plasmid positive control; ( 3) N. benthamiana untransformed 
control; lanes 4, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 and 24, 
trans/ armed plants containing sense Repm gene, show positive PCR results; lanes 7, 
10 and 14 plants show negative PCR results. 
840bp 
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Figure 5.4 PCR products generated for MP and MPS genes with primers MPJ and 
MP2 (840 bp). 
Lane ( 1) 1 kb marker; (2) plasmid positive control; ( 3) N. benthamiana untransformed 
control; lanes 5,6, 7, 9, and 10 transformed plants, containing sense MP gene; lanes 
11, 12, 14, 15, 16, 17 and 19 transformed plants containing MPS gene, show positive 
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Figure 5. 5 PCR product generated with primers CP 1 and CP7 ( 625 bp ). 
Lane (1) 100 bp marker; (2) plasmid positive control; ( 3) N. benthamiana 
untransfonned control; (4, 5, 6, 9, 11, 14, 15, 17 and 20) transfonned lines, 
containing sense CPI gene, show positive PCR results; (7, 8, 10, 12, 13, 16, 18, 19 
and 21) trannsfonned lines show negative PCR results; (22) 1 kb marker. 
�780bp 
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Figure 5.6 PCR product generated with primers CP3 and CP4 (770-790 bp). 
Lane ( 1) 1 kb marker; (2) plasmid positive control; (3) N. benthamiana untransfonned 
control; (4, 5, 6, 7, 8, 9, 11, 12, 13 and 14) transfonned lines, containing sense CP3 
gene, show the positive PCR results; (16, 17, 18, 20, 21, 22, 23, 24 and 25) 
transfonned lines, containing sense CP4 gene, show the positive PCR results; (10, 15 
and 19) transformed lines show negative PCR results. 
5.4.3.2 Southern blots 
Southern analysis of transgenic plants was only done once at the end of time allocated 
to experimental work. 
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Southern hybridization was done with Repm gene probes on DNA from seven putative 
N. benthamiana T 1 plants and one untransformed plant. The digested genomic DNA
was visuaiised (Fig. 5.7) and successfully bound to a nylon membrane. However, 
several attempts to hybridise a radioactive probe to the membrane-bound genomic 
DNA were unsuccessful. The probes bound only weakly to a high concentration (25 
ng) of plasmid containing homologous sequence. This problem was experienced by 
others in our laboratory and was thought to be inefficient labelled [32P]dCTP. 
1 2 3 4 5 6 7 8 9 
Figure 5.7 Hind III digest of approximately lSµg genomic DNA from seven 
putative T1 N. benthamiana plants and one control plant visualised on a 1% agarose 
gel. Lane 1, A Hind III molecular weight marker; lanes 2-8, transgenic genomic 
DNA; lane 9, control genomic DNA, lane 10, plasmid positive control. 
5.4.3.3 Virus challenge and ELISA assays 
The effectiveness of resistance/tolerance of transgenic N. benthamiana to CMV-LY 
was determined by observing disease symptom development and by ELISA assays. 
One week after inoculation, all (6 out of 6) nontransgenic controls and some transgenic 
plants from the same transgenic event exhibited mosaic symptoms in the upper leaves. 
Thereafter, the severity of symptoms increased in the susceptible plants, whereas some 
transgenic plants (as described in detail in the following section) remained 
symptomless. Plants of intermediate resistance expressed light to medium mosaic 
symptoms to varying degrees. 
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Rep ml construct (sense defective CMV Rep gene construct) 
The responses of 22 Repm PCR putative transgenic T 1 plants (11 each from the plants 
of NbRepml.2 and Nbrepml.4), which contained a sense defective CMV Rep gene, to 
CMV-L Y infection displayed three categories of response: (i) susceptible, systematic
mosaic on inoculated and new leaves (ii) highly resistant, no symptoms appeared on 
both inoculated and new leaves, and (iii) delayed susceptibility. Three susceptible 
plants (NbRepml-2-3, NbRepml-2-11 and NbRepml-4-10) started to show disease 
symptoms after seven days. Seven plants were fully resistant, no CMV symptom 
appeared in inoculated leaves or new leaves four weeks after inoculation. Twelve 
plants showed intermediate responses in which disease symptoms appeared in the 
inoculated leaves, but there was no visual symptoms on newly emerging leaves after 
two weeks, however they did show some disease symptoms in the new leaves after 
four weeks. 
The virus challenge results were confirmed by ELISA assays. The plants NbRepml .2-
5, NbRepml.2-7, NbRepml.2-8, NbRepml.2-10, NbRepml.4-1, NbRepml.4-3 and 
NbRepml.4-11, which exhibited no CMV symptoms, were ELISA negative both on 
the inoculated and newly emerging leaves two weeks pi. All of the susceptible plants 
showed ELISA positive results both for the inoculated and newly emerged leaves 
(Table 5.7). 
Repm2 construct (antisense mutated CMV Rep gene construct) 
The responses of 12 Repm2 PCR positive transgenic T 1 plants to CMV-LY infection 
fitted into two categories: (i) highly susceptible - nine were highly susceptible to 
CMV-L Y infection. There was no difference in response to challenge between these
plants and those of untransformed controls; (ii) delayed susceptibility - three plants 
gave an intermediate response. Two weeks after inoculation, CMV symptoms were 
present only in the inoculated leaves, but one of the three plants showed systemic 
CMV symptoms at three weeks and another one showed symptom at four weeks pi. 
The ELISA results of all of the nine CMV susceptible plants were positive for the 
inoculated and newly emerged leaves. NbRepm2. l-2, NbRepm2.1-5 and NbRepm2. l-
9, which showed the delayed susceptibility, only gave ELISA positive results for the 




Table 5.7 Absorbance readings (A4os) from EUSA assays tb detect CMV in 
transgenic N. benthamiana plants (Repml and Repm2 genes) and non-transgenic 
control at two weeks pi. A standard concentration of CMV particles was not used so 
values are relative to controls. A.figure of at least.five times that of the non-inoculated 
control (i.e. 0.045) was considered to be positive for the presence of CMV. One leaf 
each was sampled from an inoculated (i) leaf and one newly (n) emerged leaf 
Plant No ELISA. assay Plant No ELISA assay Plant No ELISA assay 
Repml-2-1 (n) 0.032 - Repml.4-1 (n) 0.010 - Repm2. l-l (n) 0.245 + 
Repml.2-1 (i) 0.126 + Repml.4-1 (i) 0.016 - Repm2.l-l (i) 0.144 + 
Repml.2-2 (n) 0.014 - Repml.4-2 (n) 0,035 - Repm2. l-2 (n) 0.016 -
Repml.2-2 (i) 0.178 + Repml.4-2 (i) 0.158 + Repm2.l-2 (i) 0.215 + 
Repml.2-3 (n) 0.204 + Repml.4-3 (n) 0.012 - Repm2.l-3 (n) 0.050 + 
Repml.2-3 (i) 0.096 + Repml.4-3 (i) 0.015 - Repm2. l-3 (i) 0.156 + 
Repml.2-4 (n) 0,025 - Repml.4-4 (n) 0.011 - Repm2.l-4 (n) 0.112 + 
Repml.2-4 (i) 0.188 + Repml.4-4 (i) 0.134 + Repm2.l-4 (i) 0.174 + 
Repml .2-5 (n) 0.021 - Repml.4-5 (n) 0.016 - Repm2. l -5 (n) 0.014 -
Repml .2-5 (i) 0.044 - Repml.4-5 (i) 0.111 + Repm2. l-5 (i) 0.198 + 
Repml .2-6(n) 0,011 - Repml.4-6 (n) 0.020 - Repm2. l -6(n) 0.147 + 
Repml-2-6 (i) 0.101 + Repml.4-6 (i) 0.144 + Repm2.l -6 (i) 0.167 + 
Repml.2-7(n) 0.012 - Repml.4-7 (n) 0.014 - Repm2.l-7(n) 0.084 + 
Repml.2-7 (i) 0.020 - Repml.4-7 (i) 0.156 + Repm2.l-7 (i) 0.133 + 
Repml.2-8 (n) 0.009 - Repml.4-8 (n) 0.012 - Repm2. l -8 (n) 0.206 + 
Repml.2-8 (i) 0.014 - Repml.4-8 (i) 0.178 + Repm2. l-8 (i) 0.143 + 
Repml .2-9 (n) 0,015 - Repml.4-9 (n) 0.036 - Repm2. l-9 (n) 0.011 -
Repml.2-9 (i) 0.124 + Repml.4-9 (i) 0.216 + Repm2.1-9 (i) 0.165 + 
Repml.2-10 (n) 0.016 - Repml.4-10 (n) 0.220 + Repm2.l-10 (n) 0.114 + 
Repml.2-10 (i) 0.014 - Repml.4-10 (i) 0.168 + Repm2.1-l 0 (i) 0.167 + 
Repml.2-11 (n) 0.182 + Repml.4-11 (n) 0,015 - Repm2. l -l l (n) 0.178 + 
Repml.2-11 (i) 0.137 + Repml.4-11 (i) 0.024 - Repm2. l-l 1 (i) 0.216 + 
Repm2.l-12 (n) 0.115 + 
Repm2.l-12 (i) 0.215 + 
Inoculated 0.118 .. 0.118 0.118 
Control 0.146 0.146 0.146 
uninoculated 0.008 0.008 0.008 
control 0.010 0.010 0.010 
MPl construct 
The responses of 11 MP PCR positive transgenic T1 plants to CMV-LY infection were 
classified into three categories: (i) susceptible - eight of eleven were highly susceptible 
to CMV-LY infection. The development of CMV symptoms on new leaves was faster 
than that on untransformed control plants during the first two weeks of pi; (ii) recovery 
- one of twelve transgenic plants (NbMPl.1-7 and NbMPl.1-11) showed the recovery
phenotype to CMV-L Y infection. Although the CMV symptoms were seen on newly 
emerging leaves, and virus particles were detected by ELISA, two weeks after 
inoculation, the plants were healthy at four weeks of pi; (iii) partial resistance - one of 
twelve plants (NbMPl.1-7) showed delayed symptoms on new leaves. Light mosaic 
symptoms were seen at three weeks pi. The ELISA assays results are given in Table 
5.8. 
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Table 5.8 Absorbance readings (A4os) from EUSA assays to detect CMV in 
transgenic N. benthamiana plants (MPl and MPSl genes) and non-transgenic 
control at two weeks pi.. A standard concentration of CMV particles was not used so 
values are relative to controls. A.figure of at least.five times that of the non-inoculated 
control (i.e. 0.055) was considered to be positive for the presence of CMV. One leaf 
each was sampled from an inoculated (i) leaf and one newly (n) emerged leaf 
Plant No ELISA assay Plant No ELISA assay 
MPl.1-1 (n) 0.314 + MPSI.3-l(n) 0.287 + 
MPl.1-1 (i) 0.246 + MPSI.3-1 (i) 0.178 + 
MPI.l-2 (n) 0.306 + MPS l .3-2(n) 0.123 + 
MPI.1-2 (i) 0.219 + MPS 1.3-2 (i) 0.200 + 
MPl.1-3 (n) 0.036 - MPS 1.3-3(n) 0.253 + 
MPI.1-3 (i) 0.189 + MPS 1.3-3 (i) 0.162 + 
MPI.1-4 (n) 0.254 + MPS l .3-4(n) 0.01 I -
MPI.1-4 (i) 0.168 + MPS 1.3-4 (i) 0.036 -
MPI.1-5 (n) 0.315 + MPS1.3-5(n) 0.024 -
MPl.1-5 (i) 0.231 + MPS 1.3-5 (i) 0.149 + 
MPI.1-6 (n) 0.342 + MPS l.3-6(n) 0.308 + 
MPI.1-6 (i) 0.158 + MPS 1.3-6 (i) 0.215 + 
MPI.1-7 (n) 0.094 + MPSI.3-7(n) 0.214 + 
MPI.1-7 (i) 0.143 + MPSl.3-7 (i) 0.166 + 
MPI.1-8 (n) 0.216 + MPS l .3-8(n) 0.024 -
MPI.1-8 (i) 0.162 + MPS 1.3-8 (i) 0.120 + 
MPI.1-14 (n) 0.206 + MPS l .3-9(n) 0.214 + 
MPI.1-14 (i) 0.241 + MPS 1.3-9 (i) 0.156 + 
MPI.1-10 (n) 0.322 + MPSl.3-10 (n) 0.045 -
MPI.1-10 (i) 0.197 + MPSl.3-IO(i) 0.122 + 
MPI.1-11 (n) 0.013 - MPSl.3-11 (n) 0.077 + 
--
MPI.1-11 (i) 0.178 + MPSl.3-11 (i) 0.136 + 
Inoculated 0.320 0.320 
Control 0.258 0.258 
uninoculated 0.012 0.012 
control 0.010 0.010 
MPSl construct (sense MPS gene) 
The responses of eleven MPS PCR positive transgenic T1 plants, which contained a 
sense MPS gene, to CMV-L Y infection also fitted into three different categories: (i) 
susceptible - seven of eleven were highly susceptible to CMV-LY infection. The 
symptoms were seen in these plants one week after inoculation; (ii) highly resistance -
one of eleven plants (NbMPSl.3-4) was immune to CMV-LY infection, in which no 
CMV symptoms appeared in either inoculated leaves or new leaves up to four weeks 
pi. This was confirmed by negative ELISA results carried out at two weeks pi; (iii) 
partial resistance - three of eleven plants (NbMPS 1.3-8 and NbMPS 1.3-10) had 
delayed symptoms on new leaves. ELISA assays from new leaves were negative at 
two weeks pi, but CMV symptoms were seen three weeks after inoculation. 
CPl-1 constructs (CPl sense construct) 
In general, transgenic N. benthaniana plants with CMV-LY CPl-1 constructs 
challenged with CMV-L Y fell into two phenotypic classes: (i) susceptible plants -
which showed symptoms one week after virus inoculation; (ii) recovery plants - which 
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initially showed symptoms but, then developed symptomless leaves that were virus 
free. All of the nine CP 1-1 plants showed CMV symptoms two weeks pi, but the 
percentage of infected plants in the first week was lower than those plants containing 
Repm2 or MPl gene (data not shown). In the next three weeks symptom development 
in CPl-1 plants was still slower than in the transgenic plants containing Repm2 or 
MPl gene. Although all of the plants were ELISA positive at two weeks pi, two plants 
were ELISA negative at four weeks pi (data not shown) and these plants were 
symptomless. 
Table 5.9 Absorbance readings (A4os) from ELISA assays to detect CMV in 
transgenic N. benthamiana plants (CPJ-1, CP3-3 and CP4-2 genes) and non­
transgenic control at two weeks pi. A standard concentration of CMV particles was 
not used so values are relative to controls. A figure of at least five times that of the 
non-inoculated control (i.e. 0.055) was considered to be positive for the presence of 
CMV. One leaf each was sampled from an inoculated (i) leaf and one newly (n)
emerged leaf
Plant No ELISA assay Plant No ELISA assay Plant No ELISA assay 
CPI.1.1-1 (n) 0.136 + CP3.l.3-1 (n) 0.265 + CP4. l.2-1 (n) 0.012 -
CPI.1.1-1 (i) 0.167 + CP3.l.3-1 (i) 0.137 + CP4.1.2-1 (i) 0.143 + 
CPI.1.1-2 (n) 0.276 + CP3. l.3-2 (n) 0.204 + CP4.l.2-2 (n) 0.254 + 
CPI.1.1-2 (i) 0.210 + CP3.l.3-2 (i) 0.178 + CP4.1.2-2 (i) 0.176 + 
CPI.1.1-3 (n) 0.114 + CP3.l.3-3 (n) 0.012 - CP4.l.2-3 (n) 0.214 + 
CPI.1.1-3 (i) 0.218 + CP3.l.3-3 (i) 0.124 + CP4.l.2-3 (i) 0.225 + 
CPI.1.1-4 (n) 0.167 + CP3.l.3-4 (n) 0.254 + CP4.1.2-4 (n) 0.014 -
CPI.1.1-4 (i) 0.148 + CP3.l.3-4 (i) 0.165 + CP4.l.2-4 (i) 0.156 + 
CPI.1.1-5 (n) 0.206 + CP3.l.3-5 (n) 0.230 + CP4.l.2-5 (n) 0.272 + 
CPI.1.1-5 (i) 0.159 + CP3.l.3-5 (i) 0.147 + CP4.1.2-5 (i) 0.258 + 
CPI.1.1-6 (n) 0.144 + CP3.l.3-6 (n) 0.011 + CP4.l.2-6 (n) 0.305 + 
CPl.1.1-6 (i) 0.162 + CP3.l.3-6 (i) 0.120 + CP4.1.2-6 (i) 0.297 + 
CPl.1.1-7 (n) 0.161 + CP3.l.3-7 (n) 0.214 + CP4.l.2-7 (n) 0.016 -
CPl.1.1-7 (i) 0.143 + CP3.l.3-7 (i) 0.169 + CP4.1.2-7 (i) 0.178 + 
CPl.1.1-8 (n) 0.122 + CP3.l.3-8 (n) 0.238 + CP4.l.2-8 (n) 0.011 -
CPI.1.1-8 (i) 0.183 + CP3.l.3-8 (i) 0.142 + CP4.l.2-8 (i) 0.014 -
CPl.1.1-9 (n) 0.092 + CP3.l.3-9 (n) 0.012 - CP4. l .2-9 (n) 0.Q15 -
CPI.1.1-9 (i) 0.124 + CP3.l.3-9 (i) 0.110 + CP4.1.2-9 (i) 0.120 + 
CP3.l.3-10 (n) 0.254 + 
CP3.l.3-10 (i) 0.132 + 
CP3.l.3-11 (n) 0.017 -
CP3.l.3-11 (i) 0.126 + 
CP3.l.3-12 (n) 0.224 + 
CP3.l.3-12 (i) 0.169 + 
CP3.l.3-13 (n) 0.305 + 
CP3.l.3-13 (i) 0.216 + 
CP3.l.3-14 (n) 0.251 + 
CP3.l.3-14 (i) 0.207 + 
Inoculated 0.214 0.318 0.214 
Control 0.186 0.186 0.186 
Uninoculated 0.008 0.008 0.008 
Control 0.013 0.013 0.013 
(Note: the level of expression of coat protein in uninoculated CP transgenic plants 
appeared to be relatively low. Expression of transgenic CP was not detected by 





The responses of fourteen CP3-1-3 PCR positive transgenic T 1 plants, which contained 
a sense CP3 gene, to CMV-L Y infection fitted into three different categories: (i) 
susceptibe; (ii) partial resistant and (iii) recovery. Eleven of fourteen plants showed 
CMV symptoms two weeks after CMV inoculation, but CMV symptoms were seen on 
three plants (CP3.1.3-3, CP3.1.3-9 and CP3.1.3-11) four weeks pi. Simultaneously, 
another two plants (CP3.1.3-2 and CP3.l.3-6) which showed symptoms at two weeks 
showed the recovery phenotype, no CMV symptoms were present on new leaves in 
these two plants, and ELISA assays were negative (data not show). 
CP4-1 construct (CP4 sense construct) 
The responses of nine CP4-1-2 PCR positive transgenic T 1 plants with a sense CP4 
gene, to CMV-L Y infection fitted into three different categories: (i) susceptible; (ii) 
partial resistant and (iii) highly resistance. 
Four of nine plants were susceptible to CMV-L Y infection, they showed symptoms 
one week pi. Another four plants had good tolerance to CMV-L Y infection, they gave 
negative ELISA results on the new leaves at two weeks pi. One plant was immune to 
CMV-LY, with no symptom four weeks pi and negative ELISA assays.
A summary of the different categories of results obtained from virus challenge of the 
transgenic lines with the different transgenes is given in Table 5.10. 





















Delay Recovery Susceptible 
12 3 
3 9 
2 1 8 
3 7 
2 7 




5.5 Transformation of narrow-leafed lupin with CMV resistance 
constructs 
5.5.1 Summary of current results - SABC 
A total of 12,500 explants of narrow-leafed lupin (cv. Kalya) were cocultivated with 
A. tumefaciens cultures containing the construct p YRRepml and 5,134 explants were
cocultivated with A. tumefaciens cultures containing the construct p YRMPS 1 (Plate 
5.2) Most explants died within four weeks of transfer to regeneration medium 
containing phosphinothricin (PPT) (20 mg/1). 
In addition, many transformants which did not die on selection medium, were lost 
because of overgrowth of A. tumefaciens on the medium. The 201 independent T 0
transformation events were selected for grafting onto non-transgenic rootstocks and 79 
plants survived for transfer to the glasshouse (Table 5.11). The narrow-leafed lupin 
transformation work was done by Ms Liu Li at the SABC, Murdoch University. There 
were no obvious morphological differences between the transgenic plants and the 
untransformed control plants. Some lines were lost due to fungal contamination in the 
glasshouse. 
Table 5.11 Summary of the narrow-leafed lupin transformation - SABC
Repml MPSl Total 
No. of explants 12,500 5,134 17,634 
No of shoots grafted 141 60 201 
No. of grafts planted 51 28 79 
in 2lasshouse 








4 5 6 
(d)
Plate 5.2 Transformation of narrow-leafed lupin (SABC, Murdoch University). 
(a) Transformed explants are selected on medium containing 20 mg/1 Basta,
untransformed shoots die.
(b) Transformed shoots in the rooting medium containing 20 mg/1 Basta.
( c) Transgenic plants growing in hydroponic solution in PC2 glasshouse.
( d) Five TO transgenic Repm plants analysed by PCR. Lane 1, 1 kb marker; lane 2,
plasmid positive control; lanes 3-7, transgenic plants showing the expected band.
PCR of DNA extracted using the Nucleon DNA Extraction kit (Amersham LIFE 
SCIENCE) with primers Rep3/Rep6 (Repm gene) and MP1/MP2 (MPS gene) 
indicated that the genes were present in 24 of the putative transgenic narrow-leafed 
plants (Table 5.11, Plate 5.2). 
171 
up the plant were selected for treatment. The PPT solution was painted onto the upper 
surfaces of leaves ( one leaflet per treatment) with a cotton bud until the entire surface 
was wet. Symptoms of damage due to PPT became apparent on leaves of non­
transgenic narrow-leafed lupin leaves within three days. Treated susceptible leaves 
initially became dull, then showed severe chlorosis, necrotic regions and leaf curling. 
Finally, necrotic leaves dried and fell off the plants. Symptoms were scored after 7 
days. All the TO plants that were PCR negative were susceptible to 50 and lOOmg/1 
PPT, but the PCR positive transgenic plants showed very good tolerance to PPT, no 
damage was apparent on the PPT treated leaves (data not shown). 
5.5.2 Summary of current results - CLIMA 
CMV resistance constructs (pYRRepml, pYRMPl, pARTRepml and pARTMPSl) 
were introduced into narrow-leafed lupin (c.v. Merrit) and faba bean using 
Agrobacterium-mediated transformation by Ms Simone Chapple (CLIMA, UW A). 
Preliminary results are given in Table 5.12. 
The putative transgenic shoots were rooted in rooting medium, and grown in the 
glasshouse to collect T 1 seeds for further analysis. The transformation experiment 
with pART vector, which contains the npt II marker gene, showed that kanamycin was 
not effective as a selectable gene. An alternative antibiotic, geneticin, was assessed as 
a selective agent in lupin transformation with the pART vector (Table 5.12). 
Table 5.12 Preliminary results of lupin transformation with CMV resistance 






























Weeks since No of healthy selection 
selection shoots 
12 8 Events Basta 
11 3 Events Basta 
10 5 Events Basta 
9 5 Events Basta 
3 0 Kanarnycin 
4 0 Kanarnycin 
4 0 Kanarnycin 
4 34 Kanarnycin 
0 150 Geneticin 
0 139 Geneticin 








Plate 5.3 Transformation of narrow-leafed lupin and faba bean with CMV 
mutated Rep and MP genes at CLIMA. 
(a) Narrow-leafed lupin shoots transformed with CMV MP gene screened on
regeneration medium containing 20 mg/1 Basta ..
(b) Narrow-leafed lupin shoots transformed with mutated CMV Rep gene selected on
the regeneration medium containing 20 mg/I Basta.
( c) and ( d) faba bean explants transformed with CMV MP gene selected on the
regeneration medium containing 20 mg/I Basta.
171 
I 1 I I 
5.6 Discussion 
5.6.1 Efficacy of CMV resistance-mediated by CMV-L Y transgenes 
5.6.1.1 Replicase gene-mediated resistance 
There have been many reports of resistance conferred in transgenic plants by the 
presence of viral replicase genes of RNA viruses (Table 1.2). Previously, Anderson et 
al. (1992) transformed tobacco lines with a truncated cDNA clone of CMV-Fny RNA 
2. A 94-bp deletion in the "polymerase active site" (GDD) resulted in a frameshift and
generated a truncated reading frame encoding 75-kDa protein compared with a 96-kDa 
wild-type protein. Analysis of the resistant tobacco lines revealed that the resistance 
was effective against strains of CMV (sg lA) following either mechanical inoculation 
with viral RNA or aphid transmission (Zaitlin et al., 1994). These results were 
supported by work done in our laboratory using transgenic tobacco seeds obtained 
from Dr Zaitlin for screening WA CMV isolates (Singh et al., 1998). However, the 
results from this research showed that resistance was only effective against CMV sg I 
isolates and did not provide protection against CMV sg II isolates e.g. CMV-L Y. 
Preliminary results from this study indicate that transgenic N. benthaniana plants 
containing the Repml gene (defective CMV-LY ORF2a) provides resistance to CMV­
LY (Table 5.10). In twenty-two PCR positive T1 plants, 7 showed an immune 
phenotype, 12 gave partial resistance, and only 3 were susceptible to CMV-L Y 
infection. Because of limited time, CMV sg I isolates have not been used to challenge 
the transgenic N benthaniana plants, and so it is not known whether these plants will 
also be resistant to CMV sg I isolates. Only CMV sg II isolates have been detected 
from narrow-leafed lupin, based on analysis of 16 commercial seed samples belonging 
to seven cultivars from 12 different localities in WA (Wylie et al., 1993) so the Repml 
gene should confer resistance to CMV in transgenic lupins. Lupin transformation with 
the Repml construct is now being undertaken both at the SABC (Murdoch University) 
and CLIMA (UW A). 
The antisense version of a defective CMV-LY RNA 2 construct, Repm2, did not give 
good resistance in transgenic N benthaniana to CMV-LY. Only three of twelve T1 
plants gave partial resistance (or delayed symptoms), the other nine plants were 
susceptible. As discussed in Chapter 1, antisense transgenes are usually less efficient 
in conferring virus resistance. However, Waterhouse et al (1998) reported virus 
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resistance in transgenic plants could be induced by simultaneous expression of sense 
and antisense RNA based on post-transcriptional gene silencing. In order to 
investigate the CMV resistance induced by this approach, the susceptible N.
benthaniana plants containing sense Repm gene have been crossed with those 
containing Repm antisense gene. Hybrid seeds produced will be tested in the future to 
see if such a result holds in this case. 
5.6.1.2 Movement protein-mediated CMV resistance 
Transgenic T1 plants containing a CMV-LY MP sense gene (MPl) did not show good 
resistance to CMV-L Y (Table 5.10). Two of twelve plants showed partial resistance 
(delayed symptoms) and two of twelve showed the recovery phenotype. The 
development of disease symptoms in the susceptible plants was faster than that in other 
transgenic and nontransgenic plants. On the other hand, the MPS transgene 
(untranslatable CMV-LY MP gene) showed some resistance to CMV-LY (Table 5.10). 
One of eleven plants was highly resistant, and three of eleven plants gave partial 
resistance to CMV-LY. A similar phenomenon was observed by Gafny et al. (1992) 
and Cooper et al. (1995). When the MP was mutated in an infectious clone of TMV 
the local and long distance movement of the virus was limited (Gafny et al., 1992). 
Plants containing this mutant MP sequence of TMV also conferred varying levels of 
resistance to a number of viruses that are not members of the tobamovirus group, 
including tobacco rattle tobravirus, peanut chlorotic streak caulimovirus, tobacco 
ringspot nepovirus and limited levels of resistance to CMV (Cooper et al., 1995). 
Overall, it is suggested that the MPS of CMV transgene may be more likely to provide 
resistance than the wild-type MP, both to reduce risks of protein production and also 
the possible enhancement of plant susceptibility to normally non-pathogenic viruses. 
5.6.1.3 CP-mediated CMV resistance 
Three different versions of CMV-LY CP gene (CPl, CP3 and CP4) were transformed 
into N. benthamiana and the PCR putative T1 plants were challenged by CMV-LY. 
The level of resistance varied in the individual transgenic plants containing one of the 
three CP genes. Although a limited number of transgenic plants have been tested to 
date, in general it appears as though the plants containing CP4-1 confer more effective 
resistance to CMV than transgenic plants with either CPl-1 or CP3-1 (Table 5.10). To 
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our knowledge, this is the first test of CP-mediated resistance in which this mutated CP 
form (the ORF is 12 amino acids longer than the wide type) gives virus resistance. 
In summary, we have developed a series of transgenic plant lines that containing 
various forms of the CMV-LY transgene sequences. Seven transgenic plants with 
Repml and one each with MPSl and CP4-1, displayed high levels of resistance to 
CMV-LY.
The high level protection achieved by introducing these transgenes may represent an 
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Chapter 6 General Discussion 
6.1 Overview of this study 
The overall aim of this project was to develop constructs conferring resistance to CMV 
sg II based on CMV-L Y MP, CP and Rep genes, to test resistance to CMV conferred 
by the constructs in transgenic N. benthamiana and narrow-leafed lupin plants, and to 
gain some understanding of possible mechanisms underlying engineered CMV 
resistance in N. benthamiana plants. Towards achieving these aims, the following 
aspects have been achieved successfully: 
• Modification of two binary vectors (pYR2 and pART27/7-4) to facilitate transgene
expression in tobacco and grain legumes.
• Development of a range of molecular constructs incorporating various forms of
the CMV-L Y movement protein, coat protein and replicase genes for plant
transformation.
• Production of transformed N. benthamiana and lupins plants containing some of
these molecular constructs.
• Positive identification of transgenic plants.
• Evaluation and identification of CMV resistance in transgenic N. benthamiana
plants by challenging with CMV and confirmation of CMV replication by ELISA
assays.
In addition, the complete genomic nucleotide sequence of CMV-LY (RNA 1, 2 and 3) 
has been elucidated and compared with the published sequences of the other CMV 
strains. This information will aid understanding of the evolution of CMV-L Y and its 
relationship to other cucumoviruses. 
The results from this study will be applied towards production of CMV resistant grain 
legumes, including narrow-leafed lupin, pea, chickpea, faba bean and lentil. In 
addition, the information gained from this research will be applied to develop second 
generation synthetic genes conferring broad spectrum resistance to the two major viral 
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6.2 CMV resistance based on CMV-LY Rep MP and CP genes 
Analysis of transgenic N. benthamiana T 1 generation lines revealed that the mutated 
CMV-L Y Rep gene (sense Repm) conferred resistance to CMV-L Y infection in 7 out
of 22 plants fron two lines tested. This result is similar to that reported by Anderson et 
al (1992) for a defective Rep construct of sg I CMV. In contrast, for the full-length 
sense MP gene (MPl) and the truncated CP gene (sense CPl) only 1 out of 16 plants 
of 1 line each tested conferred high CMV resistance. At face value the MP-based 
constructs appear less efficient at conferring CMV resistance. However it cannot be 
concluded that these transgenes will not be of practical value, because of the small 
number of lines tested. For the full-length CP gene (CP3) and CP4 only 1 out of 16 
lines each tested was CMV resistant. Similarly, further investigation of transgenic 
lines of these constructs is required to reach a firm conclusion in their practical 
usefulness. Previous studies, for example, by Mueller et al. (1995), have shown that it 
is important to test many of independent transformants before ruling out the possibility 
that resistance is not given by a particular construct. The number of independent 
transformants that showed CMV resistance may relate to the mechanism that underlies 
the different types of viral trans gene-mediated resistance. 
6.3 The Repm construct and the CMV-LY 2b gene 
The CMV ORF2b gene was identified relatively recently and its function is of 
considerable interest. The 2b protein is essential for long distance virus movement 
(Ding S.W. et al., 1994, 1995). Brignti et al. (19980) and Li et al. (1999) showed that 
the 2b protein, a viral pathogenicity determinant, prevents initiation of gene silencing 
in N. benthamiana. As described in Chapter 3 and 4, the CMV-LY mutated replicase 
(Repm) gene used in this study contained the ORF2b gene sequence (CMV-L Y RNA 
2, 2412-2714 nt). If correctly expressed, there are significant implication in transgenic 
plants. At least four phenomena might occur could be apparent in transgenic Repm 
plants. First, if the 2b gene was fully expressed, it might suppress resistance based on 
gene silencing. Second, if the 2b gene in transgenic Repm plants is silenced, no 2b 
protein will be produced, and transgenic plants may show resistance to CMV. Third, if 
the 2b gene is not express correctly because of the truncated 3' end, the 2b protein will 
not be functional, and transgenic Repm plants will also be resistant to CMV. Finally, 
if CMV resistance derived from the Repm gene is based on expression of the truncated 
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2a protein instead of the PTGS, the resistance should not be affected by the 2b gene 
whether it is expressed or not. For practical purposes, although the Repm construct 
includes the 2b gene sequence, challenge of transgenic plants with CMV, does result in 
production of resistant plants. 
6.4 Comparison of CMV-L Y RNA 1, 2 and 3 genomic sequences with 
the other published sequences of CMV 
Computer assisted comparisions of CMV-LY RNA 1-3 sequences indicate that the LY 
isolate shares 70-78% and 98-99% homology to other_ sg I and II isolates at the 
nucleotide level, respectively. Similarly, ORFla shares 84-85% and 99% amino acid 
identity, ORF2a 81-84% and 94-96% identity, ORF2b 46-56% and 95-96% identity, 
ORF3a 82-84% and 99% identity, and ORF3b 81-83% and 99% identity. The 
sequence data therefore clearly show that there is a high degree of nucleotide and 
amino acid sequence homology between the CMV-LY isolate and other CMV sg II 
strains. This further confirms that the LY isolate belongs to CMV sg II. 
6.5 CMV isolates in legume crops 
CMV that infects narrow-leafed lupins in Western Australia has been investigated in 
detail at the practical level by Dr Roger Jones in Agriculture Western Australia (Jones 
et al., 1988) and by Wylie et al. (1993) and Singh et al. (1998) at the molecular level. 
Only CMV-sg II strains were detected in narrow-leafed lupin, although CMV sg I 
isolates do occur in the same areas on subterranean clover and banana (Singh et al., 
1998). This result contrasts with that of Daniels and Campbell (1992), who concluded 
that CMV infecting legumes is sg I, based on CMV isolates collected from soybean in 
California, USA. Thus both CMV sg I and II strains can infect different legumes, but 
only CMV sg II strains have been detected in narrow-leafed lupin. 
6.6 Intellectual property issues 
Intellectual property (IP) is now a serious issue for the commercial application of plant 
genetic engineering technologies. Novel approaches developed in this area are 
effectively inventions and are therefore eligible for patent protection. For example, 
patents have already been issued for many isolated genes, promoters, and techniques 
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in Genetic Technology News). The patent rights of 35S-bar-ocs3' cassette used in this 
research are owned by AgrEvo, and the rights to the nos- npt Il-nos3' cassette are 
owned by Lubrizol, Mosanto. In the case of the 35S-bar-ocs3' cassette, which was 
used as a selectable marker in the CMV resistance constructs (p YR series) to transform 
narrow-leafed lupins, AgrEvo has not been willing to negotiate commercial access, 
thus use of the bar gene as a selectable marker in legume transformation experiments 
is no longer desirable (Barton et al., 1999). In order to deal with the IP issue of the 
bar gene, two alternative approaches have been considered. First, to assess alternative 
selectable agents for legume transformation experiments. Based on results from this 
work the bar gene will be replaced by a different selectable marker gene. Currently, 
Barton et al. (1999) reported that hygromycin strongly inhibits shoots growth of 
narrow-leafed lupins, peas, chickpeas, lentils and faba beans at concentrations in the 
medium of 50 mg/I, but paromomycin (150 mg/1) and kanamycin (400 mg/I) were not 
effective, although some bleaching can occur. Dr G. Dwyer (SABC, Murdoch 
University) is also undertaking the development of new binary vector with hygromycin 
selectable marker gene. Second, to remove the selectable marker gene (bar) after gene 
transformation is complete and it is no longer required for selection. This approach 
will simplify the IP issues associated with release of transgenic legumes and speed the 
path of some lines through the regulatory bodies. Thus, where the selectable marker 
gene would create problems for release it could be removed and the use of the gene of 
interest would not be lost. This research will also allow us to look at methods where 
selectable marker genes are removed and new genes inserted, for example, where there 
is a need for different herbicide resistances. 
6. 7 Risk assessment issues for transgenic plants
A challenge in planning to release genetically modified crop plants from contained, 
small-scale trails into general agriculture production is to identify whether these may 
pose risks to the environment, agriculture and human health. Many genetically 
engineered crop plants have a number of features in common. For example, the 
method for DNA insertion into dicotyledonous plants is usually Agrobacterium Ti­
plasmid mediated transformation. The result is the insertion of a piece of DNA into 
the plant genome. In addition, most transgenic plants contain and express a selectable 




current understanding of the safety of these common features of genetically engineered 
plants are discussed below. 
6.7.1 Use of Agrobacterium Ti-plasmid mediated transformation 
The most commonly used method for plant transformation is Agrobacterium Ti­
plasmid mediated transformation using Ti- or Ri-plasmids. As mentioned in Chapter 
5, the plasmids have usually been "disarmed" by removing the disease causing genes 
from the T-DNA. Historically, there has been concern about this method of plant 
transformation because it is based on the use of a known plant pathogen. However, 
general agreement has developed that there is negligible possiblity of the disarmed 
vector system acting as a plant pest or mediating further transfer of DNA from the 
transformed plant (Huttner et al., 1992). These authors have made a complete 
compilation of the substantial arguments that the use of A. tumefaciens Ti-plasmid for 
the gene transfer process is safe and does not itself present any risk to the environment, 
agriculture or human health. 
6. 7 .2 Use of selectable markers
The inclusion of selectable marker genes in the transferred DNA is common to most 
transgenic plants. These genes are usually antibiotic or herbicide resistance genes and 
they are included on the DNA fragment being transferred into plant cells so selection 
can be applied for the growth of transformed cells. The presence of these genes also 
helps confirm the transgenic nature of regenerated plants or subsequent progeny and 
will serve as ready tags to identify plants as transgenic. 
The most widely used selectable marker in transgenic plants is the gene npt II which 
confers resistance to the neomycin/kanamycin group of antibiotics. The safety of the 
npt II gene for use in crop plants was reviewed by Flavell et al. (1992). The questions 
they addressed were: whether the npt II gene product is toxic; whether eating the npt TI 
protein will affect antibiotic therapy; whether spread of the npt II gene from plants to 
bacteria will affect antibiotic therapy; and whether release of the npt II gene from 
plants into the environment could cause damage. In addition, Fuchs et al. (1993) 
tested the safety of the npt II protein for human or animal consumption. They studied 








rodent feeding studies. These experiments supported the assertion that the npt II gene 
is safe for widespread use. 
In addition, other selectable marker genes besides npt II also are used in plant genetic 
engineering, e.g. genes conferring tolerance to hygromycin B, methotrexate and 
gentamicin; or herbicides such as PPT, which was used in lupin transformation in this 
study. Before these other genes are considered to be safe to the environment and to 
human health, similar questions to those examined for the npt II gene need to be 
addressed. Experience from widespread consumption of 'Roundup Ready' (glypho­
sate tolerant) and 'Liberty Link' (glufosinate tolerant) products in food in north 
America indicates that there are no health risks to humans from consumption of these 
gene products. 
6.8 Recombination in plants expressing viral transgenes 
When transgenic viral resistance plants are generated, this also provides the 
opportunity for RNA recombination. Several reports indicate that viral transgene 
transcripts are available to a challenging virus for recombination (Lommel and Xiong 
1991; Gal et al., 1992; Schoelz and Wintermanel, 1993). Allison et al. (1996), using 
cowpea chlorotic mottle (CCMV) virus as a model, revealed that modification of the 
transgene significantly reduced the recovery of viable recombinants from transgenic 
plants. Based on these results, the authors suggested several ways to avoid 
recombination events involving the viral transgene by designing transgenes. These 
include: ( 1) exclude sequences known or predicted to be replication complex initiation 
sites, since this would reduce recombination significantly, (2) the trans gene should be 
the smallest viral fragments that provide useful resistance. Larger fragments provide 
not only larger recombination targets but they are more likely to encode functional 
modules that could be incorporated into another virus as a single unit. (3) select 
transgenic plants that provide the maximum resistance with the minimal amount of 
transgene expression. The fewer the transcripts, the less likely they are to be involved 
in recombination. 
In order to minimize the possibility of recombination in plants expressing CMV 
transgenes, all of the four CP gene constructs developed in this study were not 
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CP3). The constructs based on CMV-L Y Rep gene also did not include the full length 
of the 3' UTR. 
6.9 Public acceptance of genetic modified (GM) crops 
Agricultural biotechnology is making rapid progress. In additon to increasing 
fundamental understanding of plant biology, transgenic plants are being introduced 
commercially. Since 1987, the Animal and Plant Health Inspection Service of USA 
(APIDS) has approved or acknowledged 3,176 field trials in 48 different crop species 
(URL:www.aphis.usda.gov/bbep/bp/news1etter.htm1). The number of field trials continues 
roughly to double each year. The first commercial transgenic virus resistant crop in 
the marketplace was based on virus CP mediated resistance (Tricoli et al., 1995). 
Asgrow is selling squash with this type of resistance. So far, probably the most 
successful example of applying the virus CP gene strategy commercially is in 
controlling PRSV in papaya in Hawaii. From May 1998 transgenic papaya has been 
licensed for commercial growth and distribution to Hawaii papaya growers (D. Gross, 
APS net Feature,Sep. 1998 URL: http://www.scisoc.org/feature/papaya/top.html). So far this 
resistance has held up, and the future of the papaya industry in Hiwaii is very much 
dependent on these transgenic plants. 
Although transgenic maize, soybean, canola and cotton are widely grown in north 
America, for various reasons the response to GM crops and produce in Europe has met 
considerable consumer resistance. In general, those involved with the science or who 
support technology support GM produce. However, without consumer consent, the 
impact of this technology will be reduced or delayed. Scientific honesty seems to be 
the best policy to convince people about the advantages of biotechnology for crop 
improvement (Frewer et al., 1998). Scientists, farmers, consumers and policy-makers 
should objectively assess any potential hazards of GM crops in farming and food 
systems and assess any possible risks. Scientists should take part in the public debate 
and explain the technologies involved. For engineering resistance to viruses, the main 
question is centred on the ecological success of viable transgene to virus recombinants 
after gene reassortment. This cannot be predicted because current isolates are highly 
selected and well adapted, and the possibility of recombination between viruses in 
nature. It is therefore necessary to undertake to identify and assess possible risks. 
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6.10 Future work 
Because of time limitations it was not possible to complete all the aspects undertaken 
in this project. Some aspects of future work to be carried out are indicated here. 
6.10.1 Molecular analysis and glasshouse screening of CMV 
resistance constructs in transgenic N. benthamiana
Completion of work on constructs and screening will include: (1) testing all of the 
binary plasmids developed in this project in transgenic N. benthamiana, (2) 
determining the heritability and stability of CMV resistance and PPT/kanamycin 
tolerance in plants transformed with these constructs, (3) further tests to determining 
whether the basis for resistance is at the protein or RNA levels, and (4) whether the 
resistance conferred by introducing the CMV-L Y resistance genes in N. benthaniana 
will be seen in narrow-leafed lupins. To understand more about pathogen-derived 
resistance, other CMV isolates, and related and unrelated viruses should be used to 
challenge the transgenic plants. 
6.10.2 Transformation of narrow-leafed lupin with CMV resistant 
constructs 
The most effective CMV resistance genes will be transformed into advanced lupin 
cultivars/lines, to analyse the effectiveness in conferring resistance to CMV, and to 
identify prime CMV-resistant genotypes that can be provided to lupin breeders at 
Agriculture Western Australia. 
6.10.3 Designing second generation of molecular constructs for virus 
resistance in lupins 
Recent advances in fundamental understanding of engineered virus resistance using 
pathogen-derived genes will be applied to produce second generation synthetic 
resistance genes conferring broad-spectrum resistance to the two major viral pathogens 
of lupins (BYMV and CMV). 
PTGS appears to be the most common mechanism that underlies virus resistance in 




constructs should contain both sense and antisense viral sequences, for example, of 
both CMV Rep gene, BYMV Nib gene. 
Taking into account IP consideration, pyramided constructs, which combine sequences 
from both BYMV and CMV, will be chosen to provide broad-spectrum resistance to 
the two main viruses of lupins 
6. 11 Conclusions
In conclusion, most of the aims of this project have been achieved. A range of binary 
constructs containing synthetic CMV resistance genes have been developed and are 
available for transforming into the genomes of grain legumes (lupins, faba beans, peas 
and chickpea). Further analysis of transgenic N. benthamiana plants generated from 
this study may assist in confirming the mechanisms of virus resistance and other 
aspects of gene silencing. The results of this study contribute to the overall aim of 
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RNA Size Cbo) Orieinal from (countrv) SublD'OUD 
RNAl 3357 USA L 
RNA2 3050 USA I 
RNA3 2216 USA I 
RNAl 3389 Australia II 
RNA2 3035 Australia II 
RNA3 2197 Australia II 
RNAl 3358 Taiwan, China I 
RNA2 3042 Taiwan, China I 
RNA3 2214 Taiwan, China I 
RNAl 3361 Japan I 
RNA2 3051 Japan I 
RNA3 2215 Japan I 
RNAl 3359 Japan I 
RNA2 3047 Japan I 
RNA3 2213 Japan I 
RNA 1 3361 USA I 
RNA2 3060 USA I 
RNA3 2216 USA I 
RNAl 3379 China I 
RNA2 3048 China I 
RNA3 2219 China I 
RNA2 3049 Japan I 
RNA3 2217 Japan I 
RNA2 3049 Korea I 
RNA3 2225 Korea I 
RNA2 3039 Hungary II 
RNA3 2209 Hungary II 
RNA2 3048 China I 
RNA2 3048 Japan I 
RNA3 2199 UK II 
RNA3 2216 Israel I 
RNA3 2200 Japan I 
RNA3 2214 Japan I 
RNA3 2238 Japan I 
RNA4 1007 Japan I 
RNA3 2219 Japan I 
RNA3. 
� �·-
2215 Japan I 
RNA3 2218 Japan I 
RNA3 2215 USA I 
RNA3 2205 Taiwan, China I 
RNA3 2210 Japan I 
RNA3 2218 Japan I 
RNA3 2211 Japan I 
RNA2 3047 Korea I 
RNA3 2230 Korea I 
RNA4 1043 Korea I 
CP+flanks 1267 USA II 
RNA3 840 (3a) USA I 
CP 894 Korea I 
CP 835 USA I 
CP 841 USA I 
CP 834 USA I 
CP 1033 Australia I 
CP 957 Israel I 
RNA4 1041 Australia II 
CP 963 China I 
CP 880 India I 
CP 657 USA I 
CP 657 USA I 
CP 657 Japan I 
CP 657 Japan I 
CP 657 Japan I 
CP 757 Japan I 
RNA4 1007 France I 
CP 657 China I 
CP 657 China I 
CP 864 Colombia I 
CP 862 Colombia I 
CP 657 USA I 
CP 657 USA I 
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A .ppen IX . . 1ruses an d . I vira e:enes teste dfi CP or -me 1ate d . ta res1s nee 
Virus CPgene Transgenic Challenge Resistance Reference 
Genus Plant Virus/group Efficiency 
Alfamo- AlMV Tobacco AIMV/Alf Yes Loesch-Fries et al., 1987 
Tobacco AIMV Yes Turner et al., 1991 
Mut.AIMV Tobacco AlMV No Turner et al., 1991 
AIMV Tomato AIMV Yes Turner et al., 1991 
AIMV Tobacco AIMV Yes Halle et al., 1987 
AIMV Alfalfa AIMV Yes Hill et al., 1989 
Mut. AIMV Tobacco AIMV No van Dun et al., 1988 
AIMV Tobacco AIMV Yes Jayasena et al., 1997 
Carla- PMV Tobacco PMV Yes Edwards et al., 1997 
PVS Potato PVS Yes MacKenzie and Ellis 1992 
Como- BPMV Soybean BPMV Yes Di et al., 1996 
Cucumo- CMV-C Tobacco CMV-C Yes Cuozzo et al., 1988 
CMV-WL Tobacco CMV-WL Yes Namba et al., 1991 
CMV-Chi Yes 
CMV-C Yes' 
Tomato CMV-Fny Yes Xue et al., 1994 
CMV-WL Yes Fuchs et al., 1996 
CMV-O Tobacco CMV-O Yes Nakajima et al., 1993 
CMV-Y Yes 
CMMV /cucumo Yes 
Cucumber CMV-Y Yes Nishibayashi et al., 1996 
2YMV/Poty No 
CMV-Y Tobacco CMV-Y Yes Okuno et al., 1993 
CMV-IV Tomato CMV sub I & II Yes Murphy et al., 1998 
Tomato CMV sub I & II Yes Gielen et al., 1996 
CMV Melon CMV Yes Yoshioka et al., 1993 
Furo- BNYVV Sugarbeet BNYVV/Furo Yes Rubino et al., 1883 
Sugarbeet BNYVV Yes Mannerlof et al., 1996 
Ilar- TSV Tobacco TSV Yes van Dun et al., 1988 
PMTV Potato PMTV Yes Barker et al., 1998a 
-· 
Tobacco PMTV Yes Barker et al., 1998b 
Tobacco PMTV Yes Reavy et al., 1997 
Tobacco PMTV Yes Reavy et al., 1995 
Luteo- PLRV Potato PLRV Yes Kawchuk et al., 1990; 91 
Potato PLRV Yes van der Wille et al., 1991 
Potato PLRV Yes Barker et al., 1992 
Potato PLRV Yes Palucha et al., 1998 ~-
Potato PLRV Yes Barker et al., 1995 
Potato PLRV Yes Presting et al., 1995 
Nepo- GCMV Tobacco GCMV Yes Brault et al., 1993 
ArMV Tobacco ArMV Yes Bertioli et al., 1992 
TmoRSV Tobacco TmoRSV?Nepo Yes Yepes and Euch, 1996 
GFLV Tobacco GFLV Yes Bardomnet et al., 1994 
ArMV No 
Potex- PVX Tobacco PVX Yes Hemenway et al., 1988 
Potato PVX Yes Hoekema et al., 1989 
Potato PVX Yes Lawson et al., 1990 
Potato PVX Yes Feher et al., 1992 
Potato Yes Xu et al., 1995 
PAMV Tobacco PAMV Yes Leclerc et al., 1995 
Poty- PVY Potato PVY Yes Stark & Beachy, 1989 
Potato PVY Yes Sokolova et al., 1995 
SMV Tobacco SMV/Poty Yes Rabinowicz et al., 1998 
PVY Yes 
TEV/Poty Yes 
PRV Papaya PRV/Poty Yes Fitch et al., 1992 
PRV Yes Llus et al., 1997 






Plum PRV Yes Scorza et al., 199S 
PPV Tobacco PPV Yes Regner et al., 1992 
Tobacco PPV Yes Jacquet et al., 1998 
Plum PPV Yes Ravelonandro et al., 1997 
PStV Tobacco PStV Yes Cassidy and Nelson, 199S 
PWV Tobacco PWV Yes Yeh and Chu, 1996 
TEV Tobacco TEV Yes Lindbo et al., 1992 
MDMV Sweet corn MDMV Yes Murry et al., 1993 
MCMV Yes 
ZVMV Muskmelon ZVMV/Poty Yes Fang and Grumet, 1993 
LMV Potato PVY-O Yes Hassairi et al., 1998 
Lettuce LMV-O Yes Dinant et al., 1997 
VNV Tobacco VNV Yes Wang et al., 1997 
PVYN Tobacco PVYN/Poty Yes McDonald et al., 1997 
PVY-O Yes 
Potato PVY-136 Yes 
PVY-O Yes Okamoto et al., 1996 
PVYN Yes 
Tobamo- TMV Tobacco TMV/fobamo Yes Powell-Abel et al., 1986 






Tomato TMV Yes Nelson et al., 1987 
ToMV Yes 
ToMV Tomato ToMV Yes Sanders et al., 1992 
PMMV PMMV Yes Llm et al., 1997 
Tobra- TRV Tobacco TRV-TCM Yes van Dun et al., 1987 
TRV-PLB No van Dun et al., 1988 
PEBV/fobra Yes 
TRV No Ploeg, 1993 
Tombus- CyRSV Tobacco CvRSV /fombus Yes Rubino etal., 1993 
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